About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
1348 genotypes with 1849 annotations displayed of selected term and subterms
Searched Term: autoimmune response
Allelic Composition
(Genetic Background)		 Annotated Term Reference
\1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(NOD.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/Jdk) 		decreased susceptibility to autoimmune diabetes J:137009
\AA467197em1Nyam/\AA467197em1Nyam
(C.B6-AA467197em1Nyam) 		increased susceptibility to autoimmune disorder J:347271
\Abattm1c(EUCOMM)Hmgu/\Abattm1c(EUCOMM)Hmgu
\Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * DBA/2) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:333883
\Acantm2Afos/\Acantm2Afos
(involves: C57BL/6) 		decreased susceptibility to induced arthritis J:122102
\Ackr4tm1.1Rjbn/\Ackr4tm1.1Rjbn
(B6.129S6-Ackr4tm1.1Rjbn) 		increased susceptibility to experimental autoimmune encephalomyelitis J:166490
\Acla1BXSB/Slc/\Acla1BXSB/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
\Acla1NZW/Slc/\Acla1BXSB/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
\Acla2BXSB/Slc/\Acla2BXSB/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
\Acla2NZW/Slc/\Acla2BXSB/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
\Actbtm4(cre/ERT2)Npa/\Actb+
\Sgpl1tm1.1Npa/\Sgpl1tm1.1Npa
(involves: BALB/cJ * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:199525
\Adam8tm1.1Mdz/\Adam8tm1.1Mdz
(DBA/1LacJ-Adam8tm1.1Mdz) 		decreased susceptibility to induced arthritis J:155243
\Adamts5tm1.1Eam/\Adamts5+
(involves: 129S5/SvEvBrd) 		decreased susceptibility to induced arthritis J:97590
\Adamts5tm1.1Eam/\Adamts5tm1.1Eam
(involves: 129S5/SvEvBrd) 		decreased susceptibility to induced arthritis J:97590
\Adamts5tm2.2Lex/\Adamts5tm2.2Lex
(B6.129S5-Adamts5tm2.2Lex) 		decreased susceptibility to induced arthritis J:175366
\Adaz1NZM2328/J/\Adaz1NZM2328/J
(involves: C57L/J * NZM2328/J) 		increased anti-double stranded DNA antibody level J:71397
\Adgrd1tm1b(EUCOMM)Wtsi/\Adgrd1tm1b(EUCOMM)Wtsi
(C57BL/6N-Adgrd1tm1b(EUCOMM)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
\Ads1NZB/\Ads1NZB
(involves: NZB * NZW) 		increased anti-double stranded DNA antibody level J:7239, J:7111
increased susceptibility to autoimmune disorder J:7111
\Ads1NZB/\Ads1NZW
(involves: NZB * NZW) 		increased anti-double stranded DNA antibody level J:7111
increased susceptibility to autoimmune disorder J:7111
\Ads2NZB/\Ads2NZB
(involves: NZB * NZW) 		increased anti-double stranded DNA antibody level J:7111
increased susceptibility to autoimmune disorder J:7111
\Ads2NZB/\Ads2NZW
(involves: NZB * NZW) 		increased anti-double stranded DNA antibody level J:7111
increased susceptibility to autoimmune disorder J:7111
\Ads3NZB/\Ads3NZW
(involves: NZB * NZW) 		increased susceptibility to autoimmune disorder J:7111
\Ads3NZW/\Ads3NZW
(involves: NZB * NZW) 		increased anti-double stranded DNA antibody level J:7239
increased susceptibility to autoimmune disorder J:7111
\Ads4NZB/\Ads4NZB
(involves: NZB * NZW) 		decreased anti-double stranded DNA antibody level J:11074
\Ads4NZB/\Ads4NZW
(involves: NZB * NZW) 		increased susceptibility to autoimmune disorder J:7111
\Ads4NZW/\Ads4NZW
(involves: NZB * NZW) 		increased susceptibility to autoimmune disorder J:7111
\Aec1NOD/Uf/\Aec1NOD/Uf
\Aec2NOD/Uf/\Aec2NOD/Uf
(B6.NOD-Aec2NOD/Uf Aec1NOD/Uf) 		increased anti-nuclear antigen antibody level J:129282
increased susceptibility to autoimmune disorder J:128900
\Aem1C57BL/6/\Aem1NZB
(involves: C57BL/6 * NZB) 		decreased autoantibody level J:7191
\Aem2C57BL/6/\Aem2C57BL/6
(involves: C57BL/6 * NZB) 		decreased autoantibody level J:59427
\Aem2C57BL/6/\Aem2NZB
(involves: C57BL/6 * NZB) 		decreased autoantibody level J:59427
\Aem2C57BL/6/\Aem2NZB
\Aem3C57BL/6/\Aem3NZB
(involves: C57BL/6 * NZB) 		decreased autoantibody level J:59427
\Agnm1MRL/MpJ/\Agnm1MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		increased susceptibility to systemic lupus erythematosus J:97786
\Agnm2C3H/HeJ/\Agnm2MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		increased susceptibility to systemic lupus erythematosus J:97786
\Agnm2MRL/MpJ/\Agnm2MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		increased susceptibility to systemic lupus erythematosus J:97786
\Agnm3C3H/HeJ/\Agnm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		increased susceptibility to systemic lupus erythematosus J:97786
\Agnm3MRL/MpJ/\Agnm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		increased susceptibility to systemic lupus erythematosus J:97786
\Aia1NZB/Omr/\Aia1NZB/Omr
(involves: NZB/Omr * NZC/Omr) 		increased susceptibility to autoimmune hemolytic anemia J:6517
\Aia1NZB/Omr/\Aia1NZC/Omr
(involves: NZB/Omr * NZC/Omr) 		increased susceptibility to autoimmune hemolytic anemia J:6517
\Aif1tm1Nsib/\Aif1tm1Nsib
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to induced arthritis J:204462
\Aim2tm1.2Arte/\Aim2tm1.2Arte
\Dnase2atm1Osa/\Dnase2atm1Osa
\Ifnar1tm1Agt/\Ifnar1tm1Agt
(involves: 129 * BALB/c * C57BL/6 * C57BL/6J) 		increased autoantibody level J:238323
rheumatoid arthritis J:238323
\Airetm1.1Doi/\Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6) 		increased autoantibody level J:119475
increased susceptibility to autoimmune disorder J:83422
\Airetm1.1Doi/\Airetm1.1Doi
(B6.129S2-Airetm1.1Doi/Doi) 		increased autoantibody level J:107432
\Airetm1.1Doi/\Airetm1.1Doi
(NOD.129S2(B6)-Airetm1.1Doi/Doi) 		increased autoantibody level J:107432
\Airetm1.1Doi/\Airetm1.1Doi
(C.129S2-Airetm1.1Doi/Doi) 		increased autoantibody level J:107432
\Airetm1.1Doi/\Airetm1.1Doi
(SJL.129S2-Airetm1.1Doi/Doi) 		increased autoantibody level J:107432
\Airetm1Mand/\Aire+
(NOD.129P2-Airetm1Mand) 		increased autoantibody level J:188686
increased susceptibility to autoimmune diabetes J:135154, J:188686
\Airetm1Mmat/\Airetm1Mmat
(involves: C57BL/6 * CBA) 		autoimmune response J:96580
\Airetm1Mmat/\Airetm1Mmat
(C.Cg-Airetm1Mmat) 		increased autoantibody level J:96580
\Airetm1Mmat/\Airetm1Mmat
(B6.Cg-Airetm1Mmat) 		autoimmune response J:96580
\Airetm1Mmat/\Airetm2Mmat
(involves: C57BL/6 * CBA) 		autoimmune response J:141379
\Airetm1Pltn/\Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6) 		increased autoantibody level J:77873
\Airetm1Ptsn/\Airetm1Ptsn
(C57BL/6-Airetm1Ptsn) 		increased autoantibody level J:145910
\Airetm1Ptsn/\Airetm1Ptsn
(C.B6-Airetm1Ptsn) 		increased susceptibility to autoimmune disorder J:174653
\Airetm2Mmat/\Airetm2Mmat
(involves: C57BL/6 * CBA) 		autoimmune response J:141379
\Alox5tm1Fun/\Alox5tm1Fun
(B6.129S2-Alox5tm1Fun/J) 		decreased susceptibility to experimental autoimmune uveoretinitis J:108446
\Alox5aptm1Jdm/\Alox5ap+
(DBA/1LacJ-Alox5aptm1Jdm) 		decreased susceptibility to induced arthritis J:100736
\Alox5aptm1Jdm/\Alox5aptm1Jdm
(DBA/1LacJ-Alox5aptm1Jdm) 		decreased susceptibility to induced arthritis J:100736
\anan/\anan
(involves: C57BL/6 * C57BL/10Sg * C57BR/c) 		increased anti-nuclear antigen antibody level J:169366
\anan/\anan+
(involves: C57BL/6 * C57BL/10Sg * C57BR/c) 		increased anti-nuclear antigen antibody level J:169366
\anaya/\anaya
(involves: C57BL/6 * C57BL/10Sg * C57BR/c) 		increased anti-nuclear antigen antibody level J:169366
\andra/\andra
(involves: C57BL/6 * C57BL/10Sg * C57BR/c) 		increased anti-nuclear antigen antibody level J:169366
\Anta/\Anta+
(involves: C57BL/6 * C57BL/10 * C57BR/cd) 		increased anti-nuclear antigen antibody level J:169366
\Apcstm1Mpe/\Apcs+
(B6.Cg-Apcstm1Mpe) 		increased autoantibody level J:90502
\Apcstm1Mpe/\Apcstm1Mpe
(B6.Cg-Apcstm1Mpe) 		increased autoantibody level J:90502
\Apcstm1Smae/\Apcstm1Smae
(involves: 129S/SvEv * C57BL/6) 		increased autoantibody level J:71194
\Apoetm1Unc/\Apoetm1Unc
(B6.129P2-Apoetm1Unc/J) 		increased anti-double stranded DNA antibody level J:133606
increased anti-nuclear antigen antibody level J:133606
increased autoantibody level J:133606
increased susceptibility to systemic lupus erythematosus J:133606
\Apoetm1Unc/\Apoetm1Unc
(B6.Cg-Apoetm1Unc Faslpr) 		increased anti-double stranded DNA antibody level J:133606
increased anti-nuclear antigen antibody level J:133606
increased susceptibility to systemic lupus erythematosus J:133606
\Apoetm1Unc/\Apoetm1Unc
\Faslpr/\Faslpr
(MRL.Cg-Apoetm1Unc Faslpr) 		increased anti-double stranded DNA antibody level J:133606
increased anti-nuclear antigen antibody level J:133606
increased autoantibody level J:133606
increased susceptibility to systemic lupus erythematosus J:133606
\Apoetm1Unc/\Apoetm1Unc
\Faslpr/\Faslpr
(B6.Cg-Apoetm1Unc Faslpr) 		decreased autoantibody level J:121671
increased anti-double stranded DNA antibody level J:121671
increased autoantibody level J:121671
\Apoetm1Unc/\Apoetm1Unc
\Faslgld/\Faslgld
(B6.Cg-Faslgld Apoetm1Unc) 		increased anti-nuclear antigen antibody level J:200141, J:91058
increased autoantibody level J:91058
\Arfgap2tm1c(EUCOMM)Hmgu/\Arfgap2tm1c(EUCOMM)Hmgu
\Sting1em1Jmin/\Sting1em1Jmin
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(Not Specified) 		decreased susceptibility to autoimmune disorder J:363611
\Arid5atm1Rnis/\Arid5atm1Rnis
(B6.Cg-Arid5atm1Rnis) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:197418
\Arigg1NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
\Arigg2NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
\Arigg3NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
\Arigg4NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
\Arigg5NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
\Arigg6NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
\Arigg7NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
\Arigg8BALB/cByJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
\Arigg9NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
\Arigg10BALB/cByJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
\Art2atm1Fkn/\Art2atm1Fkn
\Art2btm1Fkn/\Art2btm1Fkn
\Cd38tm1Lnd/\Cd38tm1Lnd
(NOD.129(B6)-Cd38tm1Lnd Art2atm1Fkn Art2btm1Fkn/Lt) 		decreased susceptibility to autoimmune diabetes J:108097
\asa/\asa
(either: A/J or BALB/c or DBA/2J) 		increased autoantibody level J:2843
\Asbb1BALB/c/\Asbb1BALB/c
(involves: BALB/c * C57BL/6J) 		increased susceptibility to systemic lupus erythematosus J:76486
\Asbb2BALB/c/\Asbb2C57BL/6J
(involves: BALB/c * C57BL/6J) 		increased susceptibility to systemic lupus erythematosus J:76486
\Asbb2C57BL/6J/\Asbb2C57BL/6J
(involves: BALB/c * C57BL/6J) 		increased susceptibility to systemic lupus erythematosus J:76486
\Asbb3C57BL/6J/\Asbb3C57BL/6J
(involves: BALB/c * C57BL/6J) 		increased susceptibility to systemic lupus erythematosus J:76486
\Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/\Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
(B6.FVB-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu) 		increased autoantibody level J:208213
increased susceptibility to autoimmune disorder J:208213
increased susceptibility to induced arthritis J:208213
\Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/\Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
\Il6tm1Kopf/\Il6tm1Kopf
(B6.Cg-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu Il6tm1Kopf) 		increased susceptibility to induced arthritis J:208213
\Atg5tm1Myok/\Atg5tm1Myok
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv) 		increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
\Atg7tm1Tchi/\Atg7tm1Tchi
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj) 		increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
\Atxn3tm1a(KOMP)Wtsi/\Atxn3tm1a(KOMP)Wtsi
(C57BL/6N-Atxn3tm1a(KOMP)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
\Aviltm2(cre)Fawa/\Aviltm2(cre)Fawa
(B6J.129P2-Aviltm2(cre)Fawa) 		increased susceptibility to experimental autoimmune encephalomyelitis J:265529
\Axltm1Grl/\Axltm1Grl
\Mertktm1Grl/\Mertktm1Grl
(involves: C57BL/6J) 		increased anti-double stranded DNA antibody level J:70420
\Axltm1Grl/\Axltm1Grl
\Mertktm1Grl/\Mertktm1Grl
\Tyro3tm1Grl/\Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal susceptibility to autoimmune disorder J:70420
increased anti-double stranded DNA antibody level J:70420
increased autoantibody level J:70420
\Axltm1Grl/\Axltm1Grl
\Tyro3tm1Grl/\Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased anti-double stranded DNA antibody level J:70420
\B2mtm1Unc/\B2mtm1Unc
(NOD.129P2-B2mtm1Unc) 		decreased susceptibility to autoimmune diabetes J:121685, J:17000
\B2mtm1Unc/\B2mtm1Unc
(B6.129P2-B2mtm1Unc/DcrJ) 		decreased susceptibility to autoimmune diabetes J:135214
\B2mtm1Unc/\B2mtm1Unc
\Ciitatm1Ccum/\Ciitatm1Ccum
(NOD.Cg-B2mtm1Unc Ciitatm1Ccum) 		decreased susceptibility to autoimmune diabetes J:107051
\B2mtm1Unc/\B2mtm1Unc
\Emv30b/\Emv30b
\Prkdcscid/\Prkdcscid
\Tg(B2M)55Hpl/?
\Mcph1Tg(HLA-A2.1)1Enge/?
(NOD.Cg-B2mtm1Unc Mcph1Tg(HLA-A2.1)1Enge Emv30b Prkdcscid Tg(B2M)55Hpl/Dvs) 		decreased susceptibility to autoimmune diabetes J:109851
\B2mtm1Unc/\B2mtm1Unc
\Tg(B2M)55Hpl/0
(NOD.Cg-B2mtm1Unc Tg(B2M)55Hpl/Dvs) 		decreased susceptibility to autoimmune diabetes J:71837
\B2mtm1Unc/\B2mtm1Unc
\Tg(B2M)55Hpl/\Tg(B2M)55Hpl
\Mcph1Tg(HLA-A2.1)1Enge/\Mcph1Tg(HLA-A2.1)1Enge
(NOD.Cg-B2mtm1Unc Mcph1Tg(HLA-A2.1)1Enge Tg(B2M)55Hpl) 		increased susceptibility to autoimmune diabetes J:109851
\B2mtm1Unc/\B2mtm1Unc
\Tg(GFAP-B2m)9Mdos/?
(involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ) 		decreased susceptibility to autoimmune diabetes J:135214
\B2mtm1Unc/\B2mtm1Unc
\Tg(GFAP-B2m)#Mdos/?
(involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ) 		decreased susceptibility to autoimmune diabetes J:135214
\B2mtm1Unc/\B2mtm1Unc
\Tg(HLA-A/H2-D/B2M)1Dvs/0
(NOD.Cg-B2mtm1Unc Tg(HLA-A/H2-D/B2M)1Dvs) 		increased susceptibility to autoimmune diabetes J:121685
\B2mtm1Unc/\B2mtm1Unc
\Tg(TcraAI4)1Dvs/0
\Tg(TcrbAI4)1Dvs/0
(NOD.Cg-B2mtm1Unc Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs) 		decreased susceptibility to autoimmune diabetes J:93553
\B2mtm1Unc/\B2mtm1Unc
X/\Yaa
(BXSB.129P2(B6)-B2mtm1Unc/Dcr) 		increased anti-nuclear antigen antibody level J:179430
increased susceptibility to systemic lupus erythematosus J:179430
\B9d2/Tgfb1tm1Flv/\Tgfb1tm2Flv
\Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:123547
increased anti-double stranded DNA antibody level J:123547
increased anti-nuclear antigen antibody level J:123547
\B9d2/Tgfb1tm1Flv/\Tgfb1tm2Flv
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:169839
\B9d2/Tgfb1tm1Flv/\B9d2+
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:169839
\Bak1tm1Thsn/\Bak1tm1Thsn
\Baxtm1Sjk/\Baxtm2Sjk
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased anti-double stranded DNA antibody level J:100463
increased susceptibility to autoimmune disorder J:100463
\Batftm1.1Kmm/\Batftm1.1Kmm
(129S6/SvEvTac-Batftm1.1Kmm) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:150643
\Bcl2l1tm1Cant/\Bcl2l1tm1Cant
(involves: 129S6/SvEvTac) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:77507
\Bcl2l11tm1.1Ast/\Bcl2l11+
(involves: 129S1/Sv * C57BL/6) 		increased susceptibility to autoimmune disorder J:58641
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6) 		increased anti-double stranded DNA antibody level J:132217
increased anti-histone antibody level J:132217
increased anti-nuclear antigen antibody level J:132217
increased anti-single stranded DNA antibody level J:132217
increased autoantibody level J:132217
increased susceptibility to autoimmune disorder J:58641
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Faslpr/\Faslpr
(B6.Cg-Bcl2l11tm1.1Ast Faslpr) 		increased anti-double stranded DNA antibody level J:132217
increased anti-histone antibody level J:132217
increased anti-nuclear antigen antibody level J:132217
increased anti-single stranded DNA antibody level J:132217
increased autoantibody level J:132217
increased susceptibility to autoimmune disorder J:132217
\Becn1tm1.1Bflu/\Becn1tm1.1Bflu
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:203090
\Becn1tm1Ebr/\Becn1tm1Ebr
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd) 		increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
\Bhlhe40tm1Tan/\Bhlhe40tm1Tan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		abnormal susceptibility to autoimmune disorder J:72651
increased anti-nuclear antigen antibody level J:72651
\Blnktm1Dkit/\Blnktm1Dkit
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:94297
\Bmxtm1Ali/\Bmxtm1Ali
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to induced arthritis J:173099
\Bsgtm1Tmu/\Bsgtm1Tmu
(involves: 129S2/SvPas) 		increased susceptibility to systemic lupus erythematosus J:287636
\Btkxid/?
\Ptpn6me/\Ptpn6me
(involves: C57BL/6J * CBA/N * NFS) 		increased autoantibody level J:30994
\Btkxid/\Btkxid
(CBA/CaHN-Btkxid/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:92639
\Btkxid/\Btkxid
(CBA/HN-Btkxid) 		autoimmune response J:125114
\Btlatm1Kmm/\Btlatm1Kmm
(involves: 129S/SvEv) 		increased susceptibility to experimental autoimmune encephalomyelitis J:84084
\Btn2a2tm1.2Wrth/\Btn2a2tm1.2Wrth
(C57BL/6-Btn2a2tm1.2Wrth) 		increased anti-nuclear antigen antibody level J:232636
increased susceptibility to experimental autoimmune encephalomyelitis J:232636
\Bxs6BXSB/MpJ/\Bxs6BXSB/MpJ
(involves: BXSB/MpJ * C57BL/10ScSnOlaHsd) 		autoimmune response J:145903
increased autoantibody level J:145903
\Bxs6BXSB/MpJ/\Bxs6BXSB/MpJ
(B10.BXSB-(D13Mit3-D13Mit78)) 		autoimmune response J:145049
increased anti-double stranded DNA antibody level J:145049
increased anti-single stranded DNA antibody level J:145049
increased autoantibody level J:145049
\Bxs6BXSB/MpJ/\Bxs6BXSB/MpJ
\Gpab1C57BL/6J/?
(involves: BXSB/MpJ * C57BL/10ScSnOlaHsd) 		autoimmune response J:145903
increased autoantibody level J:145903
\Bxs6BXSB/MpJ/\Bxs6BXSB/MpJ
X/\Yaa
(B10.BXSB-(D13Mit3-D13Mit78) Yaa) 		autoimmune response J:145049
increased anti-double stranded DNA antibody level J:145049
increased anti-single stranded DNA antibody level J:145049
increased autoantibody level J:145049
\C1qatm1Mjw/\C1qatm1Mjw
(involves: 129P2/Ola * 129S/SvEv * C57BL/6) 		increased anti-histone antibody level J:47315
increased anti-nuclear antigen antibody level J:47315
\C1qatm1Mjw/\C1qatm1Mjw
\Sle16129S6/SvEvTac/\Sle16129S6/SvEvTac
(involves: 129S/SvEv * 129X1/Sv * C57BL/6) 		increased anti-chromatin antibody level J:118645
increased anti-double stranded DNA antibody level J:118645
increased anti-nuclear antigen antibody level J:118645
increased anti-single stranded DNA antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
\C1qatm1Mjw/\C1qatm1Mjw
\Sle16129S6/SvEvTac/\Sle16C57BL/6
(involves: 129S/SvEv * 129X1/Sv * C57BL/6) 		increased anti-chromatin antibody level J:118645
increased anti-double stranded DNA antibody level J:118645
increased anti-nuclear antigen antibody level J:118645
increased anti-single stranded DNA antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
\C1qatm1Mjw/\C1qatm1Mjw
\Sle18C57BL/6/\Sle18C57BL/6
(involves: 129S/SvEv * 129X1/Sv * C57BL/6) 		increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
\C1qatm1Mjw/\C1qatm1Mjw
\Sle18C57BL/6/\Sle18C57BL/6
(involves: 129P2/Ola * 129S/SvEv * C57BL/6) 		increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
\C1qatm1Mjw/\C1qatm1Mjw
\Sle19C57BL/6/?
(involves: 129S/SvEv * 129X1/Sv * C57BL/6) 		increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
\C1qatm1Mjw/\C1qatm1Mjw
\Sle19C57BL/6/?
(involves: 129P2/Ola * 129S/SvEv * C57BL/6) 		increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
\C1qatm1Mjw/\C1qatm1Mjw
\Sle21129P2/Ola/?
\Sle18C57BL/6/\Sle18C57BL/6
(involves: 129P2/Ola * 129S/SvEv * C57BL/6) 		increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
\C1qatm1Mjw/\C1qatm1Mjw
\Sle21129P2/Ola/\Sle21129P2/Ola
(involves: 129P2/Ola * 129S/SvEv * C57BL/6) 		increased anti-chromatin antibody level J:118645
increased anti-double stranded DNA antibody level J:118645
increased anti-nuclear antigen antibody level J:118645
increased anti-single stranded DNA antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
\C1qatm1Mjw/\C1qatm1Mjw
\Sle21129P2/Ola/\Sle21C57BL/6
(involves: 129P2/Ola * 129S/SvEv * C57BL/6) 		increased anti-chromatin antibody level J:118645
increased anti-double stranded DNA antibody level J:118645
increased anti-nuclear antigen antibody level J:118645
increased anti-single stranded DNA antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
\C1qtnf3tm1Yiw/\C1qtnf3tm1Yiw
(involves: C57BL/6NSlc) 		increased susceptibility to induced arthritis J:211893
\C1qtnf6tm1Yiw/\C1qtnf6tm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J) 		increased anti-nuclear antigen antibody level J:227217
increased autoantibody level J:227217
\C1qtnf6tm1Yiw/\C1qtnf6tm1Yiw
(B6.129P2-C1qtnf6tm1Yiw) 		increased susceptibility to experimental autoimmune encephalomyelitis J:227217
increased susceptibility to induced arthritis J:227217
\C3tm1Crr/\C3tm1Crr
(B6.129S4-C3tm1Crr) 		decreased susceptibility to autoimmune hemolytic anemia J:145432
\C3tm1Crr/\C3tm1Crr
\C4btm1Crr/\C4btm1Crr
\Faslpr/\Faslpr
(involves: 129S4/SvJae * C57BL/6 * MRL) 		increased anti-double stranded DNA antibody level J:127292
increased anti-nuclear antigen antibody level J:127292
\C3tm1Crr/\C3tm1Crr
\Faslpr/\Faslpr
(involves: 129S4/SvJae * C57BL/6 * MRL) 		decreased susceptibility to autoimmune disorder J:127292
\C3tm1Crr/\C3tm1Crr
\Fcer1gtm1Rav/\Fcer1gtm1Rav
\Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:122114
\C3tm1Crr/\C3tm1Crr
\Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:122114
\C3tm1Pkna/\C3tm1Pkna
(D1.129P2-C3tm1Pkna) 		decreased susceptibility to induced arthritis J:88872
\C3ar1tm1Raw/\C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:93791
\C4btm1Crr/\C4btm1Crr
(involves: 129S4/SvJae * C57BL/6J) 		increased anti-double stranded DNA antibody level J:111811
increased anti-nuclear antigen antibody level J:111811
increased anti-single stranded DNA antibody level J:111811
\C4btm1Crr/\C4btm1Crr
\Faslpr/\Faslpr
(involves: 129S4/SvJae * C57BL/6 * MRL) 		increased anti-double stranded DNA antibody level J:127292
increased anti-nuclear antigen antibody level J:127292
\C9orf72em1Eggn/\C9orf72em1Eggn
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:240357
\C9orf72tm1.1Eggn/\C9orf72+
(involves: C57BL/6 * C57BL/6N) 		increased autoantibody level J:240357
\C9orf72tm1.1Eggn/\C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N) 		increased anti-double stranded DNA antibody level J:240357
increased autoantibody level J:240357
increased susceptibility to autoimmune disorder J:240357
\C9orf72tm1Eggn/\C9orf72tm1Eggn
(involves: C57BL/6 * C57BL/6N) 		increased anti-double stranded DNA antibody level J:240357
increased susceptibility to autoimmune disorder J:240357
\Card19tm1Rwen/\Card19tm1Rwen
(involves: 129P2/OlaHsd * C57BL/6) 		decreased autoantibody level J:336763
\Casp1tm1Flv/\Casp1tm1Flv
\Casp4del/\Casp4del
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:57101
\Cblbtm1Hua/\Cblbtm1Hua
(B6.129P2-Cblbtm1Hua) 		increased susceptibility to experimental autoimmune encephalomyelitis J:94685
\Cblbtm1Hua/\Cblbtm1Hua
\Ubash3btm1Jni/\Ubash3btm1Jni
\Ubash3atm1Jni/\Ubash3atm1Jni
(Not Specified) 		increased susceptibility to experimental autoimmune encephalomyelitis J:89761
\Ccl2tm1Rol/\Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:68145
\Ccl2tm1Rol/\Ccl2tm1Rol
(SJL.129S4-Ccl2tm1Rol) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:68145
\Ccl4em1Narl/\Ccl4em1Narl
(C57BL/6JNarl-Ccl4em1Narl) 		decreased susceptibility to autoimmune diabetes J:346348
\Ccnt1Gt(RRR115)Byg/\Ccnt1Gt(RRR115)Byg
(involves: 129P2/OlaHsd) 		autoimmune response J:130071
\Ccr1tm1Cge/\Ccr1tm1Cge
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:63952
\Ccr2tm1Ifc/\Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:75838
\Ccr2tm2.1Ifc/\Ccr2tm2.1Ifc
\Cx3cr1tm1Litt/\Cx3cr1+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:166664
\Ccr2tm2.1Ifc/\Ccr2tm2.1Ifc
\Cx3cr1tm1Litt/\Cx3cr1tm1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:166664
\Ccr6tm1Lira/\Ccr6tm1Lira
(involves: 129 * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:148286
\Ccr7tm1Rfor/\Ccr7tm1Rfor
(B6.129P2-Ccr7tm1Rfor) 		increased susceptibility to autoimmune disorder J:110910
\Ccr8tm1Lira/\Ccr8tm1Lira
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:118417
\Cd1d1tm1Crw/\Cd1d1tm1Crw
(B6.129S4-Cd1d1tm1Crw) 		decreased susceptibility to induced arthritis J:99107
\Cd1d1tm1Luc/\Cd1d1tm1Luc
(B6.129S6-Cd1d1tm1Luc) 		autoimmune response J:122245
\Cd1d1tm1Luc/\Cd1d1tm1Luc
(C.129S6-Cd1d1tm1Luc) 		increased anti-double stranded DNA antibody level J:121187
increased anti-nuclear antigen antibody level J:121187
\Cd1d1tm1Luc/\Cd1d1tm1Luc
\Cx3cr1tm1Litt/\Cx3cr1tm1Litt
(B6.129-Cd1d1tm1Luc Cx3cr1tm1Litt) 		increased susceptibility to experimental autoimmune encephalomyelitis J:129712
\Cd4tm1(cre/ERT2)Thbu/\Cd4+
\Gfm1tm1c(EUCOMM)Wtsi/\Gfm1tm1c(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N * SJL) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:302272
\Cd4tm1Knw/\Cd4tm1Knw
(NOD.Cg-Cd4tm1Knw) 		decreased susceptibility to autoimmune diabetes J:93553
\Cd4tm1Knw/\Cd4tm1Knw
\Tg(TcraAI4)1Dvs/0
\Tg(TcrbAI4)1Dvs/0
(NOD.Cg-Cd4tm1Knw Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs) 		increased susceptibility to autoimmune diabetes J:93553
\Cd4tm1Mak/\Cd4tm1Mak
\Igh-Jtm2(3H9-VDJ*)Mwg/\Igh-J+
(B6.Cg-Cd4tm1Mak Igh-Jtm2(3H9-VDJ*)Mwg) 		increased anti-double stranded DNA antibody level J:142389
\Cd5tm1.1Chra/\Cd5tm1.1Chra
(involves: C57BL/6 * FVB/N) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:189919
\Cd5tm1Cgn/\Cd5tm1Cgn
(B6.129P2-Cd5tm1Cgn) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:189919
\Cd8atm1Mak/\Cd8atm1Mak
\Il15tm1Imx/\Il15tm1Imx
X/\Yaa
(BXSB.Cg-Cd8atm1Mak Il15tm1Imx/Dcr) 		increased anti-nuclear antigen antibody level J:179430
increased susceptibility to systemic lupus erythematosus J:179430
\Cd8atm1Mak/\Cd8atm1Mak
X/\Yaa
(BXSB.129S2(B6)-Cd8atm1Mak/4Dcr) 		increased susceptibility to systemic lupus erythematosus J:179430
\Cd19tm1(cre)Cgn/\Cd19+
\Ep300tm2Reck/\Ep300+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:147840
increased susceptibility to systemic lupus erythematosus J:147840
\Cd19tm1(cre)Cgn/\Cd19+
\Ep300tm2Reck/\Ep300+
(involves: 129/Sv * 129P2/OlaHsd * FVB/N) 		increased susceptibility to systemic lupus erythematosus J:147840
\Cd19tm1(cre)Cgn/\Cd19+
\Fastm1Ach/\Fastm1Ach
(involves: 129P2/OlaHsd * BALB/c) 		increased anti-nuclear antigen antibody level J:123556
\Cd19tm1(cre)Cgn/\Cd19+
\Fastm1Cgn/\Fastm1Cgn
(B6.Cg-Cd19tm1(cre)Cgn Fastm1Cgn) 		increased anti-single stranded DNA antibody level J:114948
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm2(Cd74/MOG)Awai/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:140751
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm2(Cd74/MOG)Awai/\Gt(ROSA)26Sor+
\Il10tm1Roer/\Il10tm1Roer
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:140751
\Cd19tm1(cre)Cgn/\Cd19+
\Ptpn6tm1Rsky/\Ptpn6tm1Rsky
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to systemic lupus erythematosus J:123568
\Cd19tm1(cre)Cgn/\Cd19+
\Tnfaip3tm1.1Awai/\Tnfaip3tm1.1Awai
(involves: 129P2/OlaHsd) 		increased anti-nuclear antigen antibody level J:175422
\Cd19tm1(cre)Cgn/\Cd19+
\Tnfaip3tm2Ama/\Tnfaip3+
(involves: 129P2/OlaHsd * C57BL/6) 		increased autoantibody level J:163917
increased susceptibility to autoimmune disorder J:163917
\Cd19tm1Tft/\Cd19tm1Tft
(B6.Cg-Cd19tm1Tft) 		decreased anti-double stranded DNA antibody level J:136210
decreased anti-nuclear antigen antibody level J:136210
increased susceptibility to experimental autoimmune encephalomyelitis J:106487
\Cd19tm1Tft/\Cd19tm1Tft
\Lyntm1Sor/\Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased anti-double stranded DNA antibody level J:71174
decreased susceptibility to systemic lupus erythematosus J:71174
\Cd22tm1Msn/\Cd22tm1Msn
(either: (involves: 129S/SvEv * BALB/c) or (involves: 129S/SvEv * C57BL/6J)) 		increased anti-double stranded DNA antibody level J:76974, J:76975
\Cd22tm2Lnit/\Cd22tm2Lnit
(involves: 129P2/OlaHsd * C57BL/6) 		autoimmune response J:198790
\Cd22tm3Lnit/\Cd22tm3Lnit
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		autoimmune response J:198790
\Cd28tm1Jmg/\Cd28tm1Jmg
(B6.129X1-Cd28tm1Jmg) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:149888
\Cd28tm1Ltu/\Cd28tm1Ltu
\Foxp3tm4(YFP/icre)Ayr/\Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to autoimmune disorder J:194503
increased susceptibility to experimental autoimmune encephalomyelitis J:194503
\Cd28tm1Mak/\Cd28tm1Mak
(NOD.129S2-Cd28tm1Mak) 		increased susceptibility to autoimmune diabetes J:93421
\Cd28tm1Mak/\Cd28tm1Mak
(involves: 129S2/SvPas * NOD) 		increased susceptibility to autoimmune diabetes J:35353
\Cd28tm1Mak/\Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:149888
\Cd28tm1Mak/\Cd28tm1Mak
(B6.129S2-Cd28tm1Mak/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:57613
\Cd28tm1Mak/\Cd28tm1Mak
\Cd40lgtm1Flv/\Cd40lgtm1Flv
(NOD.Cg-Cd40lgtm1Flv Cd28tm1Mak) 		increased susceptibility to autoimmune diabetes J:93421
\Cd28tm1Shr/\Cd28tm1Shr
\Ctla4tm1Shr/\Ctla4+
(C.129S4-Cd28tm1Shr Ctla4tm1Shr) 		increased susceptibility to autoimmune disorder J:125259
\Cd38tm1Lnd/\Cd38tm1Lnd
(NOD.129P2(B6)-Cd38tm1Lnd/LtJ) 		increased susceptibility to autoimmune diabetes J:108097
\Cd40tm1Kik/\Cd40tm1Kik
\Tg(Tnfsf13b)1Fma/?
(B6.Cg-Cd40tm1Kik Tg(Tnfsf13b)1Fma) 		increased anti-double stranded DNA antibody level J:113556
\Cd40lgtm1Flv/Y
\Faslpr/\Faslpr
(involves: 129P2/OlaHsd * 129S2/SvPas * MRL) 		decreased autoantibody level J:38492
\Cd40lgtm1Flv/Y
\Faslpr/\Faslpr
\Tcratm1Mjo/\Tcratm1Mjo
(involves: 129P2/OlaHsd * 129S2/SvPas * MRL) 		decreased autoantibody level J:38492
increased anti-double stranded DNA antibody level J:38492
\Cd40lgtm1Flv/\Cd40lgtm1Flv
(NOD.129S2-Cd40lgtm1Flv) 		decreased susceptibility to autoimmune diabetes J:93421
\Cd40lgtm1Flv/\Cd40lgtm1Flv
\Faslpr/\Faslpr
(involves: 129P2/OlaHsd * 129S2/SvPas * MRL) 		decreased autoantibody level J:38492
\Cd40lgtm1Flv/\Cd40lgtm1Flv
\Faslpr/\Faslpr
\Tcratm1Mjo/\Tcratm1Mjo
(involves: 129P2/OlaHsd * 129S2/SvPas * MRL) 		decreased autoantibody level J:38492
increased anti-double stranded DNA antibody level J:38492
\Cd44tm1.1Ugu/\Cd44tm1.1Ugu
(B6.129(Cg)-Cd44tm1.1Ugu) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:199279
\Cd44tm1.1Ugu/\Cd44tm1.1Ugu
(SJL.129(Cg)-Cd44tm1.1Ugu) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:199279
\Cd44tm1Mak/\Cd44tm1Mak
(D1.129P2-Cd44tm1Mak) 		increased susceptibility to induced arthritis J:95275
\Cd44tm2.1Ugu/\Cd44tm2.1Ugu
(B6.129-Cd44tm2.1Ugu) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:199279
\Cd44tm2Kmz/\Cd44tm2Kmz
(DBA/1LacJ-Cd44tm2Kmz) 		decreased susceptibility to induced arthritis J:74268
\Cd55tm1Mme/\Cd55tm1Mme
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to experimental autoimmune myasthenia gravis J:80116
\Cd55tm1Song/\Cd55tm1Song
(B6.129S6-Cd55tm1Song) 		increased susceptibility to experimental autoimmune myasthenia gravis J:113567
\Cd55tm1Song/\Cd55tm1Song
\Cd59atm1Bpm/\Cd59atm1Bpm
(B6.129-Cd55tm1Song Cd59atm1Bpm) 		increased susceptibility to experimental autoimmune myasthenia gravis J:113567
\Cd59atm1Bpm/\Cd59atm1Bpm
(involves: 129 * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:89014
\Cd59atm1Bpm/\Cd59atm1Bpm
(involves: 129) 		increased susceptibility to induced arthritis J:146711
\Cd59atm1Bpm/\Cd59atm1Bpm
(B6.129-Cd59atm1Bpm) 		increased susceptibility to experimental autoimmune myasthenia gravis J:113567
\Cd69tm1Naka/\Cd69tm1Naka
(C.129P2-Cd69tm1Naka) 		decreased susceptibility to induced arthritis J:84940
\Cd72b/\Cd72b
\Faslpr/\Faslpr
(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp) 		autoimmune response J:204782
decreased anti-double stranded DNA antibody level J:204782
decreased anti-nuclear antigen antibody level J:204782
decreased susceptibility to autoimmune disorder J:204782
\Cd72c/\Cd72c
\Faslpr/\Faslpr
(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp) 		autoimmune response J:204782
increased anti-chromatin antibody level J:204782
increased anti-double stranded DNA antibody level J:204782
increased anti-single stranded DNA antibody level J:204782
increased susceptibility to systemic lupus erythematosus J:204782
\Cd72tm1Tsub/\Cd72tm1Tsub
(involves: C57BL/6J) 		increased anti-chromatin antibody level J:204782
increased anti-double stranded DNA antibody level J:204782
increased anti-single stranded DNA antibody level J:204782
\Cd72tm1Tsub/\Cd72tm1Tsub
\Faslpr/\Faslpr
(involves: C57BL/6J * C57BL/6JJmsSlc * MRL/Mp) 		autoimmune response J:204782
increased anti-chromatin antibody level J:204782
increased anti-double stranded DNA antibody level J:204782
increased anti-single stranded DNA antibody level J:204782
\Cd74tm1Liz/\Cd74tm1Liz
(involves: 129S/SvEv * C57BL/6J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:72243
\Cd74tm1Liz/\Cd74tm1Liz
(B6.129S-Cd74tm1Liz) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:125654
\Cd74tm2Liz/\Cd74tm2Liz
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:72243
\Cd74tm3Liz/\Cd74tm3Liz
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:72243
\Cd79atm1(cre)Reth/\Cd79a+
\Inpp5dtm1Rav/\Inpp5dtm1Rav
(involves: 129 * BALB/c * C57BL/6) 		increased anti-chromatin antibody level J:178833
increased anti-double stranded DNA antibody level J:178833
increased anti-nuclear antigen antibody level J:178833
increased anti-single stranded DNA antibody level J:178833
increased autoantibody level J:178833
increased susceptibility to systemic lupus erythematosus J:178833
\Cd79atm1(cre)Reth/\Cd79a+
\Wastm1.1Ldn/Y
(involves: BALB/c * C57BL/6) 		increased anti-chromatin antibody level J:182528
increased anti-double stranded DNA antibody level J:182528
increased anti-single stranded DNA antibody level J:182528
increased autoantibody level J:182528
\Cd79atm1(cre)Reth/\Cd79a+
\Wastm1.1Ldn/\Wastm1.1Ldn
(involves: BALB/c * C57BL/6) 		increased anti-chromatin antibody level J:182528
increased anti-double stranded DNA antibody level J:182528
increased anti-single stranded DNA antibody level J:182528
increased autoantibody level J:182528
\Cd79atm1.1Rsky/\Cd79atm1.1Rsky
(involves: C57BL/6) 		increased anti-single stranded DNA antibody level J:179254
\Cd80tm1Shr/\Cd80tm1Shr
\Cd86tm1Shr/\Cd86tm1Shr
(B6.129S4-Cd80tm1Shr Cd86tm1Shr) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:57613
\Cd80tm1Shr/\Cd80tm1Shr
\Cd86tm2Shr/\Cd86tm2Shr
(involves: 129S4/SvJae) 		increased susceptibility to autoimmune diabetes J:113109
\Cd80tm1Shr/\Cd80tm1Shr
\Cd86tm2Shr/\Cd86tm2Shr
(involves: 129S4/SvJae * NOD) 		increased susceptibility to autoimmune diabetes J:61905
\Cd80tm1Shr/\Cd80tm1Shr
\Cd86tm2Shr/\Cd86tm2Shr
(129.SJL-Cd86tm2Shr) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:78992
increased susceptibility to experimental autoimmune encephalomyelitis J:78992
\Cd80tm1Shr/\Cd80tm1Shr
\Cd86tm2Shr/\Cd86tm2Shr
(involves: 129S4/SvJae * C57BL/6J * SJL) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:78992
\Cd80tm1Shr/\Cd80tm1Shr
\Cd86tm2Shr/\Cd86tm2Shr
\Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0
(involves: 129S4/SvJae * FVB/N * NOD) 		decreased susceptibility to autoimmune diabetes J:113109
\Cd86tm1Shr/\Cd86tm1Shr
(NOD.129S4-Cd86tm1Shr) 		decreased susceptibility to autoimmune diabetes J:71352
increased autoantibody level J:142046
increased susceptibility to autoimmune diabetes J:93421
\Cd180tm1Kmiy/\Cd180tm1Kmiy
\Faslpr/\Faslpr
(MRL.Cg-Cd180tm1Kmiy Faslpr) 		increased anti-nuclear antigen antibody level J:137066
increased autoantibody level J:137066
\Cd200tm1Jods/\Cd200tm1Jods
(C57BL/6-Cd200tm1Jods) 		increased susceptibility to experimental autoimmune encephalomyelitis J:65982
increased susceptibility to experimental autoimmune uveoretinitis J:79906
increased susceptibility to induced arthritis J:65982
\Cd247tm2.1Lov/\Cd247tm2.1Lov
(B6.Cg-Cd247tm2.1Lov) 		increased susceptibility to experimental autoimmune encephalomyelitis J:192915
\Cd274tm1.1Lex/\Cd274tm1.1Lex
(involves: 129S5/SvEvBrd) 		increased susceptibility to experimental autoimmune encephalomyelitis J:126829
\Cd274tm1Lpc/\Cd274tm1Lpc
(B6.129S-Cd274tm1Lpc) 		increased susceptibility to autoimmune disorder J:89781
\Cd274tm1Lpc/\Cd274tm1Lpc
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:142815
\Cd274tm1Lpc/\Cd274tm1Lpc
(C.129S-Cd274tm1Lpc) 		increased susceptibility to induced arthritis J:165841
\Cd274tm1Shr/\Cd274tm1Shr
(C.B6-Cd274tm1Shr) 		increased susceptibility to autoimmune diabetes J:123785
\Cd274tm1Shr/\Cd274tm1Shr
\Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6) 		increased susceptibility to autoimmune diabetes J:153040
\Cd276tm1Lpc/\Cd276tm1Lpc
(B6.129-Cd276tm1Lpc) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:237700
\Cd276tm1Lpc/\Cd276tm1Lpc
(D1J.129-Cd276tm1Lpc) 		decreased susceptibility to induced arthritis J:237700
\Cd276tm1Mak/\Cd276tm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-single stranded DNA antibody level J:84973
increased susceptibility to experimental autoimmune encephalomyelitis J:84973
\Cd300lftm1Gne/\Cd300lftm1Gne
(involves: C57BL/6N) 		increased susceptibility to experimental autoimmune encephalomyelitis J:156819
\Cdk2tm2Sgo/\Cdk2tm2Sgo
\Cdk4tm2.1Bbd/\Cdk4tm2.1Bbd
\Polr2atm1(cre/ERT2)Bbd/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased susceptibility to autoimmune diabetes J:125217
\Cdk4tm1Kiyo/\Cdk4+
\Lin9tm1Orc/\Lin9+
(involves: 129S1/Sv) 		decreased susceptibility to autoimmune diabetes J:111333
\Cdkn1atm1Led/\Cdkn1atm1Led
(involves: 129S6/SvEvTac) 		increased anti-double stranded DNA antibody level J:76041
increased anti-histone antibody level J:76041
increased anti-single stranded DNA antibody level J:76041
increased autoantibody level J:76041
\Cdkn1atm1Led/\Cdkn1atm1Led
\Gadd45atm1Ajf/\Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6)) 		increased anti-double stranded DNA antibody level J:76041
increased anti-histone antibody level J:76041
increased anti-single stranded DNA antibody level J:76041
increased autoantibody level J:76041
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
(B6;129S2-Cdkn1atm1Tyj/J) 		decreased susceptibility to induced arthritis J:108569
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased anti-double stranded DNA antibody level J:60292
increased anti-histone antibody level J:60292
increased anti-nuclear antigen antibody level J:60292
\Ceat1CBA/J/\Ceat1NOD
(involves: CBA/J * NOD-H2k) 		increased susceptibility to experimental autoimmune thyroiditis J:77545
\Ceat1NOD/\Ceat1NOD
(involves: CBA/J * NOD-H2k) 		increased susceptibility to experimental autoimmune thyroiditis J:77545
\Cfbtm1Pkna/\Cfbtm1Pkna
(D1.129P2-Cfbtm1Pkna) 		decreased susceptibility to induced arthritis J:88872
\Cfptm1Song/\Cfptm1Song
(involves: 129 * C57BL/6) 		decreased susceptibility to induced arthritis J:165497
\Cfptm2.1Song/\Cfptm2.1Song
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129 * 129P2/OlaHsd * C57BL/6 * SJL) 		decreased susceptibility to induced arthritis J:165497
\Cgnz1NZM2328/J/\Cgnz1NZM2328/J
(involves: C57L/J * NZM2328/J) 		increased susceptibility to systemic lupus erythematosus J:71397
\Chuktm2Mka/\Chuktm2Mka
\Tg(Tnfsf13b)1Fma/?
(B6.Cg-Chuktm2Mka Tg(Tnfsf13b)1Fma) 		increased anti-double stranded DNA antibody level J:113556
\Cia2DBA/1J/\Cia2DBA/1J
(involves: DBA/1J * FVB/N) 		increased susceptibility to induced arthritis J:116665
\Cia5bRIIIS/J/?
(involves: C57BL/10 * RIIIS/J) 		decreased susceptibility to induced arthritis J:101767
\Cia5bRIIIS/J/\Cia5bRIIIS/J
\Cia32B10.RIII/\Cia32RIIIS/J
(involves: C57BL/10 * RIIIS/J) 		decreased susceptibility to induced arthritis J:101767
\Cia5cRIIIS/J/?
(involves: C57BL/10 * RIIIS/J) 		decreased susceptibility to induced arthritis J:101767
\Cia7DBA/1J/\Cia7DBA/1J
(involves: B10.Q * DBA/1) 		increased susceptibility to induced arthritis J:122130
\Cia30RIIIS/J/\Cia30RIIIS/J
\Cia5B10.RIII/\Cia5B10.RIII
(involves: B10.RIII * RIIIS/J) 		decreased susceptibility to induced arthritis J:95848
\Cia31B10.RIII/\Cia31RIIIS/J
\Cia5RIIIS/J/\Cia5RIIIS/J
(involves: C57BL/10 * RIIIS/J) 		decreased susceptibility to induced arthritis J:101767
\Cia34DBA/1J/\Cia34DBA/1J
(involves: C57BL/10 * DBA/1J) 		decreased autoantibody level J:122130
decreased susceptibility to induced arthritis J:122130
\Cia35C57BL/10SnSg/\Cia35C57BL/10SnSg
\Cia42DBA/1J/\Cia42DBA/1J
(involves: B10.Q * DBA/1) 		decreased susceptibility to induced arthritis J:122130
\Cia35C57BL/10SnSg/\Cia35DBA/1J
(involves: C57BL/10 * DBA/1J) 		increased autoantibody level J:122130
increased susceptibility to induced arthritis J:122130
\Cia35C57BL/10SnSg/\Cia35DBA/1J
\Cia42DBA/1J/\Cia42DBA/1J
(involves: B10.Q * DBA/1) 		decreased susceptibility to induced arthritis J:122130
\Cia35DBA/1J/\Cia35DBA/1J
\Cia42DBA/1J/\Cia42DBA/1J
(involves: B10.Q * DBA/1) 		decreased susceptibility to induced arthritis J:122130
\Cia36DBA/1J/\Cia36DBA/1J
(involves: C57BL/10 * DBA/1J) 		decreased autoantibody level J:122130
decreased susceptibility to induced arthritis J:122130
\Cia37C57BL/10SnSg/\Cia37DBA/1J
(involves: C57BL/10 * DBA/1J) 		increased autoantibody level J:122130
increased susceptibility to induced arthritis J:122130
\Cia38DBA/1J/\Cia38DBA/1J
(involves: C57BL/10 * DBA/1J) 		increased autoantibody level J:122130
increased susceptibility to induced arthritis J:122130
\Cia39C57BL/10Sn/\Cia39C57BL/10Sn
(involves: B10.Q/Lund-H2q * B10.RIII/Lund-H2r) 		decreased susceptibility to induced arthritis J:97801
\Cia40C57BL/10SnSg/\Cia40C57BL/10SnSg
(involves: C57BL/10SnSg * DBA/1J * NFS/N) 		increased susceptibility to induced arthritis J:106522
\Cia43DBA/1J/\Cia43FVB/N
(involves: DBA/1J * FVB/N) 		increased susceptibility to induced arthritis J:146242
\Cia43FVB/N/\Cia43FVB/N
(involves: DBA/1J * FVB/N) 		increased susceptibility to induced arthritis J:146242
\Ciaaq1DBA/1J/\Ciaaq1DBA/1J
(involves: DBA/1J * FVB/NJ) 		increased autoantibody level J:122919
\Ciaaq1DBA/1J/\Ciaaq1FVB/NJ
(involves: DBA/1J * FVB/NJ) 		increased autoantibody level J:122919
\Ciitatm1Ccum/\Ciitatm1Ccum
(NOD.129S2(B6)-Ciitatm1Ccum) 		decreased susceptibility to autoimmune diabetes J:107051
\Ciitatm1Jpyt/\Ciitatm1Jpyt
(B6.129P2-Ciitatm1Jpyt) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:125654
\Clec1atm1Yiw/\Clec1atm1Yiw
(involves: C57BL/6J * C57BL/6NSlc) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:329240
\Clec4a2tm1Yiw/\Clec4a2tm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J) 		increased anti-nuclear antigen antibody level J:217720
increased autoantibody level J:217720
increased susceptibility to induced arthritis J:217720
\Clec4dtm1.1Shoy/\Clec4dtm1.1Shoy
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:203159
\Clec4etm1Tks/\Clec4etm1Tks
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:203159
\Clec5atm1Cua/\Clec5atm1Cua
(involves: C57BL/6) 		decreased susceptibility to induced arthritis J:158811
\Cntftm1Mpin/\Cntftm1Mpin
(B6.129S2-Cntftm1Mpin) 		increased susceptibility to experimental autoimmune encephalomyelitis J:126852
\Cog6tm1a(EUCOMM)Wtsi/\Cog6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cog6tm1a(EUCOMM)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
\Col17a1tm1Shzu/\Col17a1tm1Shzu
\Tg(KRT14-COL17A1)1Shzu/0
(involves: 129S/SvEv * C57BL/6J * C57BL/6Ncr) 		decreased autoantibody level J:121695
\Col17a1tm1Tiin/\Col17a1tm1Tiin
(involves: C57BL/6) 		increased autoantibody level J:220622
\Coro1aLmb3-C57BL/6Scr/\Coro1aLmb3-C57BL/6Scr
(MRL.Cg-Coro1aC57BL/6Scr Faslpr) 		decreased autoantibody level J:125557
decreased susceptibility to systemic lupus erythematosus J:125557
\Coro1aLmb3-MRL/MpScr/\Coro1aLmb3-MRL/MpScr
(B6.MRL-Coro1aMRL/MpScr Faslpr) 		increased susceptibility to systemic lupus erythematosus J:125557
\Cr2tm1Crr/\Cr2tm1Crr
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased anti-double stranded DNA antibody level J:111811
\Crhtm1Maj/\Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:98419
\Cry1tm1Jhjh/\Cry1tm1Jhjh
\Cry2tm1Jhjh/\Cry2tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to induced arthritis J:159504
\Csf2tm1Dran/\Csf2tm1Dran
\Il3tm1Glli/\Il3tm1Glli
(B6.129S2-Csf2tm1Dran Il3tm1Glli) 		increased anti-double stranded DNA antibody level J:83086
\Csf2tm1Mlg/\Csf2tm1Mlg
(involves: 129S2/SvPas) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:148120
\Csf3tm1Ard/\Csf3tm1Ard
\Junbtm3Wag/\Junbtm3Wag
\Tg(KRT5-cre)1Tak/0
(involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6) 		increased susceptibility to systemic lupus erythematosus J:155575
\Ctla4tm1Saka/\Ctla4tm1Saka
\Foxp3tm1(cre)Saka/Y
(involves: BALB/c) 		increased autoantibody level J:140085
\Ctla4tm1Shr/\Ctla4tm1Shr
(B6.129S4-Ctla4tm1Shr) 		autoimmune response J:146644
\Ctsbtm1Jde/\Ctsb+
(NOD.129P2-Ctsbtm1Jde) 		decreased susceptibility to autoimmune diabetes J:153355
\Ctsbtm1Jde/\Ctsbtm1Jde
(NOD.129P2-Ctsbtm1Jde) 		decreased susceptibility to autoimmune diabetes J:153355
\Ctsltm1Cptr/\Ctsl+
(NOD.129P2-Ctsltm1Cptr) 		decreased susceptibility to autoimmune diabetes J:153355
\Ctsltm1Cptr/\Ctsltm1Cptr
(NOD.129P2-Ctsltm1Cptr) 		decreased susceptibility to autoimmune diabetes J:153355
\Ctsstm1Eae/\Ctsstm1Eae
(involves: C57BL/6 * DBA/1LacJ) 		decreased susceptibility to induced arthritis J:53399
\Ctsstm1Eae/\Ctsstm1Eae
(NOD.D1-Ctsstm1Eae) 		decreased susceptibility to autoimmune diabetes J:153355
\Ctsstm1Hap/\Ctsstm1Hap
(B6.129S2-Ctsstm1Hap) 		decreased susceptibility to experimental autoimmune myasthenia gravis J:96401
\Cx3cr1tm1Litt/\Cx3cr1+
(B6.129P2-Cx3cr1tm1Litt) 		increased susceptibility to experimental autoimmune encephalomyelitis J:129712
\Cx3cr1tm1Litt/\Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt) 		increased susceptibility to experimental autoimmune encephalomyelitis J:129712
\Cxcl10tm1Adl/\Cxcl10tm1Adl
(B6.129S4-Cxcl10tm1Adl) 		increased susceptibility to experimental autoimmune encephalomyelitis J:87076
\Cxcr2tm1a(EUCOMM)Wtsi/\Cxcr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr2tm1a(EUCOMM)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
\Cxcr2tm1Mwm/\Cxcr2tm1Mwm
(C.129S2(B6)-Cxcr2tm1Mwm/J) 		decreased susceptibility to induced arthritis J:142880
\Cxcr4tm1Yiw/\Cxcr4tm1Yiw
\Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd) 		decreased susceptibility to induced arthritis J:164872
\Cybbtm1Din/\Cybbtm1Din
(B6.129S-Cybbtm1Din/J) 		increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
\Cyp19a1tm1Esi/\Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6) 		increased autoantibody level J:92438
\Cyp19a1tm1Sih/\Cyp19a1tm1Sih
(involves: 129S/SvEv) 		increased anti-single stranded DNA antibody level J:216958
increased autoantibody level J:216958
increased susceptibility to autoimmune disorder J:216958
\Cysltr2tm1Ykn/\Cysltr2tm1Ykn
(C.B6-Cysltr2tm1Ykn) 		autoimmune response J:182213
\Cytl1tm1Chun/\Cytl1tm1Chun
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to induced arthritis J:175377
\DbaclC57BL/6Jcl/\DbaclC57BL/6Jcl
(NOD.B6-(D4Mit193-D4Mit17)) 		increased susceptibility to autoimmune diabetes J:144964
\Dcbld2tm1a(KOMP)Wtsi/\Dcbld2tm1a(KOMP)Wtsi
(C57BL/6N-Dcbld2tm1a(KOMP)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
\Dclk1tm1a(EUCOMM)Wtsi/\Dclk1+
(C57BL/6N-Dclk1tm1a(EUCOMM)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
\Dclk1tm1a(EUCOMM)Wtsi/\Dclk1tm1a(EUCOMM)Wtsi
(C57BL/6N-Dclk1tm1a(EUCOMM)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
\Def6Gt(OST307148)Lex/\Def6Gt(OST307148)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased anti-nuclear antigen antibody level J:106469
\Del(1Aim2-Ifi205)1Stsn/\+
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N) 		increased autoantibody level J:234263
\Del(1Aim2-Ifi205)1Stsn/\Del(1Aim2-Ifi205)1Stsn
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N) 		increased autoantibody level J:234263
\Del(3Cd1d2-Cd1d1)1Crw/\Del(3Cd1d2-Cd1d1)1Crw
\Tg(TcraAV19AJ33)1Shima/0
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:112657
\Del(14Ltb4r2-Ltb4r1)1Bodd/\+
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to induced arthritis J:131779
\Del(14Ltb4r2-Ltb4r1)1Bodd/\Del(14Ltb4r2-Ltb4r1)1Bodd
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to induced arthritis J:131779
\Dffbem1(IMPC)Wtsi/\Dffbem1(IMPC)Wtsi
(C57BL/6N-Dffbem1(IMPC)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
\Dgkztm1Gak/\Dgkztm1Gak
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to induced arthritis J:293120
\Dh/\Dh+
\H2d/\H2d
(NZB.Cg-Dh) 		increased anti-erythrocyte antigen antibody level J:12036
increased anti-nuclear antigen antibody level J:12036
increased anti-single stranded DNA antibody level J:12036
increased autoantibody level J:12036
\Dicer1tm1Tara/\Dicer1tm1Tara
\Foxn1tm3(cre)Nrm/\Foxn1+
(involves: 129P2/OlaHsd * C57BL/6NHsd) 		increased susceptibility to induced arthritis J:180783
\Dnase1tm1Tmo/\Dnase1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-nuclear antigen antibody level J:62549
\Dnase1tm1Tmo/\Dnase1tm1Tmo
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-nuclear antigen antibody level J:62549
increased susceptibility to systemic lupus erythematosus J:62549
\Dnase1tm1Tmo/\Dnase1tm1Tmo
(involves: 129P2/OlaHsd * CD-1) 		decreased susceptibility to systemic lupus erythematosus J:110060
\Dnase1tm2092.1Arte/\Dnase1tm2092.1Arte
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:277126
increased anti-histone antibody level J:277126
increased anti-nuclear antigen antibody level J:277126
increased autoantibody level J:277126
increased susceptibility to systemic lupus erythematosus J:277126
\Dnase2atm1Osa/\Dnase2atm1Osa
\Ifnar1tm1Agt/\Ifnar1tm1Agt
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:114982
increased autoantibody level J:238323
rheumatoid arthritis J:238323, J:114982
\Dnase2atm1Osa/\Dnase2atm2Osa
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CBA) 		rheumatoid arthritis J:114982
\Dntttm1Gfn/\Dntttm1Gfn
\Faslpr/\Faslpr
(involves: 129S2/SvPas * C57BL/6 * MRL/MpJ) 		decreased autoantibody level J:110248
\Dock2m1Hsd/\Dock2m1Hsd
\Siaetm1.2Avrk/\Siaetm1.2Avrk
(B6NHsd.Cg-Siaetm1.2Avrk Dock2m1Hsd) 		increased anti-double stranded DNA antibody level J:144035
increased anti-histone antibody level J:144035
increased anti-single stranded DNA antibody level J:144035
\Dock8pri/\Dock8pri
(involves: C57BL/6JAnu) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:238772
\Dock10tm1Thar/\Dock10tm1Thar
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:300632
\Dtx1tm1.1Mzl/\Dtx1tm1.1Mzl
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased anti-double stranded DNA antibody level J:151605
increased anti-histone antibody level J:151605
increased autoantibody level J:151605
\Dtx1tm1.2Mzl/\Dtx1tm1.2Mzl
(B6.129-Dtx1tm1.2Mzl) 		increased anti-double stranded DNA antibody level J:151605
increased anti-histone antibody level J:151605
\Dusp1tm1Lex/\Dusp1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to induced arthritis J:126383
\Dusp2tm1Cmac/\Dusp2tm1Cmac
(B6.Cg-Dusp2tm1Cmac) 		decreased susceptibility to induced arthritis J:112609
\Dusp10tm1Flv/\Dusp10tm1Flv
(involves: 129S6/SvEvTac) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:92104
\Dusp14Gt(OST210117)Lex/\Dusp14Gt(OST210117)Lex
(B6.129S5-Dusp14Gt(OST210117)Lex) 		increased susceptibility to experimental autoimmune encephalomyelitis J:209403
\Dusp22tm1Tht/\Dusp22tm1Tht
(B6.129S7-Dusp22tm1Tht) 		increased susceptibility to autoimmune disorder J:213253
increased susceptibility to experimental autoimmune encephalomyelitis J:213253
\E2f1tm1Meg/\E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg) 		increased susceptibility to autoimmune diabetes J:93708
\E2f2tm1Zubi/\E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6) 		increased anti-double stranded DNA antibody level J:76318
increased susceptibility to autoimmune disorder J:76318
\E2f2tm1Zubi/\E2f2tm1Zubi
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J) 		increased susceptibility to autoimmune disorder J:76318
\Eae1A/J/\Eae1A/J
(involves: A/J * C57BL/10SnJ) 		increased susceptibility to experimental autoimmune encephalomyelitis J:30574
\Eae1PL/J/\Eae1PL/J
(involves: C57BL/10SnJ * PL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:30574
\Eae2RIIIS/J/\Eae2RIIIS/J
(involves: B10.RIII * RIIIS/J) 		decreased susceptibility to induced arthritis J:95848
\Eae4ABH/?
(involves: ABH * NOD) 		increased susceptibility to experimental autoimmune encephalomyelitis J:29171
\Eae5B10.S/DvTe/\Eae5SJL/J
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:49054
\Eae5SJL/J/\Eae5SJL/J
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:49054
\Eae7B10.S/DvTe/\Eae7B10.S/DvTe
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:49054
\Eae7B10.S/DvTe/\Eae7SJL/J
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:49054
\Eae7SJL/J/\Eae7SJL/J
(involves: B10.S/DvTe * SJL/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:49054
\Eae9B10.S/DvTe/\Eae9SJL/J
(involves: B10.S/DvTe * SJL/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:49054
\Eae10SJL/J/\Eae10SJL/J
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:49054
\Eae11SJL/J/?
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:53193
\Eae12SJL/J/\Eae12SJL/J
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:53193
\Eae13SJL/J/?
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:53193
\Eae14C57BL/10/?
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:69083
\Eae17SJL/J/?
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:69083
\Eae18NOD/\Eae18NOD
(involves: ABH * NOD) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:29171
\Eae26B10.RIII/\Eae26B10.RIII
(involves: B10.RIII * RIIIS/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:73850
\Eae26B10.RIII/\Eae26RIIIS/J
(involves: B10.RIII * RIIIS/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:73850
\Eae33C57BL/10SnSg/?
(involves: B10.S * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:99793
\Eae34C57BL/10SnSg/?
(involves: B10.S * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:99793
\Eae35C57BL/10SnSg/?
(involves: B10.S * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:99793
\Eae36SJL/J/?
(involves: B10.S * SJL/J) 		increased susceptibility to autoimmune disorder J:99793
\Eae37C57BL/10SnSg/?
(involves: B10.S * SJL/J) 		increased susceptibility to autoimmune disorder J:99793
\Eae38C57BL/10SnSg/?
(involves: B10.S * SJL/J) 		increased susceptibility to autoimmune disorder J:99793
\Eae42C57BL/10SnSg/?
(involves: B10.S * SJL/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:34892
\Eae42SJL/J/?
(involves: B10.S * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:34892
\Eae43B10.S/DvTe/?
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:53193
\Eae43B10.S/DvTe/\Eae43B10.S/DvTe
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:49054
\Eae44aB10.S/DvTe/\Eae44aB10.S/DvTe
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:56752
\Eae44bB10.S/DvTe/\Eae44bSJL/J
(involves: B10.S/DvTe * SJL/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:56752
\Eae44bSJL/J/\Eae44bSJL/J
(involves: B10.S/DvTe * SJL/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:56752
\Ecm1tm1Bsun/\Ecm1tm1Bsun
(involves: 129 * C57BL/6) 		increased susceptibility to autoimmune disorder J:168252
\Edil3Tg(lacZ)1Tq/\Edil3Tg(lacZ)1Tq
(Not Specified) 		increased susceptibility to induced arthritis J:254384
\Elavl1tm1.1Atas/\Elavl1tm1.1Atas
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:207013
\Endoutm1Tft/\Endoutm1Tft
\Tg(IghelMD4)4Ccg/0
\Tg(ML5sHEL)5Ccg/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6JSfd) 		increased autoantibody level J:208364
\Entpd7tm1Ktak/\Entpd7tm1Ktak
(B6.Cg-Entpd7tm1Ktak) 		increased susceptibility to experimental autoimmune encephalomyelitis J:191188
\Ephb6tm1Jwu/\Ephb6tm1Jwu
(involves: 129) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:94701
\Erars1DBA/2J/?
(involves: BXD2/TyJ * C57BL/6J * DBA/2J) 		increased anti-nuclear antigen antibody level J:96064
\Ergtm1.1Iwamo/\Ergtm1.1Iwamo
\Tg(Gdf5-cre,-ALPP)1Kng/?
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N) 		increased susceptibility to induced arthritis J:243715
\Esr1tm1Ksk/\Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J) 		increased anti-double stranded DNA antibody level J:88156
\Extl1em1Caox/\Extl1em1Caox
\Tg(Itgax-cre)1-1Reiz/0
(involves: C57BL/6 * CBA) 		increased susceptibility to autoimmune disorder J:333437
\F2tm2Jld/\F2+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2J) 		decreased susceptibility to induced arthritis J:174629
\F2rl1tm1Wrf/\F2rl1tm1Wrf
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to induced arthritis J:81119
\Faddtm1Mpa/\Faddtm1Mpa
\Mogtm1(cre)Gkl/\Mog+
(involves: C57BL/6 * SJL) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:167475
\Fam210bem1Cya/\Fam210bem1Cya
(involves: C57BL/6N) 		increased anti-double stranded DNA antibody level J:351618
increased anti-nuclear antigen antibody level J:351618
\Faslpr-cg/\Faslpr-cg
(CBA/KlJms-Faslpr-cg/J) 		autoimmune response J:24805, J:81770
increased anti-nuclear antigen antibody level J:24805
increased autoantibody level J:81770
\Faslpr/\Faslpr
(MRL/Mp-Faslpr) 		increased anti-double stranded DNA antibody level J:27634, J:131138, J:6257
increased anti-erythrocyte antigen antibody level J:27634
increased anti-nuclear antigen antibody level J:27634, J:28885
increased anti-single stranded DNA antibody level J:27634
increased autoantibody level J:28885
increased susceptibility to autoimmune disorder J:108760
\Faslpr/\Faslpr
(NOD.MRL(B6)-Faslpr) 		decreased susceptibility to autoimmune diabetes J:64051
\Faslpr/\Faslpr
(MRL/MpJ-Faslpr/J) 		increased anti-double stranded DNA antibody level J:92084, J:122315, J:7454
increased anti-nuclear antigen antibody level J:111811, J:92084, J:14151, J:7454
increased autoantibody level J:92084, J:14151
increased susceptibility to systemic lupus erythematosus J:92084
\Faslpr/\Faslpr
(NOD.MRL-Faslpr) 		decreased susceptibility to autoimmune diabetes J:78679
\Faslpr/\Faslpr
(involves: C3H * MRL/Mp) 		autoimmune response J:1060
increased anti-nuclear antigen antibody level J:34296
increased susceptibility to systemic lupus erythematosus J:34296
\Faslpr/\Faslpr
(B6.MRL-Faslpr/J) 		increased anti-double stranded DNA antibody level J:132217
increased anti-histone antibody level J:132217
increased anti-nuclear antigen antibody level J:132217
increased anti-single stranded DNA antibody level J:132217
increased autoantibody level J:132217
\Faslpr/\Faslpr
(MRL-Faslpr) 		increased anti-double stranded DNA antibody level J:126261
increased anti-nuclear antigen antibody level J:126261
\Faslpr/\Faslpr
(MRL.Cg-Irf1tm1Mak Faslpr) 		increased anti-double stranded DNA antibody level J:114771
\Faslpr/\Faslpr
(C3.MRL-Faslpr/J) 		increased anti-double stranded DNA antibody level J:7454
increased anti-nuclear antigen antibody level J:7454
increased autoantibody level J:7454
\Faslpr/\Faslpr
(B6.MRL-Faslpr) 		increased anti-double stranded DNA antibody level J:7454
increased anti-nuclear antigen antibody level J:6638, J:135036
increased autoantibody level J:135036, J:7454
\Faslpr/\Faslpr
(AK.MRL-Faslpr) 		increased anti-double stranded DNA antibody level J:7454
increased anti-nuclear antigen antibody level J:7454
increased autoantibody level J:7454
\Faslpr/\Faslpr
(MRL/MpJ-Faslpr) 		autoimmune response J:125114
increased anti-nuclear antigen antibody level J:137066
increased autoantibody level J:137066
\Faslpr/\Faslpr
(involves: C57BL/6 * MRL/Mp) 		increased anti-double stranded DNA antibody level J:73396
increased anti-single stranded DNA antibody level J:73396
\Faslpr/\Faslpr
\Fcer1gtm1Tks/\Fcer1gtm1Tks
(MRL.Cg-Fcer1gtm1Tks Faslpr) 		increased anti-double stranded DNA antibody level J:106188
\Faslpr/\Faslpr
\Havcr1tm1Kuch/\Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch Faslpr) 		increased anti-double stranded DNA antibody level J:186484
increased autoantibody level J:186484
increased susceptibility to systemic lupus erythematosus J:186484
\Faslpr/\Faslpr
\Hspa13tm1.1Smoc/\Hspa13tm1.1Smoc
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S * C57BL/6 * MRL/Mp) 		decreased autoantibody level J:303927
decreased susceptibility to systemic lupus erythematosus J:303927
\Faslpr/\Faslpr
\Ifnar1tm1Agt/\Ifnar1tm1Agt
(MRL.Cg-Ifnar1tm1Agt Faslpr) 		increased anti-nuclear antigen antibody level J:92084
increased autoantibody level J:92084
increased susceptibility to systemic lupus erythematosus J:92084
\Faslpr/\Faslpr
\Ifnar1tm1Agt/\Ifnar1tm1Agt
\Ifngr1tm1Agt/\Ifngr1tm1Agt
(MRL.Cg-Ifngr1tm1Agt Ifnar1tm1Agt Faslpr) 		decreased anti-nuclear antigen antibody level J:92084
decreased autoantibody level J:92084
decreased susceptibility to systemic lupus erythematosus J:92084
increased susceptibility to systemic lupus erythematosus J:92084
\Faslpr/\Faslpr
\Ifngtm1Ts/\Ifng+
(MRL.Cg-Ifngtm1Ts Faslpr) 		increased autoantibody level J:123834
\Faslpr/\Faslpr
\Ifngtm1Ts/\Ifngtm1Ts
(involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp) 		decreased anti-double stranded DNA antibody level J:39600
decreased anti-nuclear antigen antibody level J:39600
decreased autoantibody level J:39600
decreased susceptibility to systemic lupus erythematosus J:39600
\Faslpr/\Faslpr
\Ifngr1tm1Agt/\Ifngr1tm1Agt
(MRL.Cg-Ifngr1tm1Agt Faslpr) 		decreased anti-nuclear antigen antibody level J:92084
decreased autoantibody level J:92084
decreased susceptibility to systemic lupus erythematosus J:92084
\Faslpr/\Faslpr
\Igh-Jtm2(3H9-VDJ*)Mwg/\Igh-J+
(MRL.Cg-Faslpr Igh-Jtm2(3H9-VDJ*)Mwg) 		increased anti-double stranded DNA antibody level J:131138
\Faslpr/\Faslpr
\Ighmtm1Cgn/\Ighmtm1Cgn
(involves: 129S2/SvPas * C57BL/6 * MRL/Mp) 		increased autoantibody level J:119584
\Faslpr/\Faslpr
\Il4tm1Cgn/\Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp) 		decreased anti-nuclear antigen antibody level J:39600
decreased susceptibility to systemic lupus erythematosus J:39600
\Faslpr/\Faslpr
\Il27ratm1Mak/\Il27ratm1Mak
(MRL.Cg-Il27ratm1Mak Faslpr) 		decreased anti-double stranded DNA antibody level J:122148
decreased susceptibility to systemic lupus erythematosus J:122148
\Faslpr/\Faslpr
\Irf1tm1Mak/\Irf1+
(MRL.Cg-Irf1tm1Mak Faslpr) 		increased anti-double stranded DNA antibody level J:114771
\Faslpr/\Faslpr
\Irf1tm1Mak/\Irf1tm1Mak
(MRL.Cg-Irf1tm1Mak Faslpr) 		decreased anti-double stranded DNA antibody level J:114771
\Faslpr/\Faslpr
\Itfg2Gt(OST215121)Lex/\Itfg2Gt(OST215121)Lex
(involves: 129S5/SvEvBrd * C57BL/6J * MRL/Mp) 		increased anti-double stranded DNA antibody level J:205951
increased anti-nuclear antigen antibody level J:205951
increased susceptibility to systemic lupus erythematosus J:205951
\Faslpr/\Faslpr
\Pou2af1tm1Pmt/\Pou2af1tm1Pmt
(involves: 129P2/OlaHsd * C57BL/6 * MRL) 		autoimmune response J:125114
\Faslpr/\Faslpr
\Sh2d1arpl/\Sh2d1arpl
(MRL/Mp-Faslpr Sh2d1arpl) 		increased anti-nuclear antigen antibody level J:126261
\Faslpr/\Faslpr
\Spp1tm1Rit/\Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6 * MRL/Mp) 		increased anti-double stranded DNA antibody level J:73396
increased anti-single stranded DNA antibody level J:73396
\Faslpr/\Faslpr
\Tcratm1Mjo/\Tcratm1Mjo
(involves: 129P2/OlaHsd * 129S2/SvPas * MRL) 		decreased autoantibody level J:38492
\Faslpr/\Faslpr
\Tg(CD2-Foxj1)#Stlp/0
(MRL.Cg-Faslpr Tg(CD2-Foxj1)#Stlp) 		decreased susceptibility to systemic lupus erythematosus J:122222
increased anti-nuclear antigen antibody level J:122222
\Faslpr/\Faslpr
\Tg(Ins2-Fasl)24Ach/0
(NOD.Cg-Faslpr Tg(Ins2-Fasl)24Ach) 		decreased susceptibility to autoimmune diabetes J:81416
\Faslpr/\Faslpr
\Tg(INS-Il10)#Sar/0
(NOD.Cg-Faslpr Tg(INS-Il10)#Sar) 		increased susceptibility to autoimmune diabetes J:64051
\Faslpr/\Faslpr
\Tlr7tm1Flv/Y
(involves: 129S1/Sv * C57BL/6 * MRL/Mp) 		decreased autoantibody level J:113557
decreased susceptibility to systemic lupus erythematosus J:113557
increased anti-chromatin antibody level J:113557
increased autoantibody level J:113557
\Faslpr/\Faslpr
\Tlr9tm1Aki/\Tlr9tm1Aki
(B6.Cg-Tlr9tm1Aki Faslpr) 		autoimmune response J:135036
\Faslpr/\Faslpr
\Tlr9tm1Aki/\Tlr9tm1Aki
(MRL.Cg-Tlr9tm1Aki Faslpr) 		decreased autoantibody level J:113557
increased autoantibody level J:113557
increased susceptibility to systemic lupus erythematosus J:113557
\Faslpr/\Faslpr
\Tnfrsf9tm1Byk/\Tnfrsf9tm1Byk
(MRL.Cg-Tnfrsf9tm1Byk Faslpr) 		increased anti-nuclear antigen antibody level J:127197
increased susceptibility to systemic lupus erythematosus J:127197
\Fastheo/\Fastheo
(either: (involves: C57BL/6JAnu * C57BL/10SnSg * C57BR/cd) or (involves: C57BL/6JAnu * C57BL/10SnSg * C57BR/cd * CBA/CaJAnu)) 		increased anti-nuclear antigen antibody level J:104190
\Fastm1Ach/\Fastm1Ach
\Tg(GZMB-cre)1Jcb/?
(involves: C57BL/6 * FVB/N) 		increased anti-nuclear antigen antibody level J:123556
\Fastm1Ach/\Fastm1Ach
\Tg(Itgax-cre,-EGFP)4097Ach/?
(Not Specified) 		increased anti-nuclear antigen antibody level J:123556
\Fastm1Ach/\Fastm1Ach
\Tg(Lck-cre)548Jxm/?
(involves: C57BL/6 * CBA) 		increased anti-nuclear antigen antibody level J:123556
\Fastm1Cgn/\Fastm1Cgn
\Cd19tm1(cre)Cgn/\Cd19+
\Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Cd19tm1(cre)Cgn Fastm1Cgn) 		increased anti-single stranded DNA antibody level J:114948
\Fastm1Cgn/\Fastm1Cgn
\Mogtm1(cre)Gkl/\Mog+
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:114741
\Fastm1Cgn/\Fastm1Cgn
\Mogtm1(cre)Gkl/\Mog+
\Tnfrsf1atm1Mak/\Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:114741
\Fastm1Cgn/\Fastm1Cgn
\Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Fastm1Cgn) 		increased anti-single stranded DNA antibody level J:114948
\Fastm1Cgn/\Fastm1Cgn
\Tnfrsf1atm1Mak/\Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:114741
\Fastm1Osa/\Fastm1Osa
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:32125
increased anti-single stranded DNA antibody level J:32125
increased autoantibody level J:32125
\Fastm1Vbo/\Fastm1Vbo
\Tg(Ins2-cre)25Mgn/0
\Tg(Ins2-HA)165Bri/0
\Tg(Tcra/Tcrb)1Vbo/0
(Not Specified) 		increased susceptibility to autoimmune diabetes J:85985
\Faslgld/\Faslgld
(C3H/HeJ-Faslgld/J) 		increased anti-double stranded DNA antibody level J:7306
increased anti-nuclear antigen antibody level J:7306, J:29572
increased autoantibody level J:7306
\Faslgld/\Faslgld
(involves: C3H/HeJ * C57BL/6) 		increased anti-nuclear antigen antibody level J:153501
increased susceptibility to systemic lupus erythematosus J:153501
\Faslgld/\Faslgld
(B6.C3-Faslgld) 		increased anti-nuclear antigen antibody level J:91058
increased autoantibody level J:91058
\Fasltm1.1Ast/\Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:153501
increased anti-nuclear antigen antibody level J:153501
increased susceptibility to systemic lupus erythematosus J:153501
\Fasltm1.1Lest/\Fasltm1.1Lest
(involves: 129 * C57BL/6) 		autoimmune response J:87990
\Fbn1tm2.1Hcd/\Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased anti-nuclear antigen antibody level J:206074
increased autoantibody level J:206074
\Fbn1tm3.1Hcd/\Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased anti-nuclear antigen antibody level J:206074
increased autoantibody level J:206074
\Fbn1Tsk/\Fbn1+
(B6.Cg-Fbn1Tsk) 		increased autoantibody level J:21987, J:14166
\Fbn1Tsk/\Fbn1+
\Il4ratm1Sz/\Il4ra+
(involves: BALB/cJ * C57BL/6J * C57BL/10 * DBA/2) 		increased autoantibody level J:68448
\Fcer1gtm1Rav/\Fcer1gtm1Rav
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:126520
\Fcer1gtm1Rav/\Fcer1gtm1Rav
\Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:122114
\Fcer1gtm1Tks/\Fcer1gtm1Tks
(C57BL/6-Fcer1gtm1Tks) 		decreased susceptibility to autoimmune hemolytic anemia J:145432
\Fcgr1tm1Jsv/\Fcgr1tm1Jsv
(involves: 129P2/OlaHsd * BALB/c) 		decreased susceptibility to autoimmune hemolytic anemia J:83995
decreased susceptibility to induced arthritis J:83995
\Fcgr2btm1.2Jsv/\Fcgr2b+
X/\Yaa
(involves: C57BL/6 * FVB/N * SB/Le) 		increased anti-chromatin antibody level J:179175
increased anti-double stranded DNA antibody level J:179175
increased susceptibility to systemic lupus erythematosus J:179175
\Fcgr2btm1.2Jsv/\Fcgr2btm1.2Jsv
\Sle16C57BL/6/\Sle16C57BL/6
(involves: C57BL/6 * FVB/N) 		increased susceptibility to induced arthritis J:179175
\Fcgr2btm1Kgcs/\Fcgr2b+
(involves: C57BL/6) 		increased anti-chromatin antibody level J:190890
increased anti-double stranded DNA antibody level J:190890
increased susceptibility to induced arthritis J:190890
\Fcgr2btm1Ttk/\Fcgr2btm1.2Jsv
\Sle21129P2/Ola/\Sle21C57BL/6
(involves: 129P2/Ola * 129S4/SvJae * C57BL/6 * FVB/N) 		increased anti-chromatin antibody level J:179175
increased anti-double stranded DNA antibody level J:179175
increased anti-histone antibody level J:179175
increased anti-single stranded DNA antibody level J:179175
increased susceptibility to systemic lupus erythematosus J:179175
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
(Not Specified) 		increased susceptibility to induced arthritis J:106191
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
\Il17atm1Yiw/\Il17atm1Yiw
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased susceptibility to systemic lupus erythematosus J:191090
increased anti-double stranded DNA antibody level J:191090
increased anti-nuclear antigen antibody level J:191090
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
\Pdcd1tm1Hon/\Pdcd1tm1Hon
(involves: 129S2/SvPas * 129S4/SvJae * BALB/c) 		increased autoantibody level J:207275
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
\Sle21129P2/Ola/\Sle21129P2/Ola
(B6.129S4-Fcgr2btm1Ttk) 		increased anti-chromatin antibody level J:179175
increased anti-double stranded DNA antibody level J:179175
increased anti-histone antibody level J:179175
increased anti-single stranded DNA antibody level J:179175
increased autoantibody level J:179175
increased susceptibility to induced arthritis J:179175
increased susceptibility to systemic lupus erythematosus J:179175
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
\Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to autoimmune diabetes J:122114
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
\Tlr7tm1Flv/Y
X/\Yaa
(B6.Cg-Fcgr2btm1Ttk Tlr7tm1Flv Yaa) 		autoimmune response J:127600
increased anti-nuclear antigen antibody level J:127600
increased susceptibility to systemic lupus erythematosus J:127600
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
\Traf3ip2tm1Sbn/\Traf3ip2+
(involves: 129 * 129S4/SvJae * C57BL/6) 		increased anti-double stranded DNA antibody level J:191090
increased anti-nuclear antigen antibody level J:191090
increased autoantibody level J:191090
increased susceptibility to systemic lupus erythematosus J:191090
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
\Traf3ip2tm1Sbn/\Traf3ip2tm1Sbn
(involves: 129 * 129S4/SvJae * C57BL/6) 		decreased susceptibility to systemic lupus erythematosus J:191090
increased anti-double stranded DNA antibody level J:191090
increased anti-nuclear antigen antibody level J:191090
increased autoantibody level J:191090
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
X/\Yaa
(B6.Cg-Fcgr2btm1Ttk Yaa) 		autoimmune response J:127600
increased anti-nuclear antigen antibody level J:127600
increased susceptibility to systemic lupus erythematosus J:127600
\Fcgr3tm1Jsv/\Fcgr3tm1Jsv
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to autoimmune hemolytic anemia J:83995
\Fcgr3tm1Jsv/\Fcgr3tm1Jsv
(B6.129P2-Fcgr3tm1Jsv/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:126520
decreased susceptibility to induced arthritis J:106191
\Fcgr3tm1Jsv/\Fcgr3tm1Jsv
\Sle21129P2/Ola/\Sle21129P2/Ola
(B6.129P2-Fcgr3tm1Jsv) 		increased anti-chromatin antibody level J:179175
increased anti-double stranded DNA antibody level J:179175
increased anti-histone antibody level J:179175
increased anti-single stranded DNA antibody level J:179175
\Fcgr4tm1.1Rav/\Fcgr4tm1.1Rav
(involves: C57BL/6) 		decreased susceptibility to induced arthritis J:167375
\Fcmrtm1Ohno/\Fcmrtm1Ohno
(B6.129-Fcmrtm1Ohno) 		increased anti-chromatin antibody level J:190117
increased anti-double stranded DNA antibody level J:190117
\Fcrlbtm1Pdb/\Fcrlbtm1Pdb
(B6.129-Fcrlbtm1Pdb) 		increased anti-nuclear antigen antibody level J:165408
\Fen1tm3.1Bhsh/\Fen1+
(Not Specified) 		increased anti-double stranded DNA antibody level J:231218
increased anti-nuclear antigen antibody level J:231218
increased susceptibility to autoimmune disorder J:231218
\Fen1tm3.1Bhsh/\Fen1tm3.1Bhsh
(Not Specified) 		increased anti-double stranded DNA antibody level J:231218
increased anti-nuclear antigen antibody level J:231218
increased susceptibility to autoimmune disorder J:231218
\Ffar2tm1Dgen/\Ffar2tm1Dgen
(involves: C57BL/6) 		increased susceptibility to induced arthritis J:153951
\Fgl1tm1b(EUCOMM)Hmgu/\Fgl1tm1b(EUCOMM)Hmgu
(involves: BALB/cJ * C57BL/6N) 		increased anti-double stranded DNA antibody level J:269578
\Flicrem1Doi/\Flicrem1Doi
(NOD/ShiLtDoi-Flicrem1Doi) 		decreased susceptibility to autoimmune diabetes J:241346
\Foxo1tm1Flv/\Foxo1tm1Flv
\Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased anti-double stranded DNA antibody level J:147057
increased anti-nuclear antigen antibody level J:147057
\Foxp3tm1(cre)Saka/Y
(involves: BALB/c) 		increased autoantibody level J:140085
\Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ) 		increased susceptibility to autoimmune disorder J:82560
\Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to autoimmune disorder J:117743
\Foxp3tm1.1Ayr/\Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to autoimmune disorder J:117743
\Foxp3tm1Ayr/Y
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		increased susceptibility to autoimmune disorder J:97029
\Foxp3tm1Kuch/?
\Il6tm1Kopf/\Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:123352
\Foxp3tm2.1(EGFP/cre)Shori/Y
\Pdcd1tm1Hon/\Pdcd1tm1Hon
(involves: 129 * 129S2/SvPas * C57BL/6) 		increased susceptibility to autoimmune disorder J:234397
\Foxp3tm2Flv/Y
(involves: C57BL/6) 		increased autoantibody level J:118631
\Foxp3tm3(HBEGF/GFP)Ayr/\Foxp3+
\Gpr174tm1Cys/\Gpr174+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:222307
\Foxp3tm3(HBEGF/GFP)Ayr/\Foxp3tm3(HBEGF/GFP)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to autoimmune disorder J:117743
\Foxp3tm4(YFP/icre)Ayr/Y
\Zfp91tm1Smoc/\Zfp91tm1Smoc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to autoimmune disorder J:306129
\Foxp3tm4(YFP/icre)Ayr/\Foxp3tm4(YFP/icre)Ayr
\Ikzf4tm1Djr/\Ikzf4tm1Djr
(involves: 129S1/Sv * 129X1/SvJ) 		increased susceptibility to experimental autoimmune encephalomyelitis J:294549
\Foxp3tm8Ayr/Y
(B6.129-Foxp3tm8Ayr) 		autoimmune response J:157377
\Fpr2tm1Rjf/\Fpr2tm1Rjf
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to induced arthritis J:159658
\Fyntm1Yik/\Fyntm1Yik
(involves: C57BL/6 * CBA) 		increased susceptibility to experimental autoimmune uveoretinitis J:99347
\Gabrb3tm2.1Geh/\Gabrb3tm2.1Geh
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased susceptibility to experimental autoimmune encephalomyelitis J:333883
\Gadd45atm1Ajf/\Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6)) 		increased anti-double stranded DNA antibody level J:76041
increased anti-histone antibody level J:76041
increased anti-single stranded DNA antibody level J:76041
increased autoantibody level J:76041
\Gadd45btm1Flv/\Gadd45btm1Flv
(B6.129S6-Gadd45btm1Flv) 		increased susceptibility to experimental autoimmune encephalomyelitis J:118837
\Gadd45btm1Flv/\Gadd45btm1Flv
\Gadd45gtm1Flv/\Gadd45gtm1Flv
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6) 		increased anti-double stranded DNA antibody level J:118837
increased anti-histone antibody level J:118837
\Gata1tm6Sho/\Gata1tm6Sho
(C.129S1-Gata1tm6Sho) 		autoimmune response J:182213
\Gcc2em1Cya/\Gcc2em1Cya
(C57BL/6J-Gcc2em1Cya) 		increased autoantibody level J:346915
\Ghrtm1Jjk/\Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c) 		decreased susceptibility to autoimmune diabetes J:59132
\Ghrhtm1Salv/\Ghrhtm1Salv
(involves: 129 * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:177054
\Ghrhrlit/\Ghrhrlit
(C57BL/6J-Ghrhrlit) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:85381
\Gm614tm1.1Cya/\Gm614tm1.1Cya
\Ighg1tm1(cre)Cgn/\Ighg1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		decreased susceptibility to systemic lupus erythematosus J:307345
\Gna12tm1Citb/\Gna12tm1Citb
\Gna13tm2.1Soff/\Gna13tm2.1Soff
\Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased susceptibility to autoimmune diabetes J:149560
\Gpr132tm1Witt/\Gpr132tm1Witt
(involves: 129X1/SvJ * BALB/c) 		increased anti-nuclear antigen antibody level J:69473
\Gpr174tm1Cys/Y
(B6.129-Gpr174tm1Cys) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:222307
\Gpr174tm1Cys/\Gpr174+
(B6.129-Gpr174tm1Cys) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:222307
\Gpsm3Gt(IST12408A1)Tigm/\Gpsm3Gt(IST12408A1)Tigm
(involves: C57BL/6N) 		decreased susceptibility to induced arthritis J:193270
\Gpx7tm1Whle/\Gpx7tm1Whle
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-nuclear antigen antibody level J:193993
\Grk6tm1.1Mca/\Grk6tm1.1Mca
(B6.129S4-Grk6tm1.1Mca) 		increased anti-double stranded DNA antibody level J:225063
\Gt(ROSA)26Sortm1(DTA)Jpmb/\Gt(ROSA)26Sor+
\Tg(Plp1-cre/ERT)3Pop/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		autoimmune response J:234435
\Gt(ROSA)26Sortm1(Ptpn22*)Draw/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:201448
increased autoantibody level J:201448
\Gt(ROSA)26Sortm2.1(Cd74/MOG)Awai/\Gt(ROSA)26Sor+
(involves: C57BL/6 * BALB/cJ) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:140751
\Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/\Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky
\Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca) 		increased anti-double stranded DNA antibody level J:133215
increased anti-single stranded DNA antibody level J:133215
\Gvhd4DBA/2J/\Gvhd4DBA/2J
(involves: C57BL/10 * DBA/2J) 		increased anti-single stranded DNA antibody level J:66655
\Gvhd4DBA/2J/\Gvhd4DBA/2J
\Gvhd5DBA/2J/\Gvhd5DBA/2J
(involves: C57BL/10 * DBA/2J) 		increased anti-single stranded DNA antibody level J:66655
\Gvhd5DBA/2J/\Gvhd5DBA/2J
(involves: C57BL/10 * DBA/2J) 		increased anti-single stranded DNA antibody level J:66655
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/\Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD.Cg-Rag1tm1Mom H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell) 		increased autoantibody level J:113267
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/\Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell) 		autoimmune response J:87013, J:86540
decreased susceptibility to autoimmune disorder J:87013
increased autoantibody level J:113267
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell/\Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell) 		increased autoantibody level J:113509
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(HLA-DQA1,HLA-DQB1)1Dv/0
\Tg(HLA-DRB1)31Dmz/0
\Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA * SJL) 		decreased susceptibility to autoimmune diabetes J:68641
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(HLA-DQA1,HLA-DQB1)1Dv/0
\Tg(Ins2-CD80)3B7Flv/0
(B6.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv Tg(Ins2-CD80)3B7Flv) 		increased susceptibility to autoimmune diabetes J:59245
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(HLA-DQA1,HLA-DQB1)1Dv/0
\Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA) 		increased susceptibility to autoimmune diabetes J:68641
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(HLA-DQA1,HLA-DQB1)70Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)70Myl) 		increased autoantibody level J:88055
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(HLA-DQA1,HLA-DQB1)73Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl) 		increased autoantibody level J:88055
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(HLA-DRB1)31Dmz/0
\Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * CBA * SJL) 		decreased susceptibility to autoimmune diabetes J:68641
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		decreased susceptibility to autoimmune diabetes J:68641
\H2-Ab1b-tm1Wug/\H2-Ab1b-tm1Wug
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:204951
\H2-Ab1b-tm1Wug/\H2-Ab1b-tm1Wug
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:204951
\H2-Ab1bm12/\H2-Ab1bm12
(B6(C)-H2-Ab1bm12/KhEgJ) 		decreased susceptibility to autoimmune disorder J:100123
decreased susceptibility to experimental autoimmune myasthenia gravis J:100213
\H2-Ab1bm12/\H2-Ab1bm12
(NZB.B6(C)-H2-Ab1bm12) 		autoimmune response J:4554
increased anti-double stranded DNA antibody level J:104189
increased anti-erythrocyte antigen antibody level J:4554
increased anti-single stranded DNA antibody level J:104189
\H2-Ab1g7-em1Dvs/\H2-Ab1g7-em1Dvs
\H2-D1b-em5Dvs/\H2-D1b-em5Dvs
\H2-K1d-em1Dvs/\H2-K1d-em1Dvs
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-Ab1g7-em1Dvs H2-D1em5Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
\H2-D1b-em1Dvs/\H2-D1b-em1Dvs
(NOD/ShiLtDvs-H2-D1b-em1Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
\H2-D1b-em2Dvs/\H2-D1b-em2Dvs
(NOD/ShiLtDvs-H2-D1b-em2Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
\H2-D1b-em3Dvs/\H2-D1b-em3Dvs
(NOD/ShiLtDvs-H2-D1b-em3Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
\H2-D1b-em4Dvs/\H2-D1b-em4Dvs
(NOD/ShiLtDvs-H2-D1b-em4Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
\H2-D1b-em5Dvs/\H2-D1b-em5Dvs
\H2-K1d-em1Dvs/\H2-K1d-em1Dvs
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-D1b-em5Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
\H2-D1b-em5Dvs/\H2-D1b-em5Dvs
\H2-K1d-em1Dvs/\H2-K1d-em1Dvs
\Tg(HLA-A/H2-D/B2M)1Dvs/?
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-D1b-em5Dvs Tg(HLA-A/H2-D/B2M)1Dvs/Dvs) 		autoimmune response J:257229
increased susceptibility to autoimmune diabetes J:257229
\H2-D1b-em5Dvs/\H2-D1b-em5Dvs
\H2-K1d-em1Dvs/\H2-K1d-em1Dvs
\Tg(HLA-B39/H2-D/B2m)2Dvs/?
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-D1b-em5Dvs Tg(HLA-B39/H2-D/B2M)2Dvs/Dvs) 		autoimmune response J:257229
increased susceptibility to autoimmune diabetes J:257229
\H2-D1b-tm1Bpe/\H2-D1b-tm1Bpe
\H2-K1b-tm1Bpe/\H2-K1b-tm1Bpe
X/\Yaa
(BXSB.129P2(B6)-H2-K1b-tm1Bpe H2-D1b-tm1Bpe/Dcr) 		increased susceptibility to systemic lupus erythematosus J:179430
\H2-DMatm1Luc/\H2-DMatm1Luc
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:72243
\H2-DMatm1Luc/\H2-DMatm1Luc
(B6.129S4-H2-Dmatm1Luc) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:125654
\H2-K1d-em4Dvs/\H2-K1d-em4Dvs
(NOD/ShiLtDvs-H2-K1d-em4Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
\H2-K1d-em5Dvs/\H2-K1d-em5Dvs
(NOD/ShiLtDvs-H2-K1d-em5Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
\H2-K1d-em7Dvs/\H2-K1d-em7Dvs
(NOD/ShiLtDvs-H2-K1d-em7Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
\H2-T23tm1Cant/\H2-T23tm1Cant
(involves: 129S6/SvEvTac * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:89808
\H2-T23tm2Cant/\H2-T23tm2Cant
(B6.129S6-H2-T23tm2Cant) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:142087
\H2-T23tm2Cant/\H2-T23tm2Cant
\Tg(Tcra2D2,Tcrb2D2)1Kuch/?
(involves: 129S6/SvEvTac) 		increased susceptibility to experimental autoimmune encephalomyelitis J:142087
\H2-T23tm3Cant/\H2-T23tm3Cant
(B6.129S6-H2-T23tm3Cant) 		increased susceptibility to experimental autoimmune encephalomyelitis J:142087
\H2b/\H2b
(NOD.B10SnJ-H2b) 		decreased susceptibility to autoimmune diabetes J:14178
\H2b/\H2d
((C57BL/6 x DBA/2)F1) 		increased autoantibody level J:106141
\H2b/\H2g7
(NOD.B10SnJ-H2b) 		decreased susceptibility to autoimmune diabetes J:14178
\H2b/\H2g7
\Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL) 		rheumatoid arthritis J:36815, J:275827
\H2d/\H2d
(DBA/2) 		increased autoantibody level J:106141
\H2dlAb1-Ea/\H2dlAb1-Ea
\Tg(HLA-DRA,HLA-DRB5*0101)hiKito/0
\Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:189816
\H2dlAb1-Ea/\H2dlAb1-Ea
\Tg(HLA-DRA,HLA-DRB5*0101)loKito/0
\Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:189816
\H2g7/\H2g7
\Ins2tm1Jja/\Ins2tm1Jja
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(TcraBDC12-4.1)10Jos/0
\Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		increased susceptibility to autoimmune diabetes J:111874
\H2g7/\H2g7
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(TcraBDC12-4.1)10Jos/0
\Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		increased susceptibility to autoimmune diabetes J:111874
\H2g7/\H2g7
\Tg(Ins2-Vtcn1)#Xxz/0
\Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: C57BL/6 * NOD * SJL) 		decreased susceptibility to autoimmune diabetes J:177612
\H2g7/\H2g7
\Tg(TcraAI4)1Dvs/0
\Tg(TcrbAI4)1Dvs/0
(B6.NOD-(D17Mit21-D17Mit10) Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs) 		increased susceptibility to autoimmune diabetes J:167508
\H2g7/\H2g7
\Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(B6.Cg-H2g7 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi) 		decreased susceptibility to autoimmune diabetes J:86926
\H2g7/\H2g7
\Tg(TcraBDC12-4.1)10Jos/0
\Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		decreased susceptibility to autoimmune diabetes J:111874
\H2g7/\H2q
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(TcraBDC12-4.1)10Jos/0
\Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		increased susceptibility to autoimmune diabetes J:111874
\H2h2/\H2g7
(NOD.Cg-H2h2) 		decreased susceptibility to autoimmune diabetes J:14178
\H2h2/\H2h2
(NOD.Cg-H2h2) 		decreased susceptibility to autoimmune diabetes J:14178
\H2h4/\H2g7
(NOD.Cg-H2h4) 		decreased susceptibility to autoimmune diabetes J:14178
\H2h4/\H2h4
(NOD.Cg-H2h4) 		decreased susceptibility to autoimmune diabetes J:14178
\H2i5/\H2g7
(NOD.Cg-H2i5) 		decreased susceptibility to autoimmune diabetes J:14178
\H2i5/\H2i5
(NOD.Cg-H2i5) 		decreased susceptibility to autoimmune diabetes J:14178
\H2i7/\H2g7
(NOD.Cg-H2i7) 		decreased susceptibility to autoimmune diabetes J:14178
\H2i7/\H2i7
(NOD.Cg-H2i7) 		decreased susceptibility to autoimmune diabetes J:14178
\H2k/\H2g7
(NOD.Cg-H2k) 		decreased susceptibility to autoimmune diabetes J:14178
\H2k/\H2k
(NOD.Cg-H2k) 		increased susceptibility to autoimmune diabetes J:14178
\H2q/?
\Ncf1m1J/\Ncf1m1J
(B6.Cg-Ncf1m1J H2q) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:92437
increased susceptibility to experimental autoimmune encephalomyelitis J:92437
increased susceptibility to induced arthritis J:92437
rheumatoid arthritis J:92437
\H2q/\H2q
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(TcraBDC12-4.1)10Jos/0
\Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		decreased susceptibility to autoimmune diabetes J:111874
\H2u/\H2u
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(Tcra19,Tcrb19)#Stl/0
(either: (involves: 129S7/SvEvBrd * C57BL/6 * PL/J) or (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/10 * PL/J)) 		increased susceptibility to autoimmune disorder J:19795
\H2u/\H2u
\Tg(Tcra19,Tcrb19)#Stl/0
(either: (involves: C57BL/6 * PL/J) or (involves: C57BL/6 * C57BL/10 * PL/J)) 		increased susceptibility to autoimmune disorder J:19795
increased susceptibility to experimental autoimmune encephalomyelitis J:19795
\H2u/\H2u
\Tg(TCRA)B1Jg/?
\Tg(TCRB)C14Jg/?
(involves: C57BL/6 * C57BL/10SnSg * DBA/2 * PL/J) 		increased autoantibody level J:92991
increased susceptibility to experimental autoimmune encephalomyelitis J:92991
\Havcr1tm1Kuch/\Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch) 		autoimmune response J:186484
increased anti-double stranded DNA antibody level J:186484
\Hc0/\Hc0
\Tg(TcrbBL17)1Lmor/0
(involves: DBA/1J * SWR/J) 		decreased susceptibility to induced arthritis J:134111
\Hc1/?
\Tg(TcrbBL17)1Lmor/0
(involves: DBA/1J * SWR/J) 		increased susceptibility to induced arthritis J:134111
\Hcsttm1.1Dnax/\Hcsttm1.1Dnax
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:148086
\Hif1atm3Rsjo/\Hif1atm3Rsjo
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to induced arthritis J:107682
\Hmox1tm1.1Gkl/\Hmox1tm1.1Gkl
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:148498
\HrUSP/\HrUSP
(either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2)) 		increased susceptibility to autoimmune disorder J:21316
\Hrh3Eae8-r/?
(B10.S-H2s/SgMcdJ) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:34892
\Hrh3Eae8-r/\Hrh3Eae8-r
(involves: B10.S/DvTe * SJL/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:49054
\Hrh3Eae8-s/?
(involves: B10.S * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:49054
\Hrh3tm1Twl/\Hrh3tm1Twl
(B6.129X1-Hrh3tm1Twl) 		increased susceptibility to experimental autoimmune encephalomyelitis J:122269
\Hspa13tm1.1Smoc/\Hspa13tm1.1Smoc
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S * C57BL/6) 		decreased autoantibody level J:303927
\Ica1tm1Mdos/\Ica1tm1Mdos
(NOD.129-Ica1tm1Mdos) 		decreased susceptibility to autoimmune diabetes J:83526
\Icam1tm1Jcgr/\Icam1tm1Jcgr
\Tg(INS-Il10)#Sar/0
(NOD.Cg-Icam1tm1Jcgr Tg(INS-Il10)#Sar) 		decreased susceptibility to autoimmune diabetes J:66103
\Icostm1Flv/\Icostm1Flv
(involves: 129/Sv * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:87123
\Icostm1Flv/\Icostm1Flv
(NOD.129S1-Icostm1Flv) 		decreased anti-insulin autoantibody level J:131529
decreased autoantibody level J:131529
decreased susceptibility to autoimmune diabetes J:131529
\Id3tm1Zhu/\Id3tm1Zhu
(involves: 129S4/SvJaeSor) 		increased autoantibody level J:93916
\Idd3A/J/\Idd3A/J
(NOD.A-Idd3A/J) 		increased susceptibility to autoimmune diabetes J:120349
\Idd3C57BL/6/\Idd3C57BL/6
(NOD.B6-Idd3C57BL/6) 		decreased susceptibility to autoimmune diabetes J:120349
\Idd3CAST/EiJ/\Idd3CAST/EiJ
(NOD.CAST-Idd3CAST/EiJ) 		increased susceptibility to autoimmune diabetes J:120349
\Idd3CZECHI/EiJ/\Idd3CZECHI/EiJ
(NOD.CZECH-Idd3CZECHI/EiJ) 		decreased susceptibility to autoimmune diabetes J:120349
\Idd3SWR/J/\Idd3SWR/J
(NOD.SWR-Idd3SWR/J) 		increased susceptibility to autoimmune diabetes J:120349
\Idd4.3C57L/\Idd4.3C57L
(involves: C57L/J * NOD) 		increased susceptibility to autoimmune diabetes J:118951
\Idd6.1C3H/HeJ/\Idd6.1C3H/HeJ
(involves: C3H/HeJ * NOD) 		decreased susceptibility to autoimmune diabetes J:115021
\Idd6.2C3H/HeJ/\Idd6.2C3H/HeJ
(involves: C3H/HeJ * NOD) 		decreased susceptibility to autoimmune diabetes J:115021
\Idd6.3C3H/HeJ/\Idd6.3C3H/HeJ
(involves: C3H/HeJ * NOD) 		decreased susceptibility to autoimmune diabetes J:115021
\Ifih1Rgsc422/\Ifih1+
(D2JJcl.B6JJcl-Ifih1Rgsc422) 		autoimmune response J:209917
increased anti-double stranded DNA antibody level J:209917
increased anti-nuclear antigen antibody level J:209917
increased susceptibility to systemic lupus erythematosus J:209917
\Ifih1Rgsc422/\Ifih1Rgsc422
(D2JJcl.B6JJcl-Ifih1Rgsc422) 		increased susceptibility to systemic lupus erythematosus J:209917
\Ifnb1tm1Tl/\Ifnb1tm1Tl
(B10.129P2-Ifnb1tm1Tl) 		increased susceptibility to experimental autoimmune encephalomyelitis J:83021
\Ifngtm1Ts/\Ifngtm1Ts
(NOD.129S7-Ifngtm1Ts) 		abnormal susceptibility to autoimmune disorder J:33427
decreased susceptibility to autoimmune diabetes J:95105
\Ifngtm1Ts/\Ifngtm1Ts
(NOD.Cg-Ifngtm1Ts Prkdcscid) 		decreased susceptibility to autoimmune diabetes J:72818
\Ifngtm1Ts/\Ifngtm1Ts
(NOD.129S7(B6)-Ifngtm1Ts/DvsJ) 		decreased susceptibility to autoimmune diabetes J:72818
\Ifngtm1Ts/\Ifngtm1Ts
(C.129S7-Ifngtm1Ts) 		increased susceptibility to experimental autoimmune encephalomyelitis J:34161
\Ifngtm1Ts/\Ifngtm1Ts
(involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp) 		decreased anti-double stranded DNA antibody level J:39600
decreased anti-nuclear antigen antibody level J:39600
decreased autoantibody level J:39600
decreased susceptibility to autoimmune disorder J:39600
\Ifngtm1Ts/\Ifngtm1Ts
(involves: 129S7/SvEvBrd * A/WySn * C57BL/10SnSg * Swiss) 		decreased susceptibility to autoimmune disorder J:119207
\Ifngr1tm1Agt/\Ifngr1tm1Agt
(involves: 129S7/SvEvBrd) 		increased susceptibility to experimental autoimmune encephalomyelitis J:38363
\Ifngr1tm1Agt/\Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to experimental autoimmune myasthenia gravis J:53577
increased susceptibility to experimental autoimmune uveoretinitis J:99347
\Ifngr1tm1Agt/\Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * DBA/1OlaHsd) 		increased susceptibility to induced arthritis J:40634
\Ifngr2tm1Pbro/\Ifngr2tm1Pbro
(NOD.129S1-Ifngr2tm1Pbro) 		decreased susceptibility to autoimmune diabetes J:72818
\Igh-7tm1Led/\Igh-7tm1Led
\Lyntm1Ard/\Lyntm1Ard
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased anti-double stranded DNA antibody level J:161523
increased anti-nuclear antigen antibody level J:161523
\Igh-Jtm1(CB20)Riho/\Igh-J+
(involves: C57BL/10 * DBA/1) 		increased susceptibility to induced arthritis J:179456
\Igh-Jtm1(CB20)Riho/\Igh-Jtm1(CB20)Riho
(involves: C57BL/10 * DBA/1) 		increased susceptibility to induced arthritis J:179456
\Igh-Jtm1Aigl/\Igh-J+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:111543
\Igh-Jtm1Aigl/\Igh-J+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased susceptibility to experimental autoimmune encephalomyelitis J:111543
\Igh-Jtm1Aigl/\Igh-J+
\Mogtm1Dpd/\Mogtm1Dpd
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:151335
\Igh-Jtm1Aigl/\Igh-J+
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:151335
\Igh-Jtm1Aigl/\Igh-Jtm1Aigl
\Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N * SJL/J) 		increased autoantibody level J:149511
increased susceptibility to experimental autoimmune encephalomyelitis J:149511
\Igh-Jtm2(3H9-VDJ*)Mwg/\Igh-J+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased anti-double stranded DNA antibody level J:126940
\Igh-Jtm2(3H9-VDJ*)Mwg/\Igh-J+
(involves: 129P2/OlaHsd * BALB/c) 		increased anti-double stranded DNA antibody level J:131138
\Igh-Jtm2(3H9-VDJ*)Mwg/\Igh-J+
(B6.129P2-Igh-Jtm2(3H9-VDJ*)Mwg) 		increased anti-double stranded DNA antibody level J:142389
\Igh-Jtm3(3H9-VDJ*)Mwg/\Igh-Jtm3(3H9-VDJ*)Mwg
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased anti-double stranded DNA antibody level J:126940
\Ightm1(Ighppc1-5)Cche/\Igh+
(B6.Cg-Ightm1(Ighppc1-5)Cche) 		increased autoantibody level J:138356
\Ightm2.1Hws/\Ightm2.1Hws
(involves: BALB/c) 		increased anti-nuclear antigen antibody level J:142069
\Ighg1em1Wliu/\Ighg1em1Wliu
(C57BL/6-Ighg1em1Wliu) 		increased anti-double stranded DNA antibody level J:266937
increased anti-nuclear antigen antibody level J:266937
increased autoantibody level J:266937
\Ighmtm1Cgn/\Ighm+
(NOD.129S2-Ighmtm1Cgn) 		increased susceptibility to autoimmune diabetes J:37287
\Ighmtm1Cgn/\Ighm+
\Tg(Igh-6/Igh-V125)2Jwt/0
\Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt) 		increased susceptibility to autoimmune diabetes J:91865
\Ighmtm1Cgn/\Ighmtm1Cgn
(NOD.129S2-Ighmtm1Cgn) 		decreased susceptibility to autoimmune diabetes J:37287
\Ighmtm1Cgn/\Ighmtm1Cgn
(involves: 129S2/SvPas) 		increased susceptibility to induced arthritis J:157619
\Ighmtm1Cgn/\Ighmtm1Cgn
(NOD.129S2-Ighmtm1Cgn/DvsJ) 		decreased susceptibility to autoimmune diabetes J:80859
\Ighmtm1Cgn/\Ighmtm1Cgn
\Tg(Igh-VB1-8/Igh-6m)1Mjsk/?
(NODCaj.Cg-Ighmtm1Cgn Tg(Igh-VB1-8/Igh-6m)1Mjsk/FswJ) 		increased susceptibility to autoimmune diabetes J:93190
\Ighmtm1Cgn/\Ighmtm1Cgn
\Tg(IghelMD4)4Ccg/\Tg(IghelMD4)4Ccg
(NOD.Cg-Ighmtm1Cgn Tg(IghelMD4)4Ccg/DvsJ) 		decreased susceptibility to autoimmune diabetes J:80859
\Ighmtm1Cgn/\Ighmtm1Cgn
X/\Yaa
(BXSB.129S2(B6)-Ighmtm1Cgn/Dcr) 		decreased susceptibility to systemic lupus erythematosus J:206236
\Ighmtm1Msn/\Ighmtm1Msn
(involves: 129S/SvEv * C57BL/6) 		increased anti-double stranded DNA antibody level J:111817
increased autoantibody level J:111817
\Igktm1Dhu/\Igktm1Dhu
\Tg(H2-Ea-HA)HACIIAjca/0
\Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0
(C.Cg-Igktm1Dhu Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca) 		decreased susceptibility to autoimmune disorder J:209872
\Igkrstm1Nemz/\Igkrstm1Nemz
\Tg(BCL2)22Wehi/?
(involves: 129 * C57BL) 		increased anti-double stranded DNA antibody level J:132125
\Ikzf3tm1Kge/\Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6) 		autoimmune response J:81805
increased anti-double stranded DNA antibody level J:81805
increased anti-histone antibody level J:81805
increased anti-nuclear antigen antibody level J:81805
increased anti-single stranded DNA antibody level J:81805
increased autoantibody level J:81805, J:50626
\Ikzf4tm1.1Etms/\Ikzf4tm1.1Etms
(Not Specified) 		increased susceptibility to experimental autoimmune encephalomyelitis J:295208
\Il1atm1Yiw/\Il1atm1Yiw
\Il1btm1Yiw/\Il1btm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:165513
\Il1btm1Lvp/\Il1btm1Lvp
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to experimental autoimmune myasthenia gravis J:67001
\Il1r1em1Qizh/\Il1r1em1Qizh
(C57BL/6-Il1r1em1Qizh) 		increased susceptibility to induced arthritis J:338375
\Il1r1tm1Imx/\Il1r1tm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to experimental autoimmune uveoretinitis J:115094
\Il1r1tm1Imx/\Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J) 		increased susceptibility to induced arthritis J:125570
\Il1r1tm1Imx/\Il1r1tm1Imx
\Tnfrsf1atm1Imx/\Tnfrsf1atm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to experimental autoimmune uveoretinitis J:115094
\Il1r1tm1Imx/\Il1r1tm1Imx
\Vsig4tm1Gne/\Vsig4tm1Gne
(B6.Cg-Il1r1tm1Imx Vsig4tm1Gne) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:281762
\Il1r1tm1Roml/\Il1r1tm1Roml
(NOD.Cg-Il1r1tm1Roml) 		decreased susceptibility to autoimmune diabetes J:87251
\Il1r1tm1Roml/\Il1r1tm1Roml
(involves: 129S1/Sv) 		decreased susceptibility to induced arthritis J:120707
\Il1r2tm1Yiw/\Il1r2tm1Yiw
(B6.129P2-Il1r2tm1Yiw) 		increased susceptibility to induced arthritis J:274653
\Il1rntm1.1Cga/\Il1rntm1.1Cga
\Lyz2tm1(cre)Ifo/\Lyz2+
(D1.Cg-Il1rntm1.1Cga Lyz2tm1(cre)Ifo) 		increased susceptibility to induced arthritis J:162760
\Il1rntm1Nick/\Il1rntm1Nick
(involves: BALB/cAnNHsd) 		rheumatoid arthritis J:89034
\Il1rntm1Nick/\Il1rntm1Nick
(involves: BALB/cAnNHsd * C57BL/6) 		rheumatoid arthritis J:89034
\Il1rntm1Yiw/\Il1rntm1Yiw
(C.129-Il1rntm1Yiw) 		rheumatoid arthritis J:143719
\Il1rntm1Yiw/\Il1rntm1Yiw
\Il17atm1Yiw/\Il17a+
(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J) 		decreased susceptibility to induced arthritis J:83408
\Il2tm1.1Flv/\Il2tm1.1Flv
(NOD/ShiLtJ-Il2tm1.1Flv) 		abnormal susceptibility to autoimmune disorder J:150823
\Il2tm1Hor/\Il2+
(NOD.129P2(B6)-Il2tm1Hor/DvsJ) 		increased susceptibility to autoimmune diabetes J:120349
\Il2tm1Hor/\Il2tm1Hor
(C.129P2-Il2tm1Hor) 		increased susceptibility to autoimmune hemolytic anemia J:29799
\Il2tm1Hor/\Il2tm1Hor
(B6.129P2-Il2tm1Hor/J) 		increased susceptibility to autoimmune disorder J:113547
\Il2rbtm1Mak/\Il2rbtm1Mak
(either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas)) 		increased anti-nuclear antigen antibody level J:25940
increased susceptibility to autoimmune hemolytic anemia J:25940
\Il2rbtm1Mak/\Il2rbtm1Mak
(B6.129-Il2rbtm1Mak) 		increased anti-double stranded DNA antibody level J:113547
increased susceptibility to autoimmune hemolytic anemia J:113547
\Il2rbtm1Mak/\Il2rbtm1Mak
(C.129-Il2rbtm1Mak) 		increased anti-double stranded DNA antibody level J:113547
increased susceptibility to autoimmune hemolytic anemia J:113547
\Il4/Il13tm3Anjm/\Il4/Il13tm3Anjm
(C.129P2/OlaHsd-Il4/Il13tm3Anjm) 		decreased susceptibility to autoimmune disorder J:91403
\Il4/Il13tm3Anjm/\Il4/Il13tm3Anjm
(C.129P2/OlaHsd-Il4/Il13tm3Anjm) 		decreased susceptibility to autoimmune disorder J:91403
\Il4tm1Cgn/\Il4tm1Cgn
(NOD.129P2-Il4tm1Cgn) 		decreased susceptibility to autoimmune disorder J:95105
increased susceptibility to autoimmune disorder J:95105
\Il4tm1Cgn/\Il4tm1Cgn
(either: NOD.129-Il4tm1Cgn or (involves: 129 * NOD)) 		autoimmune response J:85924
\Il4tm1Cgn/\Il4tm1Cgn
\Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Il4tm1Cgn Tg(TcraBDC2.5,TcrbBDC2.5)1Doi) 		decreased susceptibility to autoimmune diabetes J:85924
\Il4tm1Kopf/\Il4tm1Kopf
\Lyntm1Ard/\Lyntm1Ard
(involves: 129P2/OlaHsd * 129S2/SvPas) 		increased anti-double stranded DNA antibody level J:161523
increased anti-nuclear antigen antibody level J:161523
\Il4tm1Nnt/\Il4tm1Nnt
(involves: C57BL/6) 		decreased susceptibility to autoimmune disorder J:91403
\Il4tm2Nnt/\Il4tm2Nnt
(BALB/c-Il4tm2Nnt/J) 		decreased susceptibility to autoimmune disorder J:141937
\Il5ratm1Ktk/\Il5ratm1Ktk
\Lyntm1Tya/\Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:91089
\Il6tm1Kopf/\Il6tm1Kopf
(B6.129S2-Il6tm1Kopf/J) 		decreased susceptibility to induced arthritis J:208213
\Il6sttm1Ern/\Il6sttm1Ern
(involves: 129S1/Sv * C57BL/6) 		increased susceptibility to induced arthritis J:142883
\Il6sttm1Thir/\Il6sttm1Thir
(involves: 129 * C57BL/6) 		increased anti-double stranded DNA antibody level J:133059
increased anti-nuclear antigen antibody level J:133059
increased anti-single stranded DNA antibody level J:133059
increased autoantibody level J:133059
rheumatoid arthritis J:133059
\Il9rtm1Jcrd/\Il9rtm1Jcrd
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:151907
\Il10raNZW/\Il10ra+
((NZB x NZW)F1) 		increased anti-chromatin antibody level J:102087
\Il10ratm1.1Tlg/\Il10ratm1.1Tlg
\Tg(Cd4-cre)1Cwi/?
(B6.Cg-Tg(Cd4-cre)1Cwi Il10ratm1.1Tlg) 		autoimmune response J:189797
\Il12atm1Cab/\Il12atm1Cab
\Il23atm1.1Thak/\Il23atm1.1Thak
(B6.Cg-Il12atm1Cab Il23atm1.1Thak) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:143970
\Il12rb2tm1Jm/\Il12rb2tm1Jm
(B6;129S1-Il12rb2tm1Jm/J) 		increased anti-nuclear antigen antibody level J:106805
\Il13tm1.1Anjm/\Il13tm1.1Anjm
(C.129P2-Il13tm1.1Anjm) 		decreased susceptibility to autoimmune disorder J:141937, J:91403
\Il13tm2Anjm/\Il13tm2Anjm
(B6.129P2-Il13tm2Anjm) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:131969
\Il15tm1Imx/\Il15tm1Imx
X/\Yaa
(BXSB.B6-Il15tm1Imx/Dcr) 		increased susceptibility to systemic lupus erythematosus J:179430
\Il17atm1Cdon/\Il17atm1Cdon
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:136279
\Il17atm1Yiw/\Il17atm1Yiw
\Il1rntm1Yiw/\Il1rntm1Yiw
(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J) 		decreased susceptibility to induced arthritis J:83408
\Il17atm1Yiw/\Il17atm1Yiw
\Il17ftm1Yiw/\Il17ftm1Yiw
\Il1rntm1Yiw/\Il1rntm1Yiw
(involves: 129 * BALB/c) 		rheumatoid arthritis J:143719
\Il17atm1Yiw/\Il17atm1Yiw
\Tg(CD2-Rorc)#Staka/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to autoimmune disorder J:230700
\Il17ctm1.1Cdon/\Il17ctm1.1Cdon
(involves: 129S6/SvEvTac) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:177650
\Il17ftm1Cdon/\Il17ftm1Cdon
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:136279
\Il17ftm1Yiw/\Il17ftm1Yiw
\Il1rntm1Yiw/\Il1rntm1Yiw
(involves: 129 * BALB/c) 		rheumatoid arthritis J:143719
\Il17rctm1Lex/\Il17rctm1Lex
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:159874
\Il21tm1Lex/\Il21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:123351
increased susceptibility to experimental autoimmune encephalomyelitis J:137377
\Il21rtm1Kopf/\Il21rtm1Kopf
(B6.129-Il21rtm1Kopf) 		increased susceptibility to experimental autoimmune encephalomyelitis J:137377
\Il21rtm1Wjl/\Il21rtm1Wjl
(NOD.Cg-Il21rtm1Wjl) 		decreased susceptibility to autoimmune diabetes J:139075
\Il21rtm1Wjl/\Il21rtm1Wjl
X/\Yaa
(BXSB.129(Cg)-Il21rtm1Wjl/Dcr) 		decreased susceptibility to systemic lupus erythematosus J:144484
\Il23atm1.1Thak/\Il23atm1.1Thak
(C57BL/6-Il23atm1.1Thak) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:143970
\Il23atm1Dnax/\Il23atm1Dnax
(involves: 129 * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:95542
\Il23rtm1Kuch/\Il23rtm1Kuch
(C57BL/6-Il23rtm1Kuch) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:148248
\Il25tm1Dart/\Il25tm1Dart
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:125296
\Il27tm1Cua/\Il27tm1Cua
(C57BL/6-Il27tm1Cua) 		increased susceptibility to experimental autoimmune encephalomyelitis J:147706
\Il27ratm1Mak/\Il27ratm1Mak
(B6.129P2-Il27ratm1Mak) 		decreased susceptibility to experimental autoimmune uveoretinitis J:116610
\Il27ratm1Mak/\Il27ratm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to induced arthritis J:151552
\Imh1NZB/\Imh1NZB
(involves: NZB * NZW) 		increased susceptibility to systemic lupus erythematosus J:26266
\Imh1NZB/\Imh1NZW
(involves: NZB * NZW) 		increased susceptibility to systemic lupus erythematosus J:22353
\Inpp5dtm1Rav/\Inpp5dtm1Rav
\Cd79atm1(cre)Reth/\Cd79a+
\Tg(IghAb36-65)1Wys/0
(involves: 129 * BALB/c * C57BL/6 * FVB/N) 		increased autoantibody level J:178833
\Ins1tm1Jja/\Ins1tm1Jja
(NOD.129S2-Ins1tm1Jja) 		decreased susceptibility to autoimmune diabetes J:85309
\Ins1tm1Jja/\Ins1tm1Jja
\Ins2tm1Jja/\Ins2tm1Jja
\Tg(Ins2*Y16A)1Ell/0
(NOD.Cg-Ins1tm1Jja Ins2tm1Jja Tg(Ins2*Y16A)1Ell) 		decreased susceptibility to autoimmune diabetes J:98583
\Ins1tm1Jja/\Ins1tm1Jja
\Ins2tm1Jja/\Ins2tm1Jja
\Tg(Ins2*Y16A)3Ell/0
(NOD.Cg-Ins1tm1Jja Ins2tm1Jja Tg(Ins2*Y16A)3Ell) 		decreased anti-insulin autoantibody level J:98583
decreased susceptibility to autoimmune diabetes J:98583
\Ins1tm1Jja/\Ins1tm1Jja
\Ins2tm1Mnt/\Ins2tm1Mnt
\Tg(Aire-cre)1Mnt/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		increased anti-insulin autoantibody level J:152798
\Ins1tm1Jja/\Ins1tm1Jja
\Tg(Ins2*Y16A)1Ell/0
(NOD.Cg-Ins1tm1Jja Tg(Ins2*Y16A)1Ell) 		increased susceptibility to autoimmune diabetes J:98583
\Ins1tm1Jja/\Ins1tm1Jja
\Tg(Ins2*Y16A)3Ell/0
(NOD.Cg-Ins1tm1Jja Tg(Ins2*Y16A)3Ell) 		autoimmune response J:98583
\Ins2C95S/\Ins2+
(C3HeB/FeJ-Ins2C95S) 		increased susceptibility to autoimmune diabetes J:122098
\Ins2C95S/\Ins2C95S
(C3HeB/FeJ-Ins2C95S) 		increased susceptibility to autoimmune diabetes J:122098
\Ins2tm1Jja/\Ins2tm1Jja
(NOD.129S2-Ins2tm1Jja) 		increased anti-insulin autoantibody level J:85309
\Ins2tm1Jja/\Ins2tm1Jja
\Tg(Ins2*Y16A)3Ell/0
(NOD.Cg-Ins2tm1Jja Tg(Ins2*Y16A)3Ell) 		autoimmune response J:98583
increased anti-insulin autoantibody level J:98583
\Irak1tm1Jth/Y
(B6.Cg-Irak1tm1Jth) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:82302
\Irak1tm1Jth/\Irak1tm1Jth
(B6.Cg-Irak1tm1Jth) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:82302
\Irak3tm1Flv/\Irak3tm1Flv
(NOD.129S1(B6)-Irak3tm1Flv) 		increased anti-insulin autoantibody level J:229884
increased susceptibility to autoimmune diabetes J:229884
\Irf1tm1Cwe/\Irf1tm1Cwe
(involves: 129/Sv * C57BL/6) 		decreased susceptibility to induced arthritis J:43086
\Irf1tm1Cwe/\Irf1tm1Cwe
(involves: 129) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:84367
\Irs1tm1Mfw/\Irs1tm1Mfw
\Irs2tm2Mfw/\Irs2tm2Mfw
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		increased susceptibility to autoimmune diabetes J:137845
\Irs1tm2Tka/\Irs1tm2Tka
\Irs2tm2Tka/\Irs2tm2Tka
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased susceptibility to autoimmune diabetes J:137846
\Itgavtm2Hyn/\Itgavtm2.1Hyn
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * FVB) 		increased autoantibody level J:125508
\Itgavtm2Hyn/\Itgavtm2.1Hyn
\Tg(Tek-cre)1Ywa/?
(involves: 129S2/SvPas * C57BL/6 * FVB * SJL) 		increased autoantibody level J:125508
\Itgaxtm1Bll/\Itgaxtm1Bll
(B6.129S7-Itgaxtm1Bll) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:122187
\Itgb2tm1Bay/\Itgb2tm1Bay
\Psrs1PL/J/\Psrs1PL/J
(B6.Cg-(D10Mit126-D10Mit38) Itgb2tm1Bay) 		rheumatoid arthritis J:134251
\Itgb2tm1Bay/\Itgb2tm1Bay
\Psrs1PL/J/\Psrs1PL/J
(B6.Cg-(D10Mit75-D10Mit271) Itgb2tm1Bay) 		rheumatoid arthritis J:134251
\Jak1M1Mhda/\Jak1+
(C3HeB/FeJ-Jak1M1Mhda) 		increased anti-nuclear antigen antibody level J:199153
\Junbtm3Wag/\Junbtm3Wag
\Tg(KRT5-cre)1Tak/0
(involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6) 		increased anti-histone antibody level J:155575
increased susceptibility to systemic lupus erythematosus J:155575
\KitW-sh/\KitW-sh
\Lyntm1Ard/\Lyntm1Ard
(involves: 101 * 129P2/OlaHsd * C3H/HeH) 		increased anti-double stranded DNA antibody level J:161523
increased anti-nuclear antigen antibody level J:161523
\KitW/\KitW-v
((WB KitW x B6.Cg-KitW-v)F1) 		decreased susceptibility to induced arthritis J:178942
\Ksr1tm1Shaw/\Ksr1tm1Shaw
(Not Specified) 		decreased susceptibility to induced arthritis J:140520
\Lag3tm1Daav/\Lag3+
\Tg(Foxp3-EGFP/cre)1cJbs/0
(NOD.Cg-Lag3tm1Daav Tg(Foxp3-EGFP/cre)1cJbs) 		decreased susceptibility to autoimmune diabetes J:260063
\Lag3tm1Daav/\Lag3tm1Daav
\Tg(Foxp3-EGFP/cre)1cJbs/0
(NOD.Cg-Lag3tm1Daav Tg(Foxp3-EGFP/cre)1cJbs) 		decreased susceptibility to autoimmune diabetes J:260063
\Laq1MRL/\Laq1MRL
(involves: C57BL/6 * MRL) 		increased susceptibility to autoimmune disorder J:45708
\Lat2tm1Mal/\Lat2tm1Mal
(B6.129S2-Lat2tm1Mal) 		increased anti-nuclear antigen antibody level J:126321
\Lat2tm1Mal/\Lat2tm1Mal
\Lime1tm1.1Mal/\Lime1tm1.1Mal
(involves: 129 * C57BL/6) 		increased anti-nuclear antigen antibody level J:126321
\Lat2tm1Wz/\Lat2tm1Wz
(B6.Cg-Lat2tm1Wz) 		increased anti-double stranded DNA antibody level J:116157
increased autoantibody level J:116157
\Lat2tm2Wz/\Lat2tm2Wz
\Tg(Lck-cre)548Jxm/0
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:116157
\Lattm1.1Lov/\Lattm1.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:116157
increased anti-nuclear antigen antibody level J:77099
increased autoantibody level J:77099
\Lattm1.1Lov/\Lattm1.1Lov
\Lat2tm1Wz/\Lat2tm1Wz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:116157
\Lattm1.1Mal/\Lattm1.1Mal
(involves: 129S2/SvPas) 		increased anti-chromatin antibody level J:125722
increased anti-erythrocyte antigen antibody level J:125722
increased anti-nuclear antigen antibody level J:125722
increased susceptibility to autoimmune hemolytic anemia J:125722
\Lbric-J/\Lbr+
((NZW/LacJ x C57BL/6J-Lbric-J/J)F1) 		increased anti-chromatin antibody level J:234168
increased anti-nuclear antigen antibody level J:234168
increased autoantibody level J:234168
increased susceptibility to systemic lupus erythematosus J:234168
\Lbw2NZB/BlScr/\Lbw2NZB/BlScr
(involves: NZB * NZW) 		increased anti-chromatin antibody level J:98150
increased autoantibody level J:98150
\Lbw2NZB/BlScr/\Lbw2NZW/LacScr
(involves: NZB * NZW) 		increased anti-chromatin antibody level J:98150
increased autoantibody level J:98150
\Lbw2NZW/LacScr/\Lbw2NZW/LacScr
(involves: NZB * NZW) 		decreased autoantibody level J:98150
\Lbw5NZW/LacScr/\Lbw5NZB/BlScr
(involves: NZB/BlScr * NZW/LacScr) 		increased susceptibility to systemic lupus erythematosus J:20991
\Lbw5NZW/LacScr/\Lbw5NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr) 		increased susceptibility to systemic lupus erythematosus J:20991
\Lbw6NZW/LacScr/\Lbw6NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr) 		increased susceptibility to systemic lupus erythematosus J:20991
\Lbw7NZB/BlScr/\Lbw7NZB/BlScr
(involves: NZB/BlScr * NZW/LacScr) 		increased susceptibility to systemic lupus erythematosus J:20991
\Lbw7NZB/BlScr/\Lbw7NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr) 		increased susceptibility to systemic lupus erythematosus J:20991
\Lbw8NZB/BlScr/\Lbw8NZB/BlScr
(involves: NZB/BlScr * NZW/LacScr) 		increased susceptibility to autoimmune disorder J:20991
\Lbw8NZB/BlScr/\Lbw8NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr) 		increased susceptibility to autoimmune disorder J:20991
\Lcp2twm/\Lcp2twm
(C57BL/6JSfdAnu-Lcp2twm/Anu) 		autoimmune response J:104190
\Lctlp1FVB/NJ/\Lctlp1FVB/NJ
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:122919
\Lctlp2FVB/NJ/\Lctlp2FVB/NJ
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:122919
\Leprdb/\Leprdb
(involves: C57BLKS/J) 		increased susceptibility to autoimmune diabetes J:7005
\Lgals1tm1Rob/\Lgals1tm1Rob
(involves: 129S/SvEv) 		increased susceptibility to experimental autoimmune encephalomyelitis J:123416
\Lgals9tm1Glp/\Lgals9tm1Glp
(B6.129S6-Lgals9tm1Glp) 		increased susceptibility to induced arthritis J:132889
\Lig4tm2.1Fwa/\Lig4tm2.1Fwa
(involves: 129S6/SvEvTac) 		increased anti-chromatin antibody level J:157574
increased anti-double stranded DNA antibody level J:157574
\ll/\ll
X/\Yaa
(BXSB/MpJScr-ll) 		decreased anti-nuclear antigen antibody level J:10973
decreased susceptibility to autoimmune disorder J:10973
\Lmb1C57BL/6Scr/\Lmb1C57BL/6Scr
(involves: C57BL/6-Faslpr * MRL-Faslpr) 		increased anti-double stranded DNA antibody level J:45708
\Lmb1C57BL/6Scr/\Lmb1MRL/MpScr
(involves: C57BL/6-Faslpr * MRL-Faslpr) 		increased anti-double stranded DNA antibody level J:45708
\Lmb2C57BL/6Scr/\Lmb2MRL/MpScr
(involves: C57BL/6-Faslpr * MRL-Faslpr) 		increased anti-double stranded DNA antibody level J:45708
\Lmb2MRL/MpScr/\Lmb2MRL/MpScr
(involves: C57BL/6-Faslpr * MRL-Faslpr) 		increased anti-double stranded DNA antibody level J:45708
\Lrch1em1Hwa/\Lrch1em1Hwa
(Not Specified) 		increased susceptibility to experimental autoimmune encephalomyelitis J:238772
\Lrp3em1Cya/\Lrp3em1Cya
(C57BL/6N-Lrp3em1Cya/Cya) 		increased susceptibility to induced arthritis J:345338
\Lta/Tnftm1Eug/\Lta/Tnftm1Eug
(involves: 129/Sv * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:115225
\Lta/Tnftm1Eug/\Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug) 		decreased susceptibility to induced arthritis J:115034
\Lta/Tnftm1Eug/\Lta/Tnftm1Eug
(involves: 129/Sv * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:115225
\Lta/Tnftm1Eug/\Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug) 		decreased susceptibility to induced arthritis J:115034
\Lta/Tnftm1Jods/\Lta/Tnftm1Jods
(C57BL/6-Lta/Tnftm1Jods) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:47428
\Lta/Tnftm1Jods/\Lta/Tnftm1Jods
(C57BL/6-Lta/Tnftm1Jods) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:47428
\Ltb4r1tm1Bodd/\Ltb4r1tm1Bodd
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to autoimmune disorder J:108446
\Ltb4r1tm1Bodd/\Ltb4r1tm1Bodd
(involves: 129S4/SvJaeSor) 		decreased susceptibility to induced arthritis J:131779
\Ltb4r1tm1Bodd/\Ltb4r1tm1Bodd
(either: (involves: 129S4/SvJaeSor * BALB/c ) or (involves: 129S4/SvJaeSor * C57BL/6)) 		decreased susceptibility to induced arthritis J:163271
\Ltb4r2tm1Bodd/\Ltb4r2tm1Bodd
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to induced arthritis J:163271
\Ltc4stm1Blam/\Ltc4stm1Blam
(C.129S7-Ltc4stm1Blam) 		autoimmune response J:182213
\Lxw1BXSB/Scr/?
(involves: BXSB/Scr * NZW/LacScr) 		increased anti-chromatin antibody level J:86924
\Lxw3NZW/LacScr/?
(involves: BXSB/Scr * NZW/LacScr) 		increased anti-chromatin antibody level J:86924
\Lynmld4/\Lynmld4
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:144799
\Lyntm1.1Calo/\Lyntm1.1Calo
\Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased autoantibody level J:200745
\Lyntm1Ard/\Lyntm1Ard
(involves: 129P2/OlaHsd) 		increased anti-double stranded DNA antibody level J:161523
increased anti-nuclear antigen antibody level J:161523
\Lyntm1Ard/\Lyntm1Ard
(B6.129P2-Lyntm1Ard) 		increased anti-double stranded DNA antibody level J:144799
increased anti-nuclear antigen antibody level J:144799
\Lyntm1Sor/\Lyntm1Sor
(involves: 129S4/SvJae) 		increased anti-double stranded DNA antibody level J:42037
\Lyntm1Sor/\Lyntm1Sor
(involves: 129S4/SvJaeSor) 		increased anti-double stranded DNA antibody level J:146161
increased autoantibody level J:200745
\Lyntm1Sor/\Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		increased anti-double stranded DNA antibody level J:71174
increased susceptibility to systemic lupus erythematosus J:71174
\Lyntm1Tya/\Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:29751
\Lynweeb/\Lynweeb
(C57BL/6-Lynweeb) 		increased anti-double stranded DNA antibody level J:146161
\Lyz2tm1(cre)Ifo/\Lyz2tm1(cre)Ifo
\Nrrostm1Wouy/\Nrrostm1Wouy
(involves: 129P2/OlaHsd) 		increased susceptibility to experimental autoimmune encephalomyelitis J:209569
\Map4k1tm1Tht/\Map4k1tm1Tht
(B6.129S7-Map4k1tm1Tht) 		increased susceptibility to experimental autoimmune encephalomyelitis J:116613
\Map4k3Gt(RRO270)Byg/\Map4k3Gt(RRO270)Byg
(involves: 129P2/OlaHsd) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:177642
\Mapk3tm1Gela/\Mapk3tm1Gela
(either: 129(Cg)-Mapk3tm1Gela or B6.129-Mapk3tm1Gela) 		increased susceptibility to experimental autoimmune encephalomyelitis J:107504
\Mapk11tm1Jda/\Mapk11tm1Jda
\Mapk14tm1Jda/\Mapk14tm1Jda
(involves: 129 * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:165966
decreased susceptibility to induced arthritis J:165966
\Mbpshi/\Mbpshi
(involves: BALB/c * C3HeB/Fe * SWV) 		increased susceptibility to experimental autoimmune encephalomyelitis J:48412
\Mcph1Tg(HLA-A2.1)1Enge/\Mcph1+
(NOD.B6-Mcph1Tg(HLA-A2.1)1Enge) 		increased susceptibility to autoimmune diabetes J:109851
\Mcph1Tg(HLA-A2.1)1Enge/\Mcph1Tg(HLA-A2.1)1Enge
(NOD.B6-Mcph1Tg(HLA-A2.1)1Enge) 		increased susceptibility to autoimmune diabetes J:109851
\Mertktm1Gkm/\Mertktm1Gkm
(NOD.129P2-Mertktm1Gkm) 		decreased susceptibility to autoimmune diabetes J:147153
\Mertktm1Gkm/\Mertktm1Gkm
(B6.129P2-Mertktm1Gkm) 		decreased autoantibody level J:136377
\Mex3btm1.1Mbld/\Mex3btm1.1Mbld
\Plekha5Tg(AMH-cre)1Flor/\Plekha5+
(involves: C57BL/6 * SJL) 		increased anti-sperm antibody level J:213588
\Mfge8tm1Osa/\Mfge8tm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:225063
\Mfge8tm1Osa/\Mfge8tm1Osa
\Timd4tm1Osa/\Timd4tm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:187181
increased anti-nuclear antigen antibody level J:187181
\Mir125atm1Smoc/\Mir125atm1Smoc
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:224880
\Mir140tm1.1Asah/\Mir140tm1.1Asah
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased susceptibility to induced arthritis J:160358
\Mir146tm1.1Lfl/\Mir146tm1.1Lfl
\Tg(Cr2-cre)3Cgn/0
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:266124
\Mir146tm2.1Bal/\Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N) 		increased anti-double stranded DNA antibody level J:173671
\Mir155tm1.1Rsky/\Mir155tm1.1Rsky
(B6.Cg-Mir155tm1Rsky/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:226678
\Mir204tm1.2Dic/\Mir204tm1.2Dic
\Mir211tm1.2Dic/\Mir211tm1.2Dic
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6) 		increased susceptibility to induced arthritis J:345335
\Mir210tm1.1Wtsi/\Mir210tm1.1Wtsi
(involves: C57BL/6J * C57BL/6N) 		increased anti-chromatin antibody level J:205868
increased anti-double stranded DNA antibody level J:205868
increased anti-nuclear antigen antibody level J:205868
\Mirc33tm1.1Cwh/\Mirc33tm1.1Cwh
(involves: 129X1/SvJ) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:189763
\Mmdtm1Beij/\Mmdtm1Beij
(Not Specified) 		decreased susceptibility to induced arthritis J:304637
\Mmp2tm1Ito/\Mmp2tm1Ito
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:94099
\Mmp9tm1Arnd/\Mmp9tm1Arnd
(involves: 129P2/OlaHsd) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:58833
\Mmp9tm1Tvu/\Mmp9tm1Tvu
(C3N.129S6-Mmp9tm1Tvu) 		decreased susceptibility to induced arthritis J:150311
\Mogtm1(cre)Gkl/\Mogtm1(cre)Gkl
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(C57BL/6-Mogtm1(cre)Gkl Tg(Tcra2D2,Tcrb2D2)1Kuch) 		increased susceptibility to experimental autoimmune encephalomyelitis J:151335
\Mogtm1Dpd/\Mogtm1Dpd
(B6.129S2-Mogtm1Dpd) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:85155
\Mogtm1Dpd/\Mogtm1Dpd
\Rag2tm1Cgn/\Rag2tm1Cgn
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:151335
\Mogtm1Dpd/\Mogtm1Dpd
\Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0
(SJL.Cg-Mogtm1Dpd Tg(H2-Kb-Tcra,-Tcrb)1640Kurs) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:149511
\Mogtm1Dpd/\Mogtm1Dpd
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:151335
\Mogtm1Reid/\Mogtm1Reid
(B6.129S1/Sv-Mogtm1Reid) 		increased susceptibility to experimental autoimmune encephalomyelitis J:86663
\Mogtm1Reid/\Mogtm1Reid
(129/Sv-Mogtm1Reid) 		increased susceptibility to experimental autoimmune encephalomyelitis J:86663
\Mpgtm1Lds/\Mpgtm1Lds
(involves: 129P2/OlaHsd * C57BL/6) 		autoimmune response J:118148
decreased susceptibility to autoimmune diabetes J:118148
\Mpotm1Lus/\Mpotm1Lus
(involves: 129X1/SvJ * C57BL/6J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:102965
\Mpztm1Msch/\Mpz+
(B6.129S7-Mpztm1Msch) 		autoimmune response J:59319
\Mr1tm1Gfn/\Mr1tm1Gfn
(B6.129P2-Mr1tm1Gfn) 		increased susceptibility to experimental autoimmune encephalomyelitis J:112657
\Mt1tm1Bri/\Mt1tm1Bri
\Mt2tm1Bri/\Mt2tm1Bri
(involves: 129S7/SvEvBrd) 		increased susceptibility to experimental autoimmune encephalomyelitis J:103102
\mt-Nd2m1
(ALR/Lt) 		decreased susceptibility to autoimmune diabetes J:117602, J:97969
\Mta2tm1.1Yzha/\Mta2tm1.1Yzha
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased anti-double stranded DNA antibody level J:137101
increased autoantibody level J:137101
increased susceptibility to systemic lupus erythematosus J:137101
\Mtus1Gt(RRA048)Byg/\Mtus1Gt(RRA048)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to systemic lupus erythematosus J:212144
\Mtv7BALB/c/\Mtv7BALB/c
(involves: B10.Q * BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:27701
\Mtv7BALB/c/\Mtv7DBA/2
(involves: B10.Q * BALB/c * DBA/2) 		decreased susceptibility to induced arthritis J:27701
\Mtv7DBA/2/\Mtv7DBA/2
(C.D2-Mtv7DBA/2) 		decreased susceptibility to induced arthritis J:27701
\Muc19sld/\Muc19sld
(NFS/N-Muc19sld) 		increased susceptibility to autoimmune disorder J:216958, J:20364
\Myd88tm1Aki/\Myd88tm1Aki
(involves: 129P2/OlaHsd) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:105435
\Myd88tm1Aki/\Myd88tm1Aki
(C.129P2-Myd88tm1Aki) 		decreased susceptibility to induced arthritis J:178054
\Myd88tm1Aki/\Myd88tm1Aki
\Tanktm1Aki/\Tanktm1Aki
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:151757
\Myl3tm1a(EUCOMM)Hmgu/\Myl3tm1a(EUCOMM)Hmgu
\Tg(Col2a1-cre/ERT)KA3Smac/0
(involves: C57BL/6J * C57BL/6N * FVB/N) 		increased susceptibility to induced arthritis J:343166
\Nba4NZB/\Nba4NZB
(involves: NZB * SWR) 		increased anti-double stranded DNA antibody level J:96060
increased anti-histone antibody level J:96263
increased anti-single stranded DNA antibody level J:96060
\Nba4NZB/\Nba4SWR
(involves: NZB * SWR) 		increased anti-histone antibody level J:96263
\Nba10NZB/?
(involves: C57BL/6 * NZB * SB/Le) 		increased anti-chromatin antibody level J:95829
increased anti-double stranded DNA antibody level J:95829
\Nba10NZB/\Nba10NZB
\Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZB) 		increased anti-chromatin antibody level J:134128
increased anti-double stranded DNA antibody level J:134128
increased susceptibility to systemic lupus erythematosus J:134128
\Nba10NZB/\Nba10NZB
\Tlr7tm1Aki/Y
X/\Yaa
(B6.Cg-Nba10NZB Tlr7tm1Aki Yaa) 		increased anti-chromatin antibody level J:137656
\Nba10NZB/\Nba10NZB
X/\Yaa
(C57BL/6-Nba2 Yaa) 		increased anti-chromatin antibody level J:137656
increased anti-nuclear antigen antibody level J:95829
increased autoantibody level J:137656
increased susceptibility to autoimmune disorder J:95829
\Nba12NZB/\Nba12NZB
(involves: NZB * SWR) 		increased anti-double stranded DNA antibody level J:96263
\Nba12NZB/\Nba12SWR
(involves: NZB * SWR) 		increased anti-double stranded DNA antibody level J:96263
\Nbwa1NZB/?
(involves: BALB/c * NZB * NZW) 		increased anti-chromatin antibody level J:88464
increased anti-double stranded DNA antibody level J:88464
increased anti-single stranded DNA antibody level J:88464
increased susceptibility to systemic lupus erythematosus J:88464
\Nbwa2NZB/?
(involves: BALB/c * NZB * NZW) 		increased susceptibility to systemic lupus erythematosus J:88464
\Nbwa2NZW/?
(involves: BALB/c * NZB * NZW) 		increased anti-double stranded DNA antibody level J:88464
increased susceptibility to systemic lupus erythematosus J:88464
\Ncf2tm1b(EUCOMM)Wtsi/\Ncf2+
(NZM2328.B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi) 		increased anti-double stranded DNA antibody level J:260777
increased susceptibility to systemic lupus erythematosus J:260777
\Ncf2tm1b(EUCOMM)Wtsi/\Ncf2tm1b(EUCOMM)Wtsi
(NZM2328.B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi) 		increased anti-double stranded DNA antibody level J:260777
increased susceptibility to systemic lupus erythematosus J:260777
\Ndst2tm1Rls/\Ndst2tm1Rls
(B6.Cg-Ndst2tm1Rls) 		decreased susceptibility to induced arthritis J:142880
\Nek7M1Btlr/\Nek7M1Btlr
(C57BL/6J-Nek7M1Btlr) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:226677
\Nfatc1tm1.1Fbs/\Nfatc1tm1.1Fbs
(C57BL/6-Nfatc1tm1.1Fbs) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:305649
\Nfatc1tm1Rao/\Nfatc1tm1Rao
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:177319
\Nfe2l2tm1Mym/\Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * ICR) 		increased anti-double stranded DNA antibody level J:104016
increased anti-nuclear antigen antibody level J:104016
\Nfe2l2tm1Mym/\Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to experimental autoimmune uveoretinitis J:150597
\Nfe2l2tm1Ywk/\Nfe2l2tm1Ywk
(B6.129X1-Nfe2l2tm1Ywk) 		increased anti-double stranded DNA antibody level J:165602
\Nfil3tm1.1Kubo/\Nfil3tm1.1Kubo
(B6.Cg-Nfil3tm1.1Kubo) 		increased susceptibility to experimental autoimmune encephalomyelitis J:172134
\Nfkb1tm1Bal/\Nfkb1tm1Bal
(B6;129P-Nfkb1tm1Bal/J) 		decreased susceptibility to autoimmune diabetes J:118907
\Nfkb2Lym1/\Nfkb2Lym1
(involves: BALB/c) 		autoimmune response J:154812
\Nfkbiatm1.1Pjc/\Nfkbiatm1.1Pjc
(involves: C57BL/6) 		autoimmune response J:163686
increased anti-insulin autoantibody level J:163686
increased anti-nuclear antigen antibody level J:163686
\Nfkbibtm1Bal/\Nfkbibtm1Bal
(B6.129S1-Nfkbibtm1Bal) 		decreased susceptibility to induced arthritis J:163302
\Ngfrtm1Jae/\Ngfrtm1Jae
(B6.129S4-Ngfrtm1Jae) 		increased susceptibility to experimental autoimmune encephalomyelitis J:112769
\Ninj1tm1Gto/\Ninj1+
(B6.129P2-Ninj1tm1Gto) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:209516
\Ninj1tm1Gto/\Ninj1tm1Gto
(B6.129P2-Ninj1tm1Gto) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:209516
\Nlrp3M6Btlr/\Nlrp3M6Btlr
(C57BL/6J-Nlrp3M6Btlr) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:226677
\Nlrp3tm1Wstr/\Nlrp3+
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:150053
\Nlrp3tm2Hhf/\Nlrp3tm2Hhf
\Vsig4tm1Gne/\Vsig4tm1Gne
(B6.Cg-Nlrp3tm2Hhf Vsig4tm1Gne) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:281762
\Nlrp10tm1Seis/\Nlrp10tm1Seis
(B6.Cg-Nlrp10tm1Seis) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:183989
\Nod2tm1Flv/\Nod2tm1Flv
(C.129S1-Nod2tm1Flv) 		decreased susceptibility to induced arthritis J:178054
\Nos2tm1Mrl/\Nos2tm1Mrl
(involves: 129S7/SvEvBrd * PL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:46192
\Nr3c1tm2.1Gsc/\Nr3c1+
(B6.129P2-Nr3c1tm2.1Gsc) 		increased susceptibility to experimental autoimmune encephalomyelitis J:137157
\Nr3c1tm2Gsc/\Nr3c1tm2Gsc
\Tg(Lck-cre)I57Jxm/0
(B6.Cg-Nr3c1tm2Gsc Tg(Lck-cre)I57Jxm) 		increased susceptibility to experimental autoimmune encephalomyelitis J:137157
\Nrrostm1Lex/\Nrrostm1Lex
(B6.129S5-Nrrostm1Lex) 		increased susceptibility to experimental autoimmune encephalomyelitis J:209569
\Nudt7em1Ejj/\Nudt7em1Ejj
(involves: C57BL/6N) 		increased susceptibility to induced arthritis J:266261
\Nwa2NZW/LacJ/\Nwa2NZW/LacJ
(involves: BALB/cJ * NZW/LacJ) 		increased anti-histone antibody level J:35434
increased anti-single stranded DNA antibody level J:35434
\Otub1tm1c(EUCOMM)Hmgu/\Otub1tm1c(EUCOMM)Hmgu
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		increased anti-double stranded DNA antibody level J:280549
increased anti-nuclear antigen antibody level J:280549
increased susceptibility to autoimmune disorder J:280549
increased susceptibility to systemic lupus erythematosus J:280549
\Paam1MRL/MpJ/\Paam1MRL/MpJ
(involves: C3H/HeJ * MRL/MpJ) 		increased susceptibility to autoimmune disorder J:76107
\Paam2MRL/MpJ/\Paam2MRL/MpJ
(involves: C3H/HeJ * MRL/MpJ) 		increased susceptibility to autoimmune disorder J:76107
\Padi2tm1Lex/\Padi2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		autoimmune response J:190651
\Panx3tm1c(KOMP)Wtsi/\Panx3tm1c(KOMP)Wtsi
\Tg(Col2a1-cre)1Star/0
(involves: C3H * C57BL/6 * C57BL/6J * C57BL/6N) 		decreased susceptibility to induced arthritis J:233542
\Panx3tm1d(KOMP)Wtsi/\Panx3tm1d(KOMP)Wtsi
(involves: BALB/cJ * C3H * C57BL/6 * C57BL/6N) 		decreased susceptibility to induced arthritis J:233542
\Pbat1BXSB/Slc/\Pbat1BXSB/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
\Pbat1BXSB/Slc/\Pbat1NZW/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
\Pbat2BXSB/Slc/\Pbat2BXSB/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
\Pbat2BXSB/Slc/\Pbat2NZW/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
\Pdcd1tm1.1Shr/\Pdcd1tm1.1Shr
\Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6) 		increased susceptibility to autoimmune diabetes J:153040
\Pdcd1tm1Hon/\Pdcd1tm1Hon
(C.129S2(B6)-Pdcd1tm1Hon) 		increased autoantibody level J:66979
\Pdcd1tm1Hon/\Pdcd1tm1Hon
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:140751
\Pdcd1tm1Hon/\Pdcd1tm1Hon
\Vsirtm1Lex/\Vsirtm1Lex
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:222944
\Pdcd1tm1Llc/\Pdcd1tm1Llc
(involves: 129S5/SvEvBrd) 		increased susceptibility to experimental autoimmune encephalomyelitis J:126829
\Pdcd1lg2tm3Shr/\Pdcd1lg2tm3Shr
(involves: C57BL/6 * NOD/MrkTac) 		increased susceptibility to autoimmune diabetes J:123785
\Pdcd4tm1Yhcn/\Pdcd4tm1Yhcn
(B6.129S6-Pdcd4tm1Yhcn) 		decreased susceptibility to autoimmune diabetes J:120583
decreased susceptibility to experimental autoimmune encephalomyelitis J:120583
\Pecam1tm1Mak/\Pecam1+
(D1.129P2-Pecam1tm1Mak) 		increased susceptibility to induced arthritis J:106275
\Pecam1tm1Mak/\Pecam1tm1Mak
(D1.129P2-Pecam1tm1Mak) 		increased susceptibility to induced arthritis J:106275
\Pgam1tm1.1Hiko/\Pgam1tm1.1Hiko
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:293746
\Pgap3tm1.1Ymra/\Pgap3tm1.1Ymra
(involves: 129 * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:181221
\Pgap3tm1.1Ymra/\Pgap3tm1.1Ymra
(B6.Cg-Pgap3tm1.1Ymra) 		increased anti-double stranded DNA antibody level J:203443
increased anti-single stranded DNA antibody level J:203443
\Pgia1BALB/cCrl/\Pgia1DBA/2Crl
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
increased susceptibility to autoimmune disorder J:66460
\Pgia2BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
\Pgia3DBA/2Crl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
\Pgia4BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
\Pgia6BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
\Pgia7BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
\Pgia8DBA/2/\Pgia8DBA/2
(C.D2-(D15Mit12-D15Mit267)) 		decreased susceptibility to induced arthritis J:137478
\Pgia8DBA/2/\Pgia8DBA/2
(involves: BALB/c * DBA/2) 		decreased susceptibility to induced arthritis J:137478
\Pgia9DBA/2/\Pgia9DBA/2
(C.D2-(D15Mit267-D15Mit41)) 		decreased susceptibility to induced arthritis J:137478
\Pgia9DBA/2/\Pgia9DBA/2
(involves: BALB/c * DBA/2) 		decreased susceptibility to induced arthritis J:137478
\Pgia10BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
\Pgia11BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
\Pgia13C3H/HeJCr/\Pgia13C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6) 		increased susceptibility to induced arthritis J:65424
\Pgia14C3H/HeJCr/\Pgia14C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6) 		increased susceptibility to induced arthritis J:65424
\Pgia15C3H/HeJCr/\Pgia15C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6) 		increased susceptibility to induced arthritis J:65424
\Pgia16C3H/HeJCr/\Pgia16C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6) 		increased susceptibility to autoimmune disorder J:65424
\Pgia39DBA/2Crl/\Pgia39DBA/2Crl
\Pgia6DBA/2Crl/\Pgia6DBA/2Crl
(involves: BALB/cCrl * DBA/2Crl) 		increased susceptibility to induced arthritis J:84150
\Pgia39DBA/2Crl/\Pgia39DBA/2Crl
\Pgia26BALB/cCrl/\Pgia26BALB/cCrl
(involves: BALB/cCrl * DBA/2Crl) 		increased susceptibility to induced arthritis J:84150
\Pgis1DBA/2/\Pgis1DBA/2
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
\Pgis1DBA/2/\Pgis1DBA/2
\Pgis2BALB/c/\Pgis2BALB/c
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
\Pgis1DBA/2/\Pgis1DBA/2
\Pgis2BALB/c/\Pgis2DBA/2
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
\Pgis2BALB/c/\Pgis2BALB/c
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
\Pgis2BALB/c/\Pgis2DBA/2
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
\Pglyrp1tm1Rdz/\Pglyrp1tm1Rdz
(C.129S-Pglyrp1tm1Rdz) 		increased susceptibility to induced arthritis J:178054
\Pglyrp1tm1Rdz/\Pglyrp1tm1Rdz
\Pglyrp2tm1Rdz/\Pglyrp2tm1Rdz
(C.129S-Pglyrp1tm1Rdz Pglyrp2tm1Rdz) 		decreased susceptibility to induced arthritis J:178054
\Pglyrp2tm1Rdz/\Pglyrp2tm1Rdz
(C.129S-Pglyrp2tm1Rdz) 		decreased susceptibility to induced arthritis J:178054
\Pik3c2aGt(OST288105)Lex/\Pik3c2aGt(OST288105)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased anti-double stranded DNA antibody level J:169710
\Pik3cdem1.1Pls/\Pik3cd+
(Not Specified) 		increased anti-double stranded DNA antibody level J:282486
increased anti-nuclear antigen antibody level J:282486
\Pik3cdtm1Tnr/\Pik3cdtm1Tnr
(B6.129S4-Pik3cdtm1Tnr) 		decreased susceptibility to induced arthritis J:134324
\Pik3cdtm1Tnr/\Pik3cdtm1Tnr
\Pik3cgtm1Pngr/\Pik3cgtm1Pngr
(B6.129-Pik3cdtm1Tnr Pik3cgtm1Pngr) 		decreased susceptibility to induced arthritis J:134324
\Pik3cgtm1Pngr/\Pik3cgtm1Pngr
(B6.129P2-Pik3cgtm1Pngr) 		decreased susceptibility to induced arthritis J:134324
\Pkn1tm1Kik/\Pkn1tm1Kik
(B6.129P2-Pkn1tm1Kik) 		increased anti-double stranded DNA antibody level J:193187
\Pla1aem1Appsc/\Pla1aem1Appsc
(C57BL/6J-Pla1aem1Appsc) 		decreased susceptibility to induced arthritis J:333902
\Pla2g4atm1Tksh/\Pla2g4atm1Tksh
(B6.129P2-Pla2g4atm1Tksh) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:107430
\Plautm1Mlg/\Plautm1Mlg
(B6.Cg-Plautm1Mlg) 		decreased susceptibility to induced arthritis J:75303
\Plcg1tm1Gcrp/\Plcg1tm1Rwen
\Tg(Cd4-cre)1Cwi/0
(either: B6.Cg-Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2)) 		increased anti-double stranded DNA antibody level J:157757
\Plcg2tm1Jni/\Plcg2tm1Jni
(involves: 129P2/OlaHsd) 		decreased susceptibility to induced arthritis J:157619
\Plcl2tm1Tta/\Plcl2tm1Tta
(involves: 129P2/OlaHsd) 		increased anti-nuclear antigen antibody level J:85960
\Pld4thss/\Pld4thss
(BALB/cJ-Pld4thss/GrsrJ) 		increased anti-nuclear antigen antibody level J:278304
\plt/\plt
(either: B6.DDD-plt or C.DDD-plt) 		increased susceptibility to autoimmune disorder J:110910
\Polbtm1.1Jbsw/\Polb+
(involves: 129/Sv * C57BL/6) 		increased anti-nuclear antigen antibody level J:206872
\Polbtm1.1Jbsw/\Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6) 		increased anti-nuclear antigen antibody level J:206872
increased susceptibility to systemic lupus erythematosus J:206872
\Ppargtm1.1Gonz/\Ppargtm1.1Gonz
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:168799
increased anti-nuclear antigen antibody level J:168799
increased anti-single stranded DNA antibody level J:168799
increased autoantibody level J:168799
\Ppargtm1Tka/\Pparg+
(involves: C57BL/6 * CBA * ICR) 		increased susceptibility to induced arthritis J:58222
\Ppargtm2Rev/\Ppargtm2Rev
\Tg(Cd4-cre)1Cwi/?
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased susceptibility to experimental autoimmune encephalomyelitis J:153358
\Prdm1tm1Clme/\Prdm1tm1Clme
\Tg(Itgax-cre)1-1Reiz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased anti-double stranded DNA antibody level J:178876
increased anti-nuclear antigen antibody level J:178876
increased autoantibody level J:178876
\Prf1tm1Clrk/\Prf1tm1Clrk
(involves: 129S7/SvEvBrd * BALB/c * NOD) 		decreased susceptibility to autoimmune diabetes J:64051
\Prf1tm1Clrk/\Prf1tm1Clrk
\Tg(INS-Il10)#Sar/0
(involves: 129S7/SvEvBrd * BALB/c * NOD) 		decreased susceptibility to autoimmune diabetes J:64051
\Prf1tm1Sdz/\Prf1+
(NOD.B6-Prf1tm1Sdz) 		decreased susceptibility to autoimmune diabetes J:43468
\Prf1tm1Sdz/\Prf1tm1Sdz
(NOD.B6-Prf1tm1Sdz) 		decreased susceptibility to autoimmune diabetes J:43468
\Prf1tm1Sdz/\Prf1tm1Sdz
X/\Yaa
(BXSB.B6-Prf1tm1Sdz/Dcr) 		autoimmune response J:179430
\Prkcdtm1Kin/\Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-chromatin antibody level J:76135
\Prkcdtm1Qxu/\Prkcdtm1Qxu
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-nuclear antigen antibody level J:76134
\Prkcdtm1Qxu/\Prkcdtm1Qxu
\Tg(IghelMD4)4Ccg/0
\Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * C57BL/6) 		autoimmune response J:76134
\Prkcitm1Rfar/\Prkci+
\Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		increased susceptibility to autoimmune diabetes J:123964
\Prkcqtm1Litt/\Prkcqtm1Litt
(B6.129P2-Prkcqtm1Litt) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:129421
\Prkdcscid/\Prkdcscid
\Tg(Ins2-Fasl)24Ach/0
(NOD.Cg-Prkdcscid Tg(Ins2-Fasl)24Ach) 		decreased susceptibility to autoimmune diabetes J:81416
increased susceptibility to autoimmune diabetes J:81416
\Prkdcscid/\Prkdcscid
\Tg(INS-Il10)#Sar/0
(NOD.Cg-Prkdcscid Tg(INS-Il10)#Sar) 		increased susceptibility to autoimmune diabetes J:66103
\Prkdcscid/\Prkdcscid
\Tg(TcraAI4)1Dvs/0
\Tg(TcrbAI4)1Dvs/0
(NOD.Cg-Prkdcscid Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs) 		increased susceptibility to autoimmune diabetes J:93553
\Psen1tm1Bdes/\Psen1+
\Psen2tm1Bdes/\Psen2tm1Bdes
(involves: 129P2/OlaHsd) 		autoimmune response J:91235
increased anti-single stranded DNA antibody level J:91235
increased susceptibility to autoimmune disorder J:91235
\Pstpip2Lupo/\Pstpip2Lupo
(either: (involves: C3HeB/FeJ) or (involves: C3HeB/FeJ * C57BL/6J)) 		increased autoantibody level J:125785
\Pstpip2m1Bcs/\Pstpip2m1Bcs
(involves: C57BL/6) 		autoimmune response J:196534
\Ptger4tm1Bhk/\Ptger4tm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased susceptibility to induced arthritis J:78964
rheumatoid arthritis J:78964
\Ptgs1tm1Unc/\Ptgs1tm1Unc
(B6.129P2-Ptgs1tm1Unc) 		decreased susceptibility to induced arthritis J:110716
\Ptgs2tm1Unc/\Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc) 		decreased susceptibility to induced arthritis J:110716
\Ptpn6m1Btlr/\Ptpn6m1Btlr
(C57BL/6J-Ptpn6m1Btlr/Mmucd) 		increased anti-chromatin antibody level J:142845
\Ptpn6me-v/\Ptpn6me-v
(C57BL/6J-Ptpn6me-v) 		rheumatoid arthritis J:20845
\Ptpn6me/\Ptpn6me
(C57BL/6J-Ptpn6me/J) 		autoimmune response J:5579
\Ptpn6me/\Ptpn6me
(involves: C3H/HeN * C57BL/6J * NFS) 		increased autoantibody level J:30994
\Ptpn12tm1Vei/\Ptpn12tm1Vei
\Tg(Lck-cre)1Cwi/0
(B6.Cg-Ptpn12tm1Vei Tg(Lck-cre)1Cwi) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:163910
\Ptpn22tm1.1Draw/\Ptpn22+
(involves: 129 * C57BL/6) 		autoimmune response J:201448
increased anti-double stranded DNA antibody level J:201448
\Ptpn22tm1.1Draw/\Ptpn22tm1.1Draw
(involves: 129 * C57BL/6) 		autoimmune response J:201448
increased anti-double stranded DNA antibody level J:201448
increased anti-insulin autoantibody level J:201448
\Ptpn22tm2Achn/\Ptpn22tm2Achn
\Ptprctm1Weis/\Ptprctm1Weis
(B6.Cg-Ptprctm1Weis Ptpn22tm2Achn) 		increased autoantibody level J:147129
\Ptprctm1Weis/\Ptprc+
(involves: 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:66501
increased susceptibility to autoimmune disorder J:66501
\Ptprctm1Weis/\Ptprctm1Weis
(involves: 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:66501
increased susceptibility to autoimmune disorder J:66501
\Ptprntm1Aln/\Ptprntm1Aln
(NOD.129S4-Ptprntm1Aln) 		increased susceptibility to autoimmune diabetes J:107161
\Ptprz1tm1Schl/\Ptprz1tm1Schl
(involves: 129 * Swiss Webster) 		increased susceptibility to experimental autoimmune encephalomyelitis J:79860
\Rag1tm1Mom/\Rag1tm1Mom
(involves: 129S7/SvEvBrd * C57BL/6) 		autoimmune response J:138466
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(TcraAI4)1Dvs/0
\Tg(TcrbAI4)1Dvs/0
(NOD.Cg-Rag1tm1Mom Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs/Dvs) 		increased susceptibility to autoimmune diabetes J:94192
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(TcraBDC12-4.1)10Jos/0
\Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		increased susceptibility to autoimmune diabetes J:111874
\Rag1tm1Mom/\Rag1tm1Mom
\Tnftm2Gkl/\Tnf+
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6) 		rheumatoid arthritis J:54056
\Rag2tm1.1Cgn/\Rag2tm1.1Cgn
\Tg(HLA-DR2)#Lfug/0
\Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2) 		autoimmune response J:134764
\Rasgrp1lag/\Rasgrp1lag
(involves: 129 * C57BL/6) 		increased susceptibility to systemic lupus erythematosus J:85189
\Rasgrp1m1Anu/\Rasgrp1+
(involves: C57BL/6JSfdAnu * CBA/J) 		increased anti-nuclear antigen antibody level J:207898
\Rasgrp1m1Anu/\Rasgrp1m1Anu
(C57BL/6JSfdAnu-Rasgrp1m1Anu) 		autoimmune response J:104190
\Rasgrp1m1Anu/\Rasgrp1m1Anu
(involves: C57BL/6JSfdAnu * CBA/J) 		increased anti-nuclear antigen antibody level J:207898
\Rasgrp1tm1.1Wz/\Rasgrp1tm1.1Wz
(B6.Cg-Rasgrp1tm1.1Wz) 		increased autoantibody level J:225109
\Rasgrp4tm1(cre)Rls/\Rasgrp4tm1(cre)Rls
(C57BL/6-Rasgrp4tm1(cre)Rls) 		decreased susceptibility to induced arthritis J:186519
\Rassf5tm1Kina/\Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina) 		increased anti-double stranded DNA antibody level J:168749
\Rc3h1san/\Rc3h1san
(either: C57BL/6JSfdAnu-Rc3h1san/Anu or (involves: C57BL/6JSfdAnu * CBA/Ca)) 		increased anti-double stranded DNA antibody level J:98938
increased anti-nuclear antigen antibody level J:98938
\Reltm1Hcl/\Reltm1Hcl
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:118907
decreased susceptibility to experimental autoimmune encephalomyelitis J:79107
\Rftn1tm1Ayos/\Rftn1tm1Ayos
(B6.Cg-Rftn1tm1Ayos) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:150299
\Rnaseh2bem1Anu/\Rnaseh2b+
\Tlr7em2Anu/\Tlr7+
(C57BL/6NCrl-Rnaseh2bem1Anu Tlr7em2Anu) 		increased autoantibody level J:324448
\Rnf128tm1Cdon/\Rnf128+
(involves: 129 * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:160681
\Rnf128tm1Cdon/\Rnf128tm1Cdon
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:160681
\Rnf128tm1Cdon/\Rnf128tm1Cdon
(involves: 129 * C57BL/6) 		increased anti-double stranded DNA antibody level J:160681
increased susceptibility to experimental autoimmune encephalomyelitis J:160681
\Ro60tm1Woln/\Ro60+
(involves: 129S1/Sv * C57BL/6) 		increased anti-nuclear antigen antibody level J:84627
\Ro60tm1Woln/\Ro60tm1Woln
(involves: 129S1/Sv * C57BL/6) 		increased anti-chromatin antibody level J:84627
increased anti-double stranded DNA antibody level J:84627
increased anti-histone antibody level J:84627
increased anti-nuclear antigen antibody level J:84627
increased anti-single stranded DNA antibody level J:84627
\Rorctm1.1Zsun/\Rorctm1.1Zsun
(B6(129S4)-Rorctm1.1Zsun) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:248565
\Rorctm1Litt/\Rorctm1Litt
(involves: 129P2/OlaHsd) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:248565
\Rpl13atm1.1Jesc/\Rpl13atm1.1Jesc
(NOD.129S5(Cg)-Rpl13atm1.1Jesc) 		decreased susceptibility to autoimmune diabetes J:237822
\Rr17tm1.1Cdon/\Rr17tm1.1Cdon
(involves: 129S6/SvEvTac * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:181186
\Rragcem1Efe/\Rragc+
\Tg(Vav-BCL2)69Jad/0
(Not Specified) 		decreased susceptibility to autoimmune disorder J:320567
\Rubcnem1Dgre/\Rubcnem1Dgre
(involves: C57BL/6 * C57BL/6N) 		increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
\Rxratm1Krc/\Rxratm1Krc
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased anti-double stranded DNA antibody level J:168799
increased anti-nuclear antigen antibody level J:168799
increased anti-single stranded DNA antibody level J:168799
increased autoantibody level J:168799
\S1pr1tm1Jch/\S1pr1tm1Jch
\Tg(GFAP-cre)25Mes/?
(involves: C57BL/6J * FVB/N) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:168824
\S1pr1tm1Jch/\S1pr1tm1Jch
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6J * SJL) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:168824
\Satb1tm2Kos/\Satb1tm2Kos
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca) 		increased anti-nuclear antigen antibody level J:252606
increased autoantibody level J:252606
increased susceptibility to autoimmune disorder J:252606
\Scara5tm1Ktry/\Scara5tm1Ktry
(B6N.129X1-Scara5tm1Ktry) 		increased anti-nuclear antigen antibody level J:195536
\Scarf1tm1Tkms/\Scarf1tm1Tkms
(involves: C57BL/6) 		increased anti-histone antibody level J:208237
increased anti-nuclear antigen antibody level J:208237
increased anti-single stranded DNA antibody level J:208237
increased susceptibility to systemic lupus erythematosus J:208237
\Secia1DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
\Secia2DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
\Secia3FVB/NJ/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
\Secia4DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
\Secia5DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
\Secia6DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
\Secia7FVB/NJ/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
\Secia8FVB/NJ/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
\Selltm1Flv/\Sell+
(involves: C57BL/6 * NOD) 		decreased susceptibility to autoimmune diabetes J:88947
\Selltm1Flv/\Selltm1Flv
(involves: C57BL/6 * NOD) 		decreased susceptibility to autoimmune disorder J:88947
\Selptm1Bay/\Selptm1Bay
(D1.129S7(B6J)-Selptm1Bay) 		increased susceptibility to induced arthritis J:57086
\Senp1tm1Wami/\Senp1tm1Wami
\Tg(Fabp4-cre)#Abel/0
(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel) 		increased anti-insulin autoantibody level J:228009
increased susceptibility to autoimmune diabetes J:228009
\Shcbp1tm1c(EUCOMM)Wtsi/\Shcbp1tm1c(EUCOMM)Wtsi
\Tg(Lck-cre)1Cwi/?
(involves: C57BL/6 * DBA/2) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:212898
\Shcbp1tm1d(EUCOMM)Wtsi/\Shcbp1tm1d(EUCOMM)Wtsi
(involves: C57BL/6N * FVB/N) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:212898
\Siglecgtm1Lnit/\Siglecgtm1Lnit
(involves: BALB/c) 		autoimmune response J:123353
\Sirt1tm1Mcby/\Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased anti-nuclear antigen antibody level J:160869
\Sirt1tm1Mcby/\Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ) 		increased autoantibody level J:241633
\Sit1tm1Lsmn/\Sit1tm1Lsmn
(B6.Cg-Sit1tm1Lsmn) 		increased susceptibility to experimental autoimmune encephalomyelitis J:100408
\Skap2Gt(VICTR20)21Lex/\Skap2Gt(VICTR20)21Lex
(B6.129S5-Skap2Gt(VICTR20)21Lex) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:101373
\Slamf9em1Isha/\Slamf9em1Isha
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:279164
\Slc1a5tm1Tac/\Slc1a5tm1Tac
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:254980
\Slc5a2tm1Lex/\Slc5a2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased susceptibility to autoimmune diabetes J:195941
\Sle1NZW/\Sle1NZW
\Sles1NZW/\Sles1NZW
(involves: C57BL/6 * NZW) 		decreased susceptibility to systemic lupus erythematosus J:100678
\Sle1NZW/\Sle1NZW
\Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZW) 		increased susceptibility to systemic lupus erythematosus J:134128
\Sle1aC57BL/6J/\Sle1aNZM2410/J
(involves: C57BL/6J * NZM2410/J) 		increased anti-chromatin antibody level J:67544
\Sle1aNZM2410/J/\Sle1aNZM2410/J
(involves: C57BL/6J * NZM2410/J) 		increased anti-chromatin antibody level J:67544
\Sle1bC57BL/6J/\Sle1bNZM2410/J
(involves: C57BL/6J * NZM2410/J) 		increased anti-chromatin antibody level J:67544
\Sle1bNZM2410/J/\Sle1bNZM2410/J
(involves: C57BL/6J * NZM2410/J) 		increased anti-chromatin antibody level J:67544
\Sle1cC57BL/6J/\Sle1cNZM2410/J
(involves: C57BL/6J * NZM2410/J) 		increased anti-chromatin antibody level J:67544
\Sle1cNZB/\Sle1cNZM2410/J
(involves: C57BL/6J * NZB * NZM2410/J) 		increased autoantibody level J:145133
\Sle1cNZM2410/J/\Sle1cNZM2410/J
(involves: C57BL/6J * NZM2410/J) 		increased anti-chromatin antibody level J:67544
\Sle6NZW/\Sle6NZW
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
\Sle9BXSB/J/\Sle9BXSB/J
(involves: BXSB/J * C57BL/10Ola) 		increased anti-nuclear antigen antibody level J:60445
\Sle16129S6/SvEvTac/\Sle16129S6/SvEvTac
(B6.129-Sle16129S6/SvEvTac) 		increased autoantibody level J:122132
increased susceptibility to systemic lupus erythematosus J:122132
\Sles1C57BL/6/\Sles1C57BL/6
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
\Sles1NZW/\Sles1NZW
(involves: C57BL/6 * NZW) 		decreased susceptibility to systemic lupus erythematosus J:57246
\Sles2C57BL/6/\Sles2C57BL/6
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
\Sles2C57BL/6/\Sles2NZW
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
\Sles2NZW/\Sles2NZW
(involves: C57BL/6 * NZW) 		decreased susceptibility to systemic lupus erythematosus J:57246
\Sles3C57BL/6/\Sles3C57BL/6
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
\Sles3C57BL/6/\Sles3NZW
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
\Sles3NZW/\Sles3NZW
(involves: C57BL/6 * NZW) 		decreased susceptibility to systemic lupus erythematosus J:57246
\Sles4C57BL/6/\Sles4C57BL/6
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
\Sles4C57BL/6/\Sles4NZW
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
\Sles4NZW/\Sles4NZW
(involves: C57BL/6 * NZW) 		decreased susceptibility to systemic lupus erythematosus J:57246
\Slfn8tm1Aki/\Slfn8tm1Aki
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:258797
\Smad7tm1.1Ink/\Smad7tm1.1Ink
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:184670
\Socs1tm1.1Ayr/\Socs1tm1.1Ayr
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:226678
\Socs1tm1Ayos/\Socs1tm1Ayos
\Tg(Lck-cre)1Jtak/0
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:132905
\Socs3tm1Robb/\Socs3tm1Robb
(involves: C57BL/6) 		increased susceptibility to induced arthritis J:145513
\Sod3tm1Mrkl/\Sod3tm1Mrkl
(D1.129P2-Sod3tm1Mrkl) 		increased susceptibility to induced arthritis J:106273
\Spink14tm1e(KOMP)Wtsi/\Spink14tm1e(KOMP)Wtsi
(C57BL/6N-Spink14tm1e(KOMP)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
\Spntm1Bam/\Spntm1Bam
(B6;129S4-Spntm1Bam/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:86932
\Spp1tm1Blh/\Spp1tm1Blh
(B6.129S6-Spp1tm1Blh) 		decreased susceptibility to experimental autoimmune uveoretinitis J:116272
\St14tm2Bug/\St14tm3Bug
\Tg(MMTV-cre)4Mam/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * FVB/NJ * N:Black Swiss) 		increased anti-nuclear antigen antibody level J:213072
increased autoantibody level J:213072
\Stat4tm1Gru/\Stat4tm1Gru
(NOD.129S2-Stat4tm1Gru) 		decreased susceptibility to autoimmune diabetes J:90600
\Stat4tm1Gru/\Stat4tm1Gru
\Tg(Ins2-GP)34-20Olds/0
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		abnormal susceptibility to autoimmune disorder J:107047
\Stat4tm1Gru/\Stat4tm1Gru
\Tg(Ins2-NP)25-3Olds/0
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:107047
\Stat4tm1Jni/\Stat4tm1Jni
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:96338
\Stat4tm1Jni/\Stat4tm1Jni
\Stat6tm1Jni/\Stat6tm1Jni
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6) 		increased susceptibility to autoimmune diabetes J:96338
\Stat6tm1Jni/\Stat6tm1Jni
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:96338
\Stim1tm1Kuro/\Stim1tm1Kuro
\Stim2tm1.1Kuro/\Stim2tm1.1Kuro
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:172608
\Stk17btm1Hed/\Stk17btm1Hed
(B6.129X1-Stk17btm1Hed) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:94685
\Swap70tm1Jess/\Swap70tm1Jess
(involves: 129T2/SvEms * 129X1/SvJ) 		increased autoantibody level J:71160
\Swrl2SWR/\Swrl2SWR
(involves: NZB * SWR) 		increased anti-single stranded DNA antibody level J:96060
\Swrl3NZB/\Swrl3SWR
(involves: NZB * SWR) 		increased anti-double stranded DNA antibody level J:96060
increased anti-histone antibody level J:96060
increased anti-nuclear antigen antibody level J:73097
\Swrl3SWR/\Swrl3SWR
(involves: NZB * SWR) 		increased anti-double stranded DNA antibody level J:96060
increased anti-histone antibody level J:96060
increased anti-nuclear antigen antibody level J:73097
\Syktm2.1(ZAP70)Fkfr/\Syktm2.1(ZAP70)Fkfr
(B6.129-Syktm2.1(ZAP70)Fkfr) 		increased anti-insulin autoantibody level J:188422
\Syt7tm1Nan/\Syt7tm1Nan
(involves: 129S1/Sv * C57BL/6) 		increased anti-nuclear antigen antibody level J:85201
increased susceptibility to autoimmune disorder J:85201
\Syvn1tm1Tn/\Syvn1+
(D1.Cg-Syvn1tm1Tn) 		decreased susceptibility to induced arthritis J:86009
\Tanktm1Aki/\Tanktm1Aki
(involves: 129/Sv * C57BL/6) 		increased anti-double stranded DNA antibody level J:151757
increased anti-nuclear antigen antibody level J:151757
\Tap1tm1Arp/\Tap1tm1Arp
X/\Yaa
(BXSB.129S2(B6)-Tap1tm1Arp/Dcr) 		increased susceptibility to systemic lupus erythematosus J:179430
\Tarm1tm1Yiw/\Tarm1tm1Yiw
(involves: C57BL/6 * C57BL/6NSlc) 		decreased susceptibility to induced arthritis J:301164
\Taslem1Bcgen/\Taslem1Bcgen
(BALB/cJ-Taslem1Bcgen) 		decreased susceptibility to systemic lupus erythematosus J:363059
\Tbc1d10ctm1.1Psou/\Tbc1d10ctm1.2Psou
\Cd79atm1(cre)Reth/\Cd79a+
(involves: 129S2/SvPas * BALB/c * C57BL/6J) 		increased anti-double stranded DNA antibody level J:211913
increased susceptibility to systemic lupus erythematosus J:211913
\Tbc1d10ctm1.2Psou/\Tbc1d10ctm1.2Psou
(involves: 129S2/SvPas * C57BL/6J) 		increased anti-double stranded DNA antibody level J:211913
increased susceptibility to systemic lupus erythematosus J:211913
\Tbk1tm1Arte/\Tbk1tm1Arte
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129/SvEv * 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:188560
increased anti-nuclear antigen antibody level J:188560
\Tbx21tm1Glm/\Tbx21tm1Glm
(C.129S6-Tbx21tm1Glm/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:111932
\Tcra-Jtm1Tgi/\Tcra-Jtm1Tgi
(B6.129-Tcra-Jtm1Tgi) 		decreased susceptibility to induced arthritis J:99107
\Tcratm1Mjo/\Tcra+
(NOD.129P2-Tcratm1Mjo) 		decreased susceptibility to autoimmune diabetes J:108590
\Tcratm1Mjo/\Tcratm1Mjo
(involves: 129P2/OlaHsd * BALB/c) 		increased anti-double stranded DNA antibody level J:111129
increased anti-nuclear antigen antibody level J:111129
increased autoantibody level J:111129
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
(B6.129P2-Tcrbtm1Mom Tcrdtm1Mom/J) 		decreased autoantibody level J:187766
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
\Igh-Jtm2(3H9-VDJ*)Mwg/\Igh-J+
(B6.129P2-Tcrbtm1Mom Igh-Jtm2(3H9-VDJ*)Mwg Tcrdtm1Mom) 		increased anti-double stranded DNA antibody level J:142389
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
\Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
(B6.129-Tcrbtm1Mom Traf3ip2tm1.1Lix Tcrdtm1Mom) 		increased anti-chromatin antibody level J:187766
increased anti-double stranded DNA antibody level J:187766
increased anti-histone antibody level J:187766
increased autoantibody level J:187766
\Tet1tm1.2Jae/\Tet1tm1.2Jae
\Tet2tm1.1Iaai/\Tet2tm1.1Iaai
\Tet3tm1.1Yzhg/\Tet3tm1.1Yzhg
\Tg(Rorc-cre)1Litt/0
(involves: 129 * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB) 		increased susceptibility to autoimmune disorder J:333574
\Tg(ACTB-TNFRSF6B)754Jwu/?
(B6.Cg-Tg(Actb-TNFRSF6B)754Jwu) 		increased anti-double stranded DNA antibody level J:148162
increased autoantibody level J:148162
\Tg(BCL2)22Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi) 		increased susceptibility to autoimmune disorder J:93111
\Tg(BCL2)36Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi) 		increased susceptibility to autoimmune disorder J:93111
\Tg(CAG-C1qtnf6)#Yiw/0
(involves: C57BL/6JJcl) 		decreased susceptibility to induced arthritis J:227217
\Tg(CAG-p35)1Miur/0
(involves: C57BL/6) 		autoimmune response J:126593
\Tg(CAG-p35)1Miur/0
\Tg(Mbp-cre)29Miur/0
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:126593
\Tg(CAG-SYVN1)1Tn/?
(D1.Cg-Tg(CAG-SYVN1)1Tn) 		rheumatoid arthritis J:86009
\Tg(CD2-Lrch1)#Liux/0
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:238772
\Tg(CD2-Rorc)#Staka/0
(involves: C57BL/6) 		increased anti-nuclear antigen antibody level J:230700
increased autoantibody level J:230700
increased susceptibility to autoimmune disorder J:230700
\Tg(Cd2-Smad7)#Chbe/0
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:184670
\Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6) 		increased anti-nuclear antigen antibody level J:217939
increased autoantibody level J:217939
increased susceptibility to autoimmune disorder J:217939
\Tg(Cd4-CD4)2362Litt/0
\Tg(HLA-DR2)#Lfug/0
\Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2 * SJL) 		increased susceptibility to experimental autoimmune encephalomyelitis J:134764
\Tg(Cd4-DsRed)4Lt/0
(NOD/ShiLt-Tg(Cd4-DsRed)4Lt) 		decreased susceptibility to autoimmune diabetes J:127785
\Tg(CD4-Il17re)#Cdon/0
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:177650
\Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6 * C57BL/10 * C57BR/cd) 		increased anti-nuclear antigen antibody level J:97554
\Tg(Cd152Ig)1Jbs/0
(involves: C3H * NOD) 		increased susceptibility to autoimmune diabetes J:35353
\Tg(CKMM-tTA)A3Rhvh/0
\Tg(tetO-H2-K1)#Papl/0
(B6.Cg-Tg(CKMM-tTA)A3Rhvh Tg(tetO-H2-K1)#Papl) 		increased anti-nuclear antigen antibody level J:205907
increased autoantibody level J:205907
\Tg(Col2a1-Mir140)#Asah/0
(C57BL/6-Tg(Col2a1-Mir140)#Asah) 		decreased susceptibility to induced arthritis J:160358
\Tg(Emu-TXLNA)1Amjr/0
(B6.Cg-Tg(Emu-TXLNA)1Amjr) 		increased autoantibody level J:117018
increased susceptibility to autoimmune disorder J:117018, J:145185
\Tg(FCGR2A)11Mkz/\Tg(FCGR2A)11Mkz
(involves: C57BL/6 * SJL) 		increased anti-histone antibody level J:136516
increased susceptibility to induced arthritis J:136516
\Tg(H2-Ea-G6pc2)69Tkay/?
(NOD-Tg(H2-Ea-G6pc2)69Tkay) 		increased anti-insulin autoantibody level J:117352
increased susceptibility to autoimmune diabetes J:117352
\Tg(H2-Ea-Ins2)1Wehi/\Tg(H2-Ea-Ins2)1Wehi
(NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi) 		decreased anti-insulin autoantibody level J:117352
\Tg(H2-Ead)5Lt/0
(NOD/ShiLt-Tg(H2-Ead)5Lt) 		autoimmune response J:36435
decreased susceptibility to autoimmune diabetes J:36435
\Tg(H2-Ead)12Lt/0
(NOD/ShiLt-Tg(H2-Ead)12Lt) 		autoimmune response J:36435
decreased susceptibility to autoimmune diabetes J:36435
\Tg(H2-K-MC159/EGFP)13Fkmc/\Tg(H2-K-MC159/EGFP)13Fkmc
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:138050
\Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0
(SJL.FVB-Tg(H2-Kb-Tcra,-Tcrb)1640Kurs) 		increased autoantibody level J:149511
increased susceptibility to experimental autoimmune encephalomyelitis J:149511
\Tg(HLA-A/H2-D/B2M)1Dvs/0
(NOD/ShiLtDvs-Tg(HLA-A/H2-D/B2M)1Dvs) 		increased susceptibility to autoimmune diabetes J:121685
\Tg(HLA-B27)30-4Trg/?
(involves: C57BL/6J * NOD) 		decreased susceptibility to autoimmune diabetes J:109851
\Tg(HLA-DQA1,HLA-DQB1)1Dv/0
\Tg(Ins2-CD80)3B7Flv/0
(B6.Cg-Tg(HLA-DQA1,HLA-DQB1)1Dv Tg(Ins2-CD80)3B7Flv) 		decreased susceptibility to autoimmune diabetes J:59245
\Tg(HLA-DR2)#Lfug/0
\Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2) 		increased susceptibility to experimental autoimmune encephalomyelitis J:134764
\Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz/\Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz
(involves: C57BL/6 * C57BL/10Sn * SJL/J) 		increased autoantibody level J:108635
increased susceptibility to induced arthritis J:108635
\Tg(Igh3H9)41Mwg/?
(involves: C57BL/6 * SJL) 		increased anti-single stranded DNA antibody level J:119625
\Tg(Igh-6-Cd80)1Gjf/0
(NOD.FVB-Tg(Igh-6-Cd80)1Gjf/JbsJ) 		decreased susceptibility to autoimmune diabetes J:131077
\Tg(Igh-6/Igh-V125)2Jwt/0
\Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.B6-Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt) 		increased susceptibility to autoimmune diabetes J:91865
\Tg(Igh-6/Igh-V281)3Jwt/0
(NOD.B6-Tg(Igh-6/Igh-V281)3Jwt) 		decreased susceptibility to autoimmune diabetes J:91865
\Tg(Igh-V-CD40lg)#Tsub/0
(C57BL/6-Tg(Igh-V-CD40lg)#Tsub) 		increased anti-double stranded DNA antibody level J:128824
increased anti-histone antibody level J:128824
increased anti-single stranded DNA antibody level J:128824
\Tg(Igh-V-CD40lg)#Tsub/0
(involves: C57BL/6) 		increased autoantibody level J:89855
\Tg(IghelMD4)4Ccg/\Tg(IghelMD4)4Ccg
(NOD.B6-Tg(IghelMD4)4Ccg/DvsJ) 		increased susceptibility to autoimmune diabetes J:80859
\Tg(IghH280)48Dvs/?
(NOD/ShiLtDvs-Tg(IghH280)48Dvs/J) 		increased susceptibility to autoimmune diabetes J:274578
\Tg(IghH280)48Dvs/?
\Tg(IgkH280)934Dvs/?
(NOD/ShiLtDvs-Tg(IghH280)48Dvs Tg(IgkH280)934Dvs/Dvs) 		increased susceptibility to autoimmune diabetes J:274578
\Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0
(NOD.FVB-Tg(Ighm-Ctla4Ig/Cd80)1Jbs) 		decreased susceptibility to autoimmune diabetes J:113109
\Tg(IgkH280)934Dvs/?
(NOD/ShiLtDvs-Tg(IgkH280)934Dvs/J) 		increased susceptibility to autoimmune diabetes J:274578
\Tg(Ins1-Cat,Tyr)25Pne/0
(NOD.FVB-Tg(Ins1-Cat,Tyr)25Pne) 		increased susceptibility to autoimmune diabetes J:108415
\Tg(Ins1-EGFP/GH1)14Hara/0
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara) 		increased susceptibility to autoimmune diabetes J:127015
\Tg(Ins1-EGFP/GH1)14Hara/\Tg(Ins1-EGFP/GH1)14Hara
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara) 		decreased susceptibility to autoimmune disorder J:127015
\Tg(Ins2*Y16A)1Ell/0
(NOD-Tg(Ins2*Y16A)1Ell) 		increased susceptibility to autoimmune diabetes J:98583
\Tg(Ins2*Y16A)3Ell/0
(NOD-Tg(Ins2*Y16A)3Ell) 		increased susceptibility to autoimmune diabetes J:98583
\Tg(Ins2-CD80)3B7Flv/?
(involves: C57BL/6 * CBA/Ca * NOD/Caj) 		increased susceptibility to autoimmune diabetes J:26618
\Tg(Ins2-CD80)3B7Flv/0
\Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL) 		increased susceptibility to autoimmune diabetes J:93555
\Tg(Ins2-CD80)3B7Flv/0
\Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA/Ca) 		increased susceptibility to autoimmune diabetes J:93555
\Tg(Ins2-CD86)12B70Flv/0
(involves: C57BL/6 * CBA/Ca) 		decreased susceptibility to autoimmune diabetes J:93555
\Tg(Ins2-CD86)12B70Flv/0
\Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL) 		increased susceptibility to autoimmune diabetes J:93555
\Tg(Ins2-CD86)12B70Flv/0
\Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA/Ca) 		increased susceptibility to autoimmune diabetes J:93555
\Tg(Ins2-Cd274)2Mdos/?
(NOD/ShiLt-Tg(Ins2-Cd274)2Mdos) 		increased susceptibility to autoimmune diabetes J:118934
\Tg(Ins2-cre)5Lt/0
(NOD/ShiLt-Tg(Ins2-cre)5Lt) 		increased susceptibility to autoimmune diabetes J:127015
\Tg(Ins2-cre)5Lt/\Tg(Ins2-cre)5Lt
(NOD/ShiLt-Tg(Ins2-cre)5Lt) 		decreased susceptibility to autoimmune disorder J:127015
\Tg(Ins2-crmA)27Ngkh/?
(NOD-Tg(Ins2-CrmA)27Ngkh) 		increased susceptibility to autoimmune diabetes J:132052
\Tg(Ins2-E3)1Dvs/?
(NOD.Cg-Tg(Ins2-E3)1Dvs) 		decreased susceptibility to autoimmune diabetes J:68996
\Tg(Ins2-E3*309)5Dvs/?
(NOD/ShiLtDvs-Tg(Ins2-E3*309)5Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:83195
\Tg(Ins2-E3*704)2Dvs/?
(NOD/ShiLtDvs-Tg(Ins2-E3*704)2Dvs) 		decreased susceptibility to autoimmune diabetes J:83195
\Tg(Ins2-E3*734)3Dvs/0
(NOD/ShiLtDvs-Tg(Ins2-E3*734)3Dvs/DvsJ) 		decreased susceptibility to autoimmune diabetes J:106340
\Tg(Ins2-E3*734)4Dvs/?
(NOD/ShiLtDvs-Tg(Ins2-E3*734)4Dvs/DvsJ) 		decreased susceptibility to autoimmune diabetes J:106340
\Tg(Ins2-Fas*I246N)1Ach/0
(NOD-Tg(Ins2-Fas*I246N)1Ach) 		decreased susceptibility to autoimmune diabetes J:81416
\Tg(Ins2-Fas*I246N)1Ach/0
\Tg(Ins2-Fasl)24Ach/0
(NOD-Tg(Ins2-Fas*I246N)1Ach Tg(Ins2-Fasl)24Ach) 		decreased susceptibility to autoimmune diabetes J:81416
\Tg(Ins2-Fasl)24Ach/0
(NOD-Tg(Ins2-Fasl)24Ach/J) 		increased susceptibility to autoimmune diabetes J:78679, J:81416
\Tg(Ins2-GAD2)2Lt/0
(NOD/ShiLt-Tg(Ins2-GAD2)2Lt) 		decreased susceptibility to autoimmune diabetes J:100251
\Tg(Ins2-GP)34-20Olds/0
(involves: BALB/c * C57BL/6) 		increased susceptibility to autoimmune diabetes J:81287
\Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * SJL) 		decreased susceptibility to autoimmune diabetes J:93555
\Tg(Ins2-Iapp)6Soel/\Tg(Ins2-Iapp)6Soel
(involves: FVB/N) 		decreased susceptibility to autoimmune diabetes J:130022
\Tg(Ins2-IAPP)RHFSoel/\Tg(Ins2-IAPP)RHFSoel
(involves: FVB/N) 		increased susceptibility to autoimmune diabetes J:130022
\Tg(Ins2-NP)25-3Olds/0
(involves: BALB/c * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:81287
increased susceptibility to autoimmune diabetes J:81287
\Tg(Ins2-OVA)59Wehi/?
(involves: BALB/c * C57BL/6) 		increased susceptibility to autoimmune diabetes J:99560
\Tg(Ins2-OVA)307Wehi/?
(involves: BALB/c * C57BL/6) 		increased susceptibility to autoimmune diabetes J:99560
\Tg(Ins2-OVA)307Wehi/0
\Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * C57BL/6JWehi) 		autoimmune response J:99451
\Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: C57BL/6) 		increased susceptibility to autoimmune diabetes J:122114
\Tg(INS-Il10)#Sar/0
\Tnfrsf1atm1Mak/\Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6J * NOD) 		increased susceptibility to autoimmune diabetes J:64051
\Tg(INS-Il10)#Sar/0
\Tnfrsf1btm1Mwm/\Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6J * NOD) 		increased susceptibility to autoimmune diabetes J:64051
\Tg(KRT5-rtTA)1Glk/0
\Tg(tetO/CMV-Tslp)#Sfz/0
(C.Cg-Tg(KRT5-rtTA)1Glk Tg(tetO/CMV-Tslp)#Sfz) 		increased autoantibody level J:182756
increased susceptibility to autoimmune hemolytic anemia J:182756
\Tg(Lck-Socs3)1Kubo/0
(Not Specified) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:132905
\Tg(Lck-Stk17b)26.1Wals/?
(B6.Cg-Tg(Lck-Stk17b)26.1Wals) 		increased anti-nuclear antigen antibody level J:149973
increased susceptibility to experimental autoimmune encephalomyelitis J:149973
\Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf) 		increased anti-double stranded DNA antibody level J:129951
increased anti-nuclear antigen antibody level J:128976
increased autoantibody level J:129951
\Tg(Lck-Tslp)1Chea/0
(B6.Cg-Tg(Lck-Tslp)1Chea) 		increased anti-nuclear antigen antibody level J:72982
\Tg(Lck/Emu-Rftn1)1Ayos/?
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:150299
\Tg(Mir125a)#Smoc/0
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:224880
\Tg(Plp1-Eif2ak3*)18Pop/0
(C57BL/6J-Tg(Plp1-Eif2ak3*)18Pop) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:238042
\Tg(Psp-Rbbp4)1Yoha/0
(involves: C57BL/6) 		increased autoantibody level J:141378
increased susceptibility to autoimmune disorder J:141378
\Tg(SV40-Igh-64C8)H3Hon/0
\Tg(SV40-Igk4C8)L1Hon/0
(involves: C57BL/6) 		increased anti-erythrocyte antigen antibody level J:139864
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6) 		increased susceptibility to autoimmune disorder J:83278
increased susceptibility to experimental autoimmune encephalomyelitis J:83278
\Tg(Tcra,Tcrb)24Efro/0
(D1.Cg-Tg(Tcra,Tcrb)24Efro) 		autoimmune response J:104243
increased autoantibody level J:104243
increased susceptibility to autoimmune disorder J:104243
\Tg(TcraAI4)1Dvs/0
(NOD-Tg(TcraAI4)1Dvs) 		increased susceptibility to autoimmune diabetes J:93553
\Tg(TcraAI4)1Dvs/0
\Tg(TcrbAI4)1Dvs/0
(NOD-Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs) 		increased susceptibility to autoimmune diabetes J:94192
\Tg(TcraAV19AJ33)1Shima/?
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:112657
\Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Tg(TcraBDC2.5,TcrbBDC2.5)1Doi) 		decreased susceptibility to autoimmune diabetes J:87251
\Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL) 		rheumatoid arthritis J:36815
\Tg(TcraTcrbNY4.1)1Pesa/0
(NOD.Cg-Tg(TcraTcrbNY4.1)1Pesa) 		increased susceptibility to autoimmune diabetes J:108768
\Tg(TcrbBL17)1Lmor/0
(involves: DBA/1J * SWR/J) 		increased susceptibility to induced arthritis J:134111
\Tg(TcrbBL17)1Lmor/\Tg(TcrbBL17)1Lmor
(involves: DBA/1J * SWR/J) 		increased susceptibility to induced arthritis J:134111
\Tg(TcrLCMV)327Sdz/\Tg(TcrLCMV)327Sdz
(NOD.Cg-Tg(TcrLCMV)327Sdz/Dvs) 		autoimmune response J:71050
\Tg(tetO-MAP2K1)#Ahsa/?
\Tg(CD2-rtTA)CRza/?
(involves: C57BL/6 * C57BL/10 * CBA * SJL) 		increased anti-double stranded DNA antibody level J:174339
\Tg(Tlr7)1Boll/0
(involves: C57BL/6) 		autoimmune response J:127600
increased anti-nuclear antigen antibody level J:127600
X/\Tg(Tlr7)6Boll
(involves: C57BL/6) 		autoimmune response J:127600
increased anti-nuclear antigen antibody level J:127600
\Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J) 		increased anti-double stranded DNA antibody level J:58798
increased anti-single stranded DNA antibody level J:58798
increased autoantibody level J:58798
\Tg(Tnfsf13b)1Fma/0
(B6.Cg-Tg(Tnfsf13b)1Fma) 		increased autoantibody level J:114782
\Tg(Tnfsf13b)1Fma/?
(B6.Cg-Tg(Tnfsf13b)1Fma) 		increased anti-double stranded DNA antibody level J:113556
\Tgfb1tm3.1Flv/\Tgfb1tm3.1Flv
\Tg(Cd4-cre)1Cwi/0
\Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD * SJL) 		increased susceptibility to autoimmune diabetes J:196160
\Tgfbr2tm1.2Hlm/\Tgfbr2tm1.2Hlm
\Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		autoimmune response J:148747
\Tgfbr2tm1.2Hlm/\Tgfbr2tm1.2Hlm
\Tg(Cd4-cre)1Cwi/0
\Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD * SJL) 		increased susceptibility to autoimmune diabetes J:196160
\Tgfbr2tm1.2Hlm/\Tgfbr2tm1.2Hlm
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
\Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * NOD * SJL) 		increased susceptibility to autoimmune diabetes J:196160
\TgTn(pb-CAG-Gm614)#Cya/0
(involves: C57BL/6) 		increased susceptibility to systemic lupus erythematosus J:307345
\Thbs1tm1Hyn/\Thbs1tm1Hyn
(involves: 129S2/SvPas * C57BL/6) 		increased anti-single stranded DNA antibody level J:153126
\Thop1Gt(CSG163)Byg/\Thop1Gt(CSG163)Byg
(B6.129P2-Thop1Gt(CSG163)Byg) 		increased susceptibility to experimental autoimmune encephalomyelitis J:290567
\Tigittm1Sdl/\Tigittm1Sdl
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:168902
\Tigittm1Sdl/\Tigittm1Sdl
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:168902
\Timd4tm1Kuch/\Timd4tm1Kuch
(C57BL/6-Timd4tm1Kuch) 		increased anti-double stranded DNA antibody level J:160747
\Timd4tm1Kuch/\Timd4tm1Kuch
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
\Tlr4Lps-d/\Tlr4Lps-d
(involves: C3H/HeJ) 		increased susceptibility to induced arthritis J:96356
\Tlr4tm1Aki/\Tlr4tm1Aki
(C.129P2-Tlr4tm1Aki) 		decreased susceptibility to induced arthritis J:178054
\Tlr5tm1Flv/\Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6) 		increased susceptibility to autoimmune diabetes J:158055
\Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu) 		increased anti-double stranded DNA antibody level J:324448
increased anti-nuclear antigen antibody level J:324448
increased anti-single stranded DNA antibody level J:324448
increased autoantibody level J:324448
increased susceptibility to systemic lupus erythematosus J:324448
\Tlr7em2Anu/\Tlr7+
(C57BL/6NCrl-Tlr7em2Anu) 		increased anti-double stranded DNA antibody level J:324448
increased anti-nuclear antigen antibody level J:324448
increased anti-single stranded DNA antibody level J:324448
increased autoantibody level J:324448
\Tlr7em2Anu/\Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu) 		increased anti-nuclear antigen antibody level J:324448
increased anti-single stranded DNA antibody level J:324448
increased susceptibility to systemic lupus erythematosus J:324448
\Tlr7tm1Flv/\Tlr7tm1Flv
(B6.129S1-Tlr7tm1Flv) 		decreased anti-insulin autoantibody level J:165267
\Tlr8/Tlr7tm1Vlcg/\Tlr8/Tlr7tm1Vlcg
(B6.Cg-Tlr8/Tlr7tm1Vlcg) 		decreased anti-insulin autoantibody level J:165267
\Tlr8/Tlr7tm1Vlcg/\Tlr7+
\Tlr8/Tlr7tm1Vlcg/\Tlr8tm1Vlcg
(B6.Cg-Tlr8/Tlr7tm1Vlcg Tlr8tm1Vlcg) 		decreased anti-insulin autoantibody level J:165267
\Tlr8/Tlr7tm1Vlcg/\Tlr8/Tlr7tm1Vlcg
(B6.Cg-Tlr8/Tlr7tm1Vlcg Tlr8tm1Vlcg) 		decreased anti-insulin autoantibody level J:165267
\Tlr8tm1Vlcg/\Tlr8tm1Vlcg
(B6.129S1-Tlr8tm1Vlcg) 		increased anti-double stranded DNA antibody level J:165267
increased anti-nuclear antigen antibody level J:165267
\Tlr9tm1Aki/\Tlr9tm1Aki
(B6.129P2-Tlr9tm1Aki) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:105435
\Tmem178tm1Lex/\Tmem178tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to induced arthritis J:228311
\TnfBpsm1/\Tnf+
(involves: C57BL/6) 		rheumatoid arthritis J:226052
\TnfBpsm1/\TnfBpsm1
(involves: C57BL/6) 		rheumatoid arthritis J:226052
\Tnftm1.1Sned/\Tnftm1.1Sned
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129 * 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to autoimmune disorder J:95684
\Tnftm1.1Sned/\Tnftm1.1Sned
\Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2) 		decreased susceptibility to autoimmune disorder J:95684
\Tnftm1Gkl/\Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:114740
\Tnftm1Gkl/\Tnftm1Gkl
(involves: 129S/SvEv) 		decreased susceptibility to autoimmune disorder J:95684
\Tnftm1Gkl/\Tnftm2Gkl
(involves: 129S/SvEv * C57BL/6) 		rheumatoid arthritis J:54056
\Tnftm1Jods/\Tnftm1Jods
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:44545, J:98591
\Tnftm1Jods/\Tnftm1Jods
(C57BL/6-Tnftm1Jods) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:118417
\Tnftm1Jods/\Tnftm1Jods
(C57BL/6-Ltatm1Jods) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:47428
\Tnftm1Ljo/\Tnftm1Ljo
(involves: 129S1/Sv) 		decreased susceptibility to autoimmune disorder J:95684
\Tnftm2Gkl/\Tnf+
(involves: 129S/SvEv * C57BL/6) 		rheumatoid arthritis J:54056
\Tnftm2Gkl/\Tnf+
\Tnfrsf1btm1Mwm/\Tnfrsf1btm1Mwm
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		rheumatoid arthritis J:54056
\Tnftm2Gkl/\Tnftm2Gkl
(involves: 129S/SvEv * C57BL/6) 		rheumatoid arthritis J:54056
\Tnftm2Jods/\Tnftm2Jods
(C57BL/6-Tnftm2Jods) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:98591
\Tnftm3Gkl/\Tnftm3Gkl
(involves: 129S/SvEv * C57BL/6) 		autoimmune response J:114740
decreased susceptibility to experimental autoimmune encephalomyelitis J:114740
\Tnfaip3tm2Ama/\Tnfaip3tm2Ama
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6) 		increased autoantibody level J:163917
increased susceptibility to autoimmune disorder J:163917
\Tnfrsf1atm1.1Gkl/\Tnfrsf1atm1.1Gkl
(involves: 129/Sv * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:92470
\Tnfrsf1atm1Blt/\Tnfrsf1atm1Blt
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:115225
\Tnfrsf1atm1Blt/\Tnfrsf1atm1Blt
\Tnfrsf1btm1Mwm/\Tnfrsf1btm1Mwm
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:115225
\Tnfrsf1atm1Imx/\Tnfrsf1atm1Imx
\Tnfrsf1btm1Imx/\Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to experimental autoimmune uveoretinitis J:115094
decreased susceptibility to induced arthritis J:120707
\Tnfrsf1atm1Mak/\Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6J * NOD) 		decreased susceptibility to autoimmune diabetes J:64051
\Tnfrsf1atm1Mak/\Tnfrsf1atm1Mak
\Tnip1Gt(E059E05)Wrst/\Tnip1Gt(E059E05)Wrst
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased susceptibility to systemic lupus erythematosus J:180054
\Tnfrsf1btm1Mwm/\Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6J * NOD) 		decreased susceptibility to autoimmune diabetes J:64051
\Tnfrsf1btm1Mwm/\Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:115225
\Tnfrsf13btm1Vmd/\Tnfrsf13btm1Vmd
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:82331
increased anti-nuclear antigen antibody level J:82331
\Tnfsf4tm1Shr/\Tnfsf4tm1Shr
(NOD.129S4-Tnfsf4tm1Shr) 		decreased susceptibility to autoimmune diabetes J:86926
\Tnfsf10tm1Mjs/\Tnfsf10tm1Mjs
(B6.129-Tnfsf10tm1Mjs) 		increased susceptibility to autoimmune diabetes J:82145
increased susceptibility to experimental autoimmune encephalomyelitis J:101672
increased susceptibility to induced arthritis J:82145
\Tnfsf13tm1Pod/\Tnfsf13tm1Pod
(B6.Cg-Tnfsf13tm1Pod) 		decreased susceptibility to induced arthritis J:141374
\Tnfsf15tm1Cdon/\Tnfsf15tm1Cdon
(B6.129-Tnfsf15tm1Cdon) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:136280
\Tnfsf15tm1Hluo/\Tnfsf15tm1Hluo
(D1LacJ.129(B6)-Tnfsf15tm1Hluo) 		decreased susceptibility to induced arthritis J:207029
\Tnip1Gt(E059E05)Wrst/\Tnip1Gt(E059E05)Wrst
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:180054
increased anti-nuclear antigen antibody level J:180054
increased susceptibility to systemic lupus erythematosus J:180054
\Tnip1m1Btlr/\Tnip1m1Btlr
(C57BL/6J-Tnip1m1Btlr) 		increased anti-double stranded DNA antibody level J:265175
\Tnip1tm1.1Pcoh/\Tnip1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:176826
\Tnip1tm1.1Pcoh/\Tnip1tm1.1Pcoh
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:176826
increased anti-nuclear antigen antibody level J:176826
\Tpp2tm1.1Gnie/\Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac) 		increased anti-nuclear antigen antibody level J:221205
increased autoantibody level J:221205
\Tpsab1m1/\Tpsab1m1
\Tpsb2tm1(cre)Adch/\Tpsb2tm1(cre)Adch
(B6.Cg-Tpsb2tm1(cre)Adch Tpsab1m1) 		decreased susceptibility to induced arthritis J:142880
\Tpsb2tm1.1Mfg/\Tpsb2tm1.1Mfg
(B6.129-Tpsb2tm1.1Mfg) 		decreased susceptibility to induced arthritis J:142880
\Traf3tm1Bshp/\Traf3tm1Bshp
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL) 		autoimmune response J:124329
increased anti-double stranded DNA antibody level J:124329
\Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
(involves: 129/Sv * BALB/c) 		increased anti-double stranded DNA antibody level J:93923
increased anti-histone antibody level J:93923
increased anti-single stranded DNA antibody level J:93923
increased autoantibody level J:93923
\Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
(C.129-Traf3ip2tm1.1Lix) 		increased autoantibody level J:138560
\Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
(B6.129-Traf3ip2tm1.1Lix) 		increased anti-chromatin antibody level J:187766
increased anti-double stranded DNA antibody level J:187766
increased anti-histone antibody level J:187766
increased anti-nuclear antigen antibody level J:187766
increased autoantibody level J:187766
\Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
\Tnfsf13btm1Msc/\Tnfsf13btm1Msc
(involves: 129 * 129S2/SvPas * BALB/c) 		increased autoantibody level J:138560
\Traf3ip2tm1Sbn/\Traf3ip2tm1Sbn
(either: B6.129-Traf3ip2tm1Sbn or (involves: 129) or (involves: 129 * BALB/c)) 		decreased susceptibility to autoimmune disorder J:144320
\Trem1tm1(KOMP)Vlcg/\Trem1tm1(KOMP)Vlcg
(C57BL/6N-Trem1tm1(KOMP)Vlcg/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
\Trex1em3Gpt/\Trex1em3Gpt
(C57BL/6JGpt-Trex1em3Gpt) 		increased susceptibility to autoimmune disorder J:330879
\Trex1tm1.1Fwpe/\Trex1tm1.1Fwpe
(involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac) 		increased anti-double stranded DNA antibody level J:220965
increased susceptibility to systemic lupus erythematosus J:220965
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd) 		increased autoantibody level J:202757
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-nuclear antigen antibody level J:181257
increased susceptibility to systemic lupus erythematosus J:181257
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N) 		increased autoantibody level J:234263
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to autoimmune disorder J:243357
\Trim21tm1Mwah/\Trim21tm1Mwah
(C57BL/6-Trim21tm1Mwah) 		autoimmune response J:151775
increased autoantibody level J:151775
\Trim25tm1Mura/\Trim25+
\Usp15L749R/\Usp15+
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:259382
\Tsc22d3tm1.2Efmd/Y
(Not Specified) 		abnormal susceptibility to autoimmune disorder J:201728
\Tusc2tm1Avi/\Tusc2+
(involves: 129S1/Sv * C57BL/6J) 		increased anti-nuclear antigen antibody level J:119985
increased susceptibility to autoimmune disorder J:119985
\Tusc2tm1Avi/\Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J) 		increased anti-nuclear antigen antibody level J:119985
increased susceptibility to autoimmune disorder J:119985
\Tusc2tm1Avi/\Tusc2tm1Avi
(involves: 129S1/Sv) 		increased susceptibility to autoimmune disorder J:309768
\Tyk2E775K/\Tyk2E775K
(B10.D1-H2q/SgJ) 		decreased susceptibility to induced arthritis J:69051
\Tyrobptm1Lll/\Tyrobptm1Lll
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:64763
\Tyrobptm1Lll/\Tyrobptm1Lll
(involves: 129P2/OlaHsd) 		decreased susceptibility to induced arthritis J:158811
\Tyrobptm1Ttk/\Tyrobptm1Ttk
(B6.129P2-Tyrobptm1Ttk) 		increased anti-double stranded DNA antibody level J:177613
increased autoantibody level J:177613
\Ubash3btm1Jni/\Ubash3btm1Jni
\Ubash3atm1Jni/\Ubash3atm1Jni
(Not Specified) 		increased susceptibility to experimental autoimmune encephalomyelitis J:89761
\Unc93b1tm1.1Kmiy/\Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-nuclear antigen antibody level J:174308
increased autoantibody level J:174308
\Usp15L749R/\Usp15+
(involves: 129S1/SvImJ * C57BL/6J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:259382
\Usp15L749R/\Usp15L749R
(involves: 129S1/SvImJ * C57BL/6J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:259382
\Usp15L749R/\Usp15tm1Pgrs
(involves: 129S1/SvImJ * C57BL/6J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:259382
\Usp15tm1Pgrs/\Usp15tm1Pgrs
(Not Specified) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:259382
\Usp25Gt(RRS805)Byg/\Usp25Gt(RRS805)Byg
(involves: 129P2/OlaHsd) 		increased susceptibility to experimental autoimmune encephalomyelitis J:188557
\Vdrtm1Ska/\Vdrtm1Ska
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		decreased susceptibility to autoimmune diabetes J:112519
\Vdrtm1Ska/\Vdrtm1Ska
(NOD.Cg-Vdrtm1Ska/CmatJ) 		increased susceptibility to autoimmune diabetes J:127787
\Vsig4tm1Gne/\Vsig4tm1Gne
(C57BL/6-Vsig4tm1Gne) 		increased susceptibility to experimental autoimmune encephalomyelitis J:281762
\Vsirtm1Lex/\Vsirtm1Lex
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:222944
\Vtcn1tm1Xxz/\Vtcn1tm1Xxz
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		increased susceptibility to autoimmune diabetes J:177612
increased susceptibility to experimental autoimmune encephalomyelitis J:177612
\Vwftm1Wgr/\Vwftm1Wgr
(B6.129S2-Vwftm1Wgr) 		increased susceptibility to experimental autoimmune encephalomyelitis J:140334
\Wastm1Itl/Y
(Not Specified) 		increased anti-double stranded DNA antibody level J:153247
\Wastm1Itl/\Wastm1Itl
(Not Specified) 		increased anti-double stranded DNA antibody level J:153247
\Wastm1Sbs/Y
(involves: 129S6/SvEvTac) 		increased anti-double stranded DNA antibody level J:153247
\Wastm1Sbs/Y
(involves: 129S6/SvEvTac * C57BL/6) 		increased anti-chromatin antibody level J:182528
increased anti-double stranded DNA antibody level J:182528
increased anti-single stranded DNA antibody level J:182528
increased autoantibody level J:182528
\Wastm1Sbs/\Wastm1Sbs
(involves: 129S6/SvEvTac) 		increased anti-double stranded DNA antibody level J:153247
\Wastm1Sbs/\Wastm1Sbs
(involves: 129S6/SvEvTac * C57BL/6) 		increased anti-chromatin antibody level J:182528
increased anti-double stranded DNA antibody level J:182528
increased anti-single stranded DNA antibody level J:182528
increased autoantibody level J:182528
\Wastm2Itl/Y
(Not Specified) 		increased anti-double stranded DNA antibody level J:153247
\Wastm2Itl/\Wastm2Itl
(Not Specified) 		increased anti-double stranded DNA antibody level J:153247
\Wipf1tm1Geha/\Wipf1tm1Geha
(involves: 129S6/SvEvTac * C57BL/6) 		increased autoantibody level J:116168
\Xcl1tm1.1Dnax/\Xcl1tm1.1Dnax
(either: (involves: 129/Sv * BALB/c) or (involves: 129/Sv * C57BL/6)) 		autoimmune response J:176844
\Xkrxtm1b(EUCOMM)Wtsi/\Xkrxtm1b(EUCOMM)Wtsi
(C57BL/6N-Xkrxtm1b(EUCOMM)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
X/\Yaa
((NZB x BXSB)F1) 		increased anti-erythrocyte antigen antibody level J:6235
increased anti-nuclear antigen antibody level J:6235
increased autoantibody level J:6235
increased susceptibility to autoimmune disorder J:6235
X/\Yaa
((SJL/J x BXSB)F1) 		increased susceptibility to autoimmune disorder J:6235
X/\Yaa
((C57BL/6J x BXSB)F1) 		increased susceptibility to autoimmune disorder J:6235
X/\Yaa
(involves: BXSB * NZB) 		increased susceptibility to autoimmune disorder J:6235
X/\Yaa
(BXSB/MpJ) 		increased anti-erythrocyte antigen antibody level J:6235
increased anti-nuclear antigen antibody level J:179430
increased susceptibility to autoimmune disorder J:108760, J:6235
X/\Yaa
((NZW x SB)F1) 		increased susceptibility to autoimmune disorder J:7276
X/\Yaa
((NZW x BXSB)F1) 		increased susceptibility to autoimmune disorder J:7276
X/\Yaa
(BXSB/MpJScr) 		increased anti-nuclear antigen antibody level J:10973
increased susceptibility to autoimmune disorder J:10973
\YaailNZW/Ola/?
(involves: C57BL/6Ola * NZW/Ola) 		increased anti-double stranded DNA antibody level J:52110
\Zap70m1Saka/\Zap70m1Saka
(involves: BALB/c) 		increased autoantibody level J:86607
increased susceptibility to induced arthritis J:154166
rheumatoid arthritis J:86607
\Zap70m1Saka/\Zap70tm2.1Weis
(involves: 129S4/SvJae * BALB/c) 		decreased susceptibility to induced arthritis J:154166
\Zc3h12atm1Aki/\Zc3h12atm1Aki
(involves: 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:147868
increased anti-nuclear antigen antibody level J:147868
\Zc3h12atm1c(EUCOMM)Hmgu/\Zc3h12atm1c(EUCOMM)Hmgu
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA) 		increased anti-nuclear antigen antibody level J:304105
increased autoantibody level J:304105
\Zc3h12dtm1Tom/\Zc3h12dtm1Tom
(B6.Cg-Zc3h12dtm1Tom) 		increased susceptibility to experimental autoimmune encephalomyelitis J:209383
\Zfp36tm2.1Pjb/\Zfp36tm2.1Pjb
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:229078
decreased susceptibility to induced arthritis J:229078
\Zranb1tm1c(EUCOMM)Hmgu/\Zranb1tm1c(EUCOMM)Hmgu
\Tg(Itgax-cre)1-1Reiz/0
(involves: 129S4/SvJaeSor * C57BL/6N * CBA) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:235701
\Zranb1tm1d(EUCOMM)Hmgu/\Zranb1tm1d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:235701
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
03/25/2025
MGI 6.24 		The Jackson Laboratory